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SYNTHESIS OF ANTHRAQUINONE DERIVATIVES AND THEIR CONJUGATES 
WITH 2'-DEOXYNUCLEOSIDES AS NEW PROBES FOR ELECTRON TRANSFER 
STUDIES IN DNA  
by 
REHAM A. I. ABOU-ELKHAIR 
 
Under the Direction of Dr. Thomas L. Netzel 
 
ABSTRACT 
Anthraquinone (AQ) has been used in electron transfer studies in DNA.  The focus of this 
dissertation is the synthesis of conjugates between AQ derivatives and 2’-deoxyadenosine (dA), 
which can be used to induce adenine oxidation in DNA.  Different AQ derivatives were attached 
to dA via ethynyl or ethanyl linkers.  If incorporated into DNA, these short linkers should enable 
regiocontrol for electron transfer from adenine within the DNA duplex structure.  The challenge 
in working with anthraquinone-2’-deoxynucleosides conjugates is that they and their 
intermediates are insoluble in water and only sparingly soluble in most organic solvents.  A 
strategy used to overcome this problem was the use of either tert-butyldiphenylsilyl (TBDPS) or 
4,4’-dimethoxytrityl (DMTr) 5’-protected deoxynucleosides as starting materials.  A water-
soluble, ethynyl-linked AQ-dA conjugate with a 3’-benzyl hydrogen phosphate was synthesized 
  
using DMTr protection.  The DMTr group was not stable to the hydrogenation required to make 
the ethanyl-linked AQ-dA conjugate with 3’-benzyl hydrogen phosphate.  Hence the latter was 
synthesized starting with the TBDPS protecting group.  Both of these syntheses were based on 
the Pd coupling between ethynylanthraquinone and 8-bromodeoxyadenosine derivatives.  New 
conjugates between AQ and A, in which the AQ moieties have been modified with formyl, 
trifluoroacetyl and methyl ester groups as electron withdrawing substituents were also 
synthesized.  The synthesis of these AQ-dA conjugates was based on Pd coupling between 
bromoanthraquinone and 8-ethynyldeoxyadenosine derivatives.  This route avoided the use of 
ethynylanthraquinone derivatives that had extremely low solubility and photoinstability.  Other 
anthraquinones with electron withdrawing groups (which should provide enhanced driving force 
to enable respective AQ derivative to oxidize adenine) were synthesized as models.  Cyclic 
voltammetry showed that the conjugate with the two ester groups and ethynyl linker was the 
most easily reduced of the derivatives synthesized.  Conjugates between AQ and dU were also 
synthesized.  Those conjugates can potentially be used to oxidize guanine or adenine or they can 
be used as a deep trap for an electron in reduced DNA. 
 
INDEX WORDS:   Anthraquinone, Electron transfer, Adenine oxidation, 2’-Deoxyadenosine, 
2’-Deoxyuridine, Short linkers, tert-Butyldiphenylsilyl, 4,4’-
Dimethoxytrityl, 3’-Benzyl hydrogen phosphate, Ethynylanthraquinone, 8-
Ethynyldeoxyadenosine. 
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Chapter 1 
General Introduction 
1.1.  Biological Significance of Electron Transfer in Oxidized DNA   
Deoxyribonucleic acid (DNA) stores the genetic information of cells and controls the 
production of proteins and is thus responsible for the biochemistry of an organism.  Interaction of 
DNA with various oxidants could lead to its damage.1-3  Because guanine (G) is the most easily 
oxidized DNA base,4,5 8-oxoguanine (8oxoG) that results from the oxidation of guanine (G) is 
the most abundant DNA oxidative damage.6,7  Accumulation of 8oxoG in the DNA could 
contribute to aging, apoptosis and mutations that can lead to unregulated cell division and 
cancer.3,8-11  
Experiments have shown that charges can migrate over long distances along the DNA 
double helix.12-17  This process is facilitated by the π-stacked array of its aromatic heterocyclic 
base pairs that are only 3.4 Å apart.  This phenomenon has a role in DNA oxidative damage.  For 
example, a radical cation (hole) formed initially on other nucleobases may undergo migration 
through the bases until it is trapped on G, which has the lowest oxidation potential of four DNA 
bases.  GG or GGG sequences have even lower oxidation potentials than single Gs.18  This 
promotes the hole transfer to those G clusters by one electron migration from G clusters to the 
single G•+ (or hole migration from the single G to the G cluster).  This process is referred to as 
electron transfer (ET) or hole transfer.  The resulting G•+ in the G cluster is relatively long lived 
(millisecond to second timescale) in the absence of reducing agents,19 which further promotes 
formation of 8oxoG at G clusters. 
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1.2.  Mechanisms for Hole Migration in DNA 
Many studies have been conducted in order to investigate the mechanistic details of ET in 
DNA.14,15,18,20-27  Depending on the coupling strength between different base pairs and the 
energetics of the system one of the two following mechanisms will prevail.   
1. The Tunneling Mechanism:  also described as charge transfer, is a single step that is 
strongly distance dependent and favored in case of endergonic DNA bridge oxidation. 
This occurs when the energy of the DNA orbitals are higher than the donor and the 
acceptor, where the charge tunnels through the DNA bases that acts as a bridge 
without occupying it.  A typical case of this process is the hole transfer between G’s in 
duplex oligomers containing small stretches of A•T base pairs.  
2. The Hopping Mechanism:  also described as charge transport, is a multistep process 
that can occur over long distances (up to 200 Å).  In this case the process is weakly 
distance dependent and is favored in the case of exergonic bridge oxidation. This 
occurs when the donor and acceptor orbitals are close in energy from that of the 
bridge, and the charge transiently occupies the bridge orbitals.  In this case DNA 
bases themselves can act as the charge carriers.  
1.3.  General Background on Hole Transfer Studies in DNA 
The migration of both positive charges (hole) and negative charges (excess electron) in 
DNA has been studied.28  Many studies were focused on hole transfer because of its biological 
relevance in DNA oxidative damage.  In those studies DNA was modified with electron 
accepting moieties in different ways.  One class of those modifications involved incorporation of 
photosensitizers.17,29  In this case an electron is transferred directly from the DNA to the excited 
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photosensitizer, depending on the redox potential of both of the sensitizer and the interacting 
DNA base.  This creates a hole that can migrate to distant sites along the DNA.  The ease of 
oxidation of DNA bases is in the order of G > A > C > T.4,5  Even though in oxidized DNA both 
G or A can act as the charge carriers,30 many studies of this type were focused on monitoring the 
process of hole transfer by the detection of DNA damage at G residues rather than A residues.  
This is attributed to the higher reactivity of the G radical cation (G•+)31 in addition to its stability.  
When G•+ is formed in duplex DNA, it can be easily trapped by water to form 8-oxoG in the 
steps shown in Figure 1.1. 
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Figure 1.1.  Steps involved in the formation of 8oxoG. 
1.4.  Oxidation of Adenine and its Role in Hole Migration in DNA 
1.4.1.  Reactivity of Adenine Radical Cation 
Among the four DNA bases, A has the second lowest ionization potential after G, and 
experiments have shown that both G and A can be charge carriers as discussed above.  However, 
in contrast to G•+, trapping of A•+ by water is insignificant, because it occurs through a transition 
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state that is much higher in energy than that in case of G•+.32  Recent experiments have studied 
the oxidation of DNA duplexes containing only adenine and thymine (T).33 One of these 
duplexes contained a sequence of five consecutive As and was modified with an anthraquinone 
(AQ) covalently attached to the sugar at one end (AQ-End, Figure 1.2) and a 32P label at the 5’ 
end of the complementary strand (3’-AATTAATTAAAAATTAATTATAT*-5’).  It was 
expected that photolysis of this duplex would result in cleavage at the consecutive A sequence. 
However, cleavage was observed primarily at the four TT sequences, with cleavage decreasing 
with increasing distance between the AQ and the TT site.  Introduction of a GG sequence in a 
related duplex that contained four TTT separated by AA sequences stopped the cleavage at T and 
lead to reaction at GG even though this sequence was beyond the farthest TTT farthest from the 
AQ.  Replacing T with uridine (whose structure differs from T by only the absence of the methyl 
group) in a duplex with no Gs showed no cleavage.  The authors proposed that trapping of the 
radical cation of T happens much more readily than trapping of A•+.  Thus, even though A•+ 
should be more readily formed by oxidation, products from oxidation of T are observed.   
In another study on photocleavage of DNA duplexes comprised of all four DNA bases, 
AQ was linked to the backbone of one strand either at its 5’-end or in the middle.34  The AQ 
moiety was either adjacent to A or flanked between two As; the complementary strand contained 
GG sequences and Ts complementary to As.  Photocleavage resulted in products due to reaction 
at the GG sequences and new products that were obtained in a comparable yield, depending on 
the position of AQ in the duplex.  These new products were identified as due to interstrand cross-
links between AQ and T residues (mainly the 3’-T), which arise from the reaction between the 
semi-quinone radicals resulting from AQ reduction and the methyl radical in T•+.  This study and 
the one above clearly demonstrated that G•+  is much more reactive than A•+  and that it is the 
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reactivity of the radical cation of the DNA base that determines the cleavage site, but not its 
stability. 
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Figure 1.2.  Structural drawings of residues used to study hole transfer in DNA. 
1.4.2.  Hole Hopping Among Adenines 
Giese and co-workers have studied the mechanism for hole transfer from G•+ to a GGG 
sequence through a number of A•T base pairs in DNA modified with 4’-pivaloyl (4’PV, Figure 
1.2).30,35  When the A•T bridge was short (up to three A•T base pairs), then an increase in the 
length of the bridge caused a dramatic decrease in the hole transfer efficiency, ascribed to a 
tunneling process.  When G•+ and GGG were separated by four or more A•T base pairs the hole 
transfer rate became independent of bridge length.  This was explained as a situation where the 
rate of hole transfer from G•+ to A exceeded the rate of tunneling-mediated hole transfer to GGG.  
Nearest neighbor hole transfer among A’s was even faster than G•+ to A transfer.  These studies 
provided evidence that a hole can migrate in oxidized DNA by A-hopping. 
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1.4.3.  Importance of Adenine Oxidation in Creating Long Lived Charge Separated State 
and Improving the Yield of Hole Transfer 
Majima and co-workers have investigated the effect of A-hopping through consecutive 
adenine sequences using laser flash photolysis experiments.36  In their system both 
naphthaldiimide (NDI) as an electron acceptor and phenothiazine (PTZ) as a donor were 
conjugated to DNA (Figure 1.2).  Photoexcitation of NDI at 355-nm lead to the reduction of NDI 
and formation of a hole on DNA that migrated rapidly to PTZ.  The charge separation (CS) and 
charge recombination (CR) between NDI and PTZ were observed by monitoring the formation 
and decay of the transient absorption of NDI•–.  The yields of the CS via hole transfer through the 
consecutive A-hopping were slightly dependent on the number of A bases between the NDI and 
PTZ, while the CR rate was strongly dependent on the distance.  This suggested that CS occurred 
by hopping while CR occurred by tunneling.  Increasing the number of consecutive As slowed 
down CR but did not greatly affect CS. The charge-separated state persisted over 300 µs when 
NDI was separated from PTZ by eight A bases.  In this experiment, long stretches of As 
provided a spatial separation for the charges.  However, the yield of this transfer was low (~2%), 
due to the rapid initial CR between NDI•– and adjacent A•+.  The same study also found that the 
charge separation yields were dramatically decreased by interruption of the consecutive A 
sequence with a G, presumably because the hole was trapped on G preventing it from further 
migration along the DNA.  A similar decrease in charge separation yield was observed when the 
consecutive As were changed to AT repeats, interpreted as less efficient interstrand A-hopping 
compared to the intrastrand process.  This idea was also supported by looking at the effect of 
flanking sequences on the redox active drugs in the DNA CT reaction; charge transport was 
more efficient through (AA)n than (AT)n series of the same length.37   
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Majima and co-workers also studied the role of A oxidation by comparing the yields of 
hole transfer using four different imide derivatives as photosensitizers (Sens) in the presence and 
absence of a consecutive A stretch in DNA.38  The consumption of G in this DNA was quantified 
as a measure of the yield; the farther away the G•+ from the Sens•–, the longer the lifetime of the 
radical cation and the greater the chance of its reaction to give products.  The Sens used were 
anionic naphthaldiimide phosphate derivative (NDIP) that can oxidize A while unbound to DNA, 
two cationic Sens that bind to DNA and can oxidize A and one anionic Sens that does not bind to 
DNA and can oxidize only G.  Bound Sens oxidize DNA from their triplet excited state and 
unbound Sens react from their singlet excited state.  In the case of derivatives that could oxidize 
A from the singlet state, DNA damage yield increased as the length of the consecutive A stretch 
increased.  This was consistent with hole hopping between adjacent As, with final formation of 
the G•+.  With the derivative that oxidizes only G, the yield was moderate and there was no 
preference for a consecutive A stretch.  Interestingly, the most efficient hole transfer occurred 
from the anionic NDIP even though it was not bound to DNA.  It appears that using a photo-
oxidant that is capable of oxidizing A from the triplet state allows the formation of an initial 
triplet charge separated state (NDIP•–/A•+), which is relatively long lived because charge 
recombination is spin forbidden.39    
1.5.  Anthraquinone (AQ) as DNA Photo-oxidant via Adenine Oxidation 
To study hole transfer DNA in a high yield it may be essential to start the oxidation at A 
using a strategy that will produce a sufficiently long lived initial A•+ photoproduct.  One way to 
achieve this goal is to obtain this photoproduct in the triplet excited state.  Linking the photo-
oxidant to A will provide regiocontrol that is expected to diminish direct oxidation of other DNA 
bases by the photo-oxidant in the duplex under study.  The shorter and the more rigid the linker, 
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the better this regiocontrol should be.  AQ derivatives with the proper redox properties would 
provide an excellent tool to form a primary AQ•–/A•+ charge transfer product in the triplet state.  
The AQ moiety is a particularly good choice because when excited it intersystem crosses very 
rapidly (< 600 fs)39 to give the triplet state.  Hence, even when it is covalently attached to A, it is 
expected to react from the triplet state rather than the singlet state to form AQ•–/A•+ in the triplet 
state. Therefore, the research in this dissertation was focused on the synthesis of conjugates 
between AQ and 2’-deoxyadenosine (dA) with ethynyl and ethanyl linkers where AQ was 
attached to the C-8 of dA.  Linking AQ to the C-8 of dA would allow AQ to be pointing into the 
major groove if the conjugate is to be incorporated into DNA. 
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Chapter 2 
Synthesis of Two 8-[(Anthraquinone-2-yl)-linked]-2’-Deoxyadenosine 3’-Benzyl Hydrogen 
Phosphates for Studies of Photoinduced Hole Transport in DNA 
This chapter is a reprint of a paper published in Nucleosides, Nucleotides & Nucleic Acids © 
2005 Taylor & Francis, Inc.  I did all of the experimental work, as well as most of the writing. 
(Reference:  R. A. I. Abou-Elkhair and T. L. Netzel, Nucleosides, Nucleotides & Nucleic Acids, 
2005, 24, 85-110). 
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2.1.  Abstract 
 The challenge in working with anthraquinone-2’-deoxyadenosine (AQ-dA) conjugates is 
that they are insoluble in water and only sparingly soluble in most organic solvents.  However, 
water-soluble AQ-dA conjugates with short linkers are required for study of their 
electrochemical and intramolecular electron transfer properties in this solvent prior to their use in 
laser kinetics investigations of photoinduced hole (cation) transport in DNA.  This paper first 
describes the synthesis of a water-soluble, ethynyl-linked AQ-dA conjugate, 8-[(anthraquinone-
2-yl)ethynyl]-2’-deoxyadenosine 3’-benzyl hydrogen phosphate, based on initial formation of a 
5’-O-(4,4’-dimethoxytrityl) (5’-O-DMTr) intermediate.  Because intended H2 over Pd/C 
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reduction of the ethynyl linker in 5’-O-DMTr protected 2’-deoxyadenosines cleaves the DMTr 
protecting group and precipitates multiple side products, this work also describes the synthesis of 
an ethanyl-linked AQ-dA conjugate, 8-[2-(anthraquinone-2-yl)ethyl]-2’-deoxyadenosine 3’-
benzyl hydrogen phosphate, starting with a 5’-O-tert-butyldiphenylsilyl protecting group.   
2.2.  Introduction 
The DNA double helix presents a unique medium for electron transfer (ET) due to the π-
stacked array of its aromatic heterocyclic base pairs.  Several approaches have been developed to 
study ET in DNA.1-23  In most of these approaches, either photoexcitation or ionizing irradiation 
is employed to inject a hole (cation radical) or an excess electron (anion radical) into the DNA 
base stack depending, respectively, upon whether a DNA base is initially oxidized or 
reduced.24,25  Long range ET is then monitored, generally indirectly, by detecting effects due to 
the oxidation or reduction of a nucleobase remote from the injection site.26-33  In these 
experiments yields of the detected oxidized or reduced bases or their chemical products are low 
(≤5 × 10-3).34-38  Our approach is to develop modified nucleosides that will permit direct study of 
the short- and long-range dynamics of charge transport in modified DNA duplexes using real-
time transient absorbance (TA) spectroscopy.  Key to reaching this goal is the construction of 
DNA containing covalently modified nucleosides that can yield long-lived charge separated (CS) 
products upon photoexcitation.  CS products can be comprised of either holes or excess electrons 
on DNA bases depending on the nature of the conjugate group joined to a particular base.   
From a hole transfer perspective, conjugates between electron-deficient derivatives of 
anthraquinone (AQ) and 2’-deoxyadenosine (dA) are interesting as sources of holes in 
DNA.12,13,15,16,39-47  In AQ-dA conjugates photoexcited AQ is expected to be the electron 
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acceptor, and adenine is expected to be the electron donor; thus photoexcitation of such 
conjugates is expected to form the AQ•−/dA•+ CS product.  Photoexcited AQ is unique in that it 
intersystem crosses very rapidly (≤600 fs) from its lowest energy 1(n,π*) state to its lowest 
energy 3(π,π*) state.48  This rapid intersystem crossing rate makes AQ a non-fluorescent 
molecule.  If AQ in its triplet state were able to oxidize dA, the CS product would also be a 
triplet.  Such a 3(AQ•−/dA•+) product should be relatively long-lived, because its back electron 
transfer reaction is spin forbidden.  The formation and lifetime of such a CS product could be 
monitored by TA detection of the anthraquinone anion radical (AQ•−) in the 500-600 nm 
region.48  If AQ-dA conjugates would produce the 3(AQ•−/dA•+) product when inserted into 
DNA, the dA•+ hole could be created at a specific site in a DNA duplex.  The expected long 
lifetime of the initial triplet CS product may then allow the initial dA•+ hole to hop to nearby 
purine bases (Gs or other As).  If so, a reversibly hopping purine cation might be able to be 
observed as it is trapped on a distant base of lower D•+/D reduction potential such as guanine or 
7,8-dihydro-8-oxoguanine.  Separating AQ•− from its associated hole in the 3(AQ•−/dA•+) 
photoproduct should prolong the lifetime of the resulting AQ•−/dA/dN•+ secondary charge 
separated (SCS) product, where dN is any purine base.  Key questions concern how efficiently 
can SCS products be produced and how long can they be made to live. 
Upon photoexcitation of the ethynyl-linked AQ-dA conjugate, 1a, and the ethanyl-linked 
AQ-dA conjugate, 2a, (see Figure 1) at 341 nm in methanol ( MeOH), we observed formation of 
the 3(π,π*) state of AQ (AQ*) but no formation of the hoped for 3(AQ•−/dA•+) photoproduct.48  
Additionally, photoexcitation of a bimolecular solution of dA and 2-anthraquinone sulfonic acid 
sodium salt (AQS−) in MeOH also produced only the AQ-localized 3(π,π*) state of AQS−.48  The 
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above results showed that in MeOH the energy of initial triplet state of AQ in 1a, 2a, and AQS− 
was below the energy of the AQ•−/dA•+ CS state.  Surprisingly, the AQS•2−/dA•+ CS product was 
found after changing the medium of the last experiment from MeOH to water.48  Thus in the 
latter experiment, interactions with water stabilized the CS product more than in MeOH, as 
changing the solvent from MeOH to water does not appreciably change the energy of the 3(π,π*) 
state of AQS−.   
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Figure 2.1.  Structures of four AQ-dA conjugates:  the 3’-benzyl phosphate nucleotides 1 and 2 
are soluble in both water and MeOH, while the nucleosides 1a and 2a are insoluble in water but 
sparingly soluble in MeOH. 
 Water can lower the energy of an AQ•−/dA•+ CS product compared to MeOH in at least 
four ways.  First, the high dielectric constant of water (ε = 78) can lower the free energy of the 
CS state compared to MeOH (ε = 38).  However, dielectric stabilization is likely to be small in 
this case, because it scales as 1/ε.  Second, hydrogen bonding at the AQ-carbonyls can increase 
the stability of AQ•−.  However, again there is not likely to be much difference in this effect 
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between MeOH and water.  Third, deprotonation of dA•+ at N6 in water to form dA•(-H) could 
provide nearly 500 meV of extra stabilization energy.  Thus, in water a new, much more stable 
CS product, AQ•−/dA•(-H), could be formed.  However, for this free energy change to drive 
reductive quenching of AQ* by dA, a proton would have to move from dA first so that ET could 
follow.  Energetic considerations make this seem unlikely.  Fourth, our electrochemical studies 
show that AQS− is nearly 300 mV easier to reduce in water at pH 13 than in acetonitrile 
(MeCN).49  This surprising “hydroelectrochemical” effect on AQS− reduction is independent of 
protonation of AQS•2−, which does not occur at or above pH 7.49  The last of these four modes of 
AQ•−/dA•+ CS product stabilization appears likely to be the reason that reductive quenching of 
the AQ-localized 3(π,π*) state of AQS− by dA occurs in water but not in MeOH.  Our goal here 
is to synthesize the water-soluble AQ-dA 3’-phosphates, 1 and 2, so that their electrochemistry 
and intramolecular ET photochemistry can be studied in water.  If they can be shown to undergo 
reductive quenching of their 3(π,π*) excited states to form 3(AQ•−/dA•+) photoproducts in water, 
it will then be desirable to transform them into the corresponding phosphoramidite reagents for 
incorporation into DNA oligomers for studies of hole transport in DNA.   
 Synthesis of the 3’-phosphate AQ-dA conjugates 1 and 2 appears appealing for study of 
the chemistry of water soluble AQ-dA conjugates, because the phosphate group is attached to the 
sugar and, therefore, is not likely to affect the redox potentials of either the AQ or dA subunits.  
From the perspective of substitution of 1 and 2 into DNA duplexes, the rigid ethynyl linker in 1 
appears advantageous over the more flexible ethanyl linker in 2, because it will likely permit 
fewer nonbonded interactions between the anthraquinonyl group and neighboring DNA bases.  
However, at this point the electrochemistry and ET photochemistry of neither compound is 
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known in water and both need to be made and studied.  The challenge in working with AQ-dA 
conjugates is that in general they are insoluble in water and only sparingly soluble in most 
organic solvents.  Thus the goal of producing moderate amounts of the 3’-phosphates 1 and 2 
requires development of protecting group strategies to increase the solubility of synthetic 
intermediates.  Since the 4,4’-dimethoxytrityl (DMTr) group is commonly used to make 
phosphoramidite reagents for use on automated solid-phase DNA synthesizers, we begin this 
work with a description of the synthesis of the ethynyl-linked AQ-dA 3’-phosphate conjugate 1 
based on initial formation of a 5’-O-DMTr intermediate as shown in Scheme 1.  Unfortunately, 
attempted reduction of the ethynyl linker in 5’-O-DMTr protected 2’-deoxyadenosines with H2 
over Pd/C cleaves the DMTr protecting group and precipitates multiple side products.  Thus this 
work also describes in Scheme 2 a synthetic strategy based on initial 5’-O-tert-butyldiphenylsilyl 
(5’-O-TBDPS) protection of 8-bromo-2’-deoxyadenosine to make the ethanyl-linked AQ-dA 
conjugate 2.  Finally, useful syntheses of two substituted-anthraquinones are described in 
Scheme 3. 
2.3.  Results and Discussion 
2.3.1.  Synthesis of an Ethynyl Linked AQ-dA Conjugate (1)   
The water insoluble AQ-dA nucleosides 1a and 2a were made on a 100-mg scale without 
protecting groups, but with silica gel column purification difficulties.  However, their extremely 
poor solubility in organic solvents precluded phosphorylating them directly with POCl3 in 
trimethyl phosphate50-52 or β-cyanoethyl phosphate.53  To allow chemical transformations of AQ-
dA intermediates in organic solvents, 8-bromo-2’-deoxyadenosine must first be protected at the 
5’-O position to ensure that its AQ-adducts remain soluble.  With this in mind, we attempted to 
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use (BnO)2POCl and tert-BuMgCl to produce a 5’-O protected 3’-phosphate.  Unfortunately, this 
modified version of a reported reaction54 did not succeed.  Either phosphite triester55,56 or 
phosphoramidite coupling57-60 followed by oxidation also appeared reasonable as alternate ways 
of producing our desired 5’-O protected 3’-phosphates of AQ-dA.  We chose the latter procedure 
as dibenzyl N,N-diisopropylphosphoramidite was commercially available, while tribenzyl 
phosphite was not. 
 The synthetic strategy to form 1 described in Scheme 1 was developed based on trial 
phosphorylation reactions of 2’-deoxyadenosine rather than the more expensive 8-bromo-2’-
deoxy adenosine reagent.  The goal of these trial reactions was three-fold:  1) to test 
phosphoramidite chemistry without N6-protection, 2) to determine the stability of phosphate 
protection toward DMTr deprotection, and 3) to establish the stability of both the N-glycosidic 
bond and the phosphate group itself toward the conditions needed to produce the 2’-
deoxyadenosine 3’-benzyl phosphate products in Scheme 1.  While unprotected, ethynyl and 
ethanyl AQ-dA conjugates are only sparingly soluble in most solvents, all three 3’-dibenzyl 
phosphates in Scheme 1 were readily soluble in a variety of standard organic solvents.  However, 
purification of 7 was sometimes a problem as will be discussed. 
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Scheme 2.1.  Reagents and conditions:  (a) DMTrCl, 4-DMAP, TEA, Py, rt, 4 h; (b) i- 
(BnO)2PN(iPr)2, Me-tetrazol, THF, rt, 1 h; ii- m-CPBA in CH2Cl2, -78 °C, 15 min; (c) Pd(Ph3P)4, 
CuI, TEA, DMF, 65 °C, 6 h; (d) 30% DCA in CH2Cl2, rt, 30 min; (e) DABCO, 1,4-dioxane, 
reflux, 2 h. 
2.3.2.  Synthesis of 5’-O-Dimethoxytrityl-8-bromo-2’-deoxyadenosine 3’-Dibenzyl 
Phosphate (5) from 2’-Deoxyadenosine   
Treatment of 2’-deoxyadenosine with Br2 in a 1 M solution of acetate buffer at pH 4.0 in 
the dark for 4 h produced 3 in 79% yield.    Adjusting the pH to 4.0 rather than 5.061 or 5.462 and 
using a buffer concentration of 1 M was essential to dissolve the starting materials.  Additionally, 
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pure 3 was obtained by extracting it from the buffer with chloroform (CHCl3);63 extraction was 
aided by CHCl3 mixing with the large amount of acetic acid used required to drop the pH of the 
buffer to 4.0.  Evaporation of CHCl3 resulted in a solution of 3 in acetic acid; acetic acid in turn 
was removed by co-evaporation with toluene.  1H and 13C NMR data for 3 were identical to those 
previously published, and the product was used without further purification.  Alternately, 
separation of 3 from the acetate buffer was also done by precipitation following neutralization 
with sodium hydroxide.64  However, in this case recrystallization from boiling water was 
required to separate a trace amount of unreacted 2’-deoxyadenosine.  The yield for this latter 
product collection method was only 50%.  
5’-O-Dimethoxytrityl-8-bromo-2’-deoxyadenosine (4) was prepared in 72% yield by 
tritylation of 3 using DMTrCl, TEA, and 4-DMAP (as a catalyst) in pyridine.65  DMTrCl was 
added dropwise as a solution in pyridine at 0 °C.  This procedure was intended to increase the 
selectivity of tritylation at 5’-OH.  Phosphorylation of 4 by coupling with (BnO)2PN(iPr)2 
followed by oxidation produced 5 as shown in Scheme 1.  Based on our trial phosphorylation of 
2’-deoxyadenosine, we avoided using less than 1.5 equivalents of (BnO)2PN(iPr)2 in order to 
completely react 4, and hoped that any N6-phosphorylated side-product would be easily 
removable by silica gel chromatography as in the trial chemistry.  However, the amount of this 
side product here, as shown by TLC, was larger than the amount seen previously when 
phosphorylating 5’-O-DMTr-2’-deoxyadenosine.  This could have been due to additional 
activation of N6 in 4 by the inductive effect of Br at C8.  Worse, complete separation of the 
3’,N6-bis(dibenzyl phosphate) side product from the 3’-dibenzy phosphate 5 was required 
biotage chromatography.  Therefore, to eliminate N6-phosphorylation, it was worth re-optimizing 
the number of equivalents of (BnO)2PN(iPr)2 used.  Some published procedures used lower 
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equivalents of similar phosphoramidite reagents but an excess of the required base.66,67  Based on 
this reasoning, 2.2 equivalents of Me-tetrazol were used with 1.2 equivalents of (BnO)2PN(iPr)2 
keeping all other conditions unchanged.  This modified procedure yielded a single spot of 5 on 
TLC with complete consumption of 4.  
2.3.3.  Coupling Anthraquinone to 5 Followed by Two Deprotections to Yield 1 
5’-O-Dimethoxytrityl-8-[(anthraquinone-2-yl)ethynyl]-2’-deoxyadenosine 3’-dibenzyl 
phosphate (7) was synthesized by Pd(0) catalyzed cross-coupling of 5 and 6.  The coupling was 
achieved by stirring the reactants in DMF at 65 °C for 5-6 h under anhydrous conditions with 
two equivalents of TEA (as base) and catalytic amounts of tetrakis(triphenylphosphine) 
palladium(0) (Pd(Ph3P)4) and CuI.  Monitoring the progress of this reaction by TLC was not 
possible, because both the starting material 5 and the product 7 had the same Rf in most 
commonly used eluting solvent mixtures.  The time of the reaction was suggested by comparison 
with similar Pd(0) catalyzed cross-coupling reactions in the literature (2.5-6 h).67-69  Complete 
consumption of 5 by reaction with 6 was essential to obtain 7 pure after silica gel 
chromatography; purity of 7 was checked by 1H NMR.  Frequently, however, 5 reacted 
incompletely even when fresh Pd(Ph3P)4 catalyst and 30% excess of 6 were used.  Unfortunately, 
in these cases increasing the reaction time did not lead to a complete reaction.  Because 
unreacted 5 and 7 underwent the same kinds of reactions in Scheme 1, proceeding to the next 
step also yielded products with same Rf values.  Thus, obtaining 8 pure was also a problem 
unless all of 5 reacted when forming 7.  However, obtaining 1 pure was not a problem as HPLC 
separated it cleanly from all other reaction products. 
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The DMTr group of 7 in Scheme 1 was cleaved by stirring with 40 equivalents of 30% 
DCA in dichloromethane (CH2Cl2) at room temperature for 30 min.  (Lower concentrations or 
equivalents of the acid caused incomplete detritylation of trial compound 5’-O-DMTr-2’-
deoxyadenosine 3’-dibenzyl phosphate.)  After silica gel chromatographic purification, 8-
[(anthraquinone-2-yl)ethynyl]-2’-deoxyadenosine 3’-dibenzyl phosphate (8) was obtained in 
76% yield.  No depurination of 8 was observed during the acidic cleavage of DMTr. 
Mono-deprotection of the dibenzyl phosphate group in 8 to produce 1 was achieved by 
treatment with 2.7 equivalents of DABCO under anhydrous conditions in refluxing 1,4-dioxane.  
During purification of 1 by preparative HPLC eluting with MeCN/water, the Bn-quaternarized 
DABCO counter cation was replaced by hydrogen as judged by 1H NMR.  Hydrogenolysis was 
not used for benzyl deprotection as this would have also reduced the alkynyl linker.  
Additionally, benzyl deprotection of trial 2’-adenosine 3’-dibenzyl phosphate with 5 equivalents 
of TMSBr in anhydrous CH2Cl2 followed by quenching with 1 M aqueous ammonium 
bicarbonate70 produced a mixture of unidentified products as judged by 1H NMR.  Thus this 
benzyl deprotection method was not used either.  Note also that 2.7 equivalents of DABCO 
produced only monobenzyl deprotected 1 without evidence of any dibenzyl deprotected product. 
2.3.4.  Synthesis of an Ethanyl Linked AQ-dA Conjugate (2) 
The initial strategy to synthesize 2 was based on using Pd/C catalyzed hydrogenation of 8 
both to reduce the ethynyl linker and also to remove the benzyl groups on the 3’-phosphate.71  
Surprisingly, however, this strategy was not successful due to precipitation of multiple side 
products following benzyl cleavage prior to complete reduction of the triple bond.  (In our 
experience unprotected ethynyl-linked AQ-dA conjugates had poorer solubility in most organic 
  
25
solvents than the corresponding ethanyl-linked conjugates).  Therefore, we decided to reduce the 
triple bond independently from 3’-dibenzyl phosphate deprotection.  Additionally, since 
protected phosphates were more stable and easier to handle than unprotected ones, we also 
decided to form a 3’-dibenzyl-protected phosphate intermediate immediately after reduction of 
the ethynyl linker.  The last step in our synthesis of the water-soluble AQ-dA nucleotide 2 (as 
shown in Scheme 2) was then a second hydrogenation to monobenzyl-deprotect the 3’-dibenzy 
phosphate intermediate 13. 
To improve the solubility of AQ-dA intermediates prior to hydrogenation of the alkynyl 
linker, we tried to use DMTrCl to protect the 5’-OH of 3 before coupling it to 6 (2-
ethynylanthraquinone).  Accordingly, we reacted 5’-O-DMTr-protected 4 (see Scheme 1) with 6 
using Pd(0) catalyzed cross-coupling chemistry.  However, hydrogenation of the resulting 
product, 5’-O-DMTr-8-[anthraquinone-2-yl]ethynyl-2’-deoxyadenosine, using 10% Pd/C and H2 
(40 psi) at room temperature for 24 h cleaved the DMTr group and precipitated multiple side 
products as determined by TLC.  This was surprising, because DMTr protection of 5’-OH on 2’-
deoxyuridine was stable to the same hydrogenation conditions.72,73  Perhaps the 5’-O DMTr 
group in 2’-deoxypurine nucleosides was more labile than in 2’-deoxypyrimidine nucleosides.74  
However, it was also true that trityl groups on other compounds were cleaved by hydrogenation 
under similar conditions.75  Clearly, a different 5’-OH protecting group was needed to solubilize 
intermediates during our synthesis of 2.  We selected the tert-butyldiphenylsilyl (TBDPS) group, 
because it could selectively protect 5’-OH in 2’-deoxyribonucleosides,76-79 and it could be 
cleaved under mild conditions using NH4F in MeOH.80  Finally, our second water-soluble AQ-
dA target compound 2 was successfully prepared as described in Scheme 2 following initial 5’-
OH protection of 3 with TBDPSCl. 
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Scheme 2.2.  Reagents and conditions:  (a) TBDPSCl, Im, Py, rt, 3h; (b) Pd(Ph3P)4, CuI, TEA, 
DMF, 65 °C, 6 h; (c) 10% Pd/C, H2, 40 psi, EtOAc/MeOH, rt, 24 h; (d) i- (BnO)2PN(iPr)2, Me-
tetrazol, THF, rt, 1h; ii- m-CPBA in CH2Cl2, -78 °C, 15 min; (e) NH4F, MeOH/THF, 60 °C, 6 h; 
(f) 10% Pd/C, H2, 40-45 psi, EtOAc/MeOH, rt, 31 h. 
2.3.5.  Synthesis of 5’-O-tert-Butyldiphenylsilyl-8-[2-(anthraquinone-2-yl)ethyl]-2’-
deoxyadenosine (11) 
Compound 11 was synthesized in three steps starting with 3 as described in Scheme 2.  
To produce a 5’-O protected form of 3, TBDPSCl (1.05 equivalents) was added dropwise at 0 °C 
to a mixture of 3 and imidazol (1 equivalent each) in anhydrous pyridine; stirring at room 
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temperature for 3 h afforded 9 in 91% yield after silica gel chromatographic purification.  When 
more equivalents of imidazol and TBDPSCl were used, disilylation of 3 occurred readily.  
Importantly for future work, both the purity and yield of 5’-O-TBDPS protected 9 were better 
than those of 5’-O-DMTr protected 4 (see Scheme 1). 
5’-O-tert-Butyldiphenylsilyl-8-[(anthraquinone-2-yl)ethynyl]-2’-deoxyadenosine (10) 
was synthesized in 90% yield via Pd(0) catalyzed cross-coupling between 9 and 6.  The coupling 
was achieved by stirring the reactants in DMF at 65 °C for 5-6 h under anhydrous conditions 
with two equivalents of TEA (as base) and catalytic amounts of Pd(Ph3P)4 and CuI.  Filtration of 
the reaction mixture over Celite separated insoluble materials from the reaction products.  
Yellow colored 10 was frequently purified with two silica gel columns to remove dark colored 
impurities that developed during the reaction.  However, many times even after two 
chromatographic purifications, 10 was still mixed with a trace amount of unreacted 9.  This was 
the case because nucleosides 9 and 10 had nearly the same Rf in most commonly used eluting 
solvent mixtures.  A similar problem was encountered previously when synthesizing 1 also 
starting with 3; in fact both 8-bromo-2’-deoxyadenosine nucleosides 9 and 4 protected, 
respectively, with TBDPS and DMTr groups had the same Rf values.  Even using fresh 
Pd(Ph3P)4 catalyst, 30% excess of 6, and increased reaction time did not always eliminate 9.  The 
latter contaminant was easily eliminated, however, after ethynyl reduction during purification of 
11. 
5’-O-tert-Butyldiphenylsilyl-8-[2-(anthraquinone-2-yl)ethyl]-2’-deoxyadenosine (11) 
was produced in 86% yield by hydrogenation of 10 using 10% Pd/C and H2 (40 psi) at room 
temperature for 24 h in MeOH/ethyl acetate (EtOAc) (3:2).  The yellow color of 11 was less 
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intense than that of 10 and it was more soluble in organic solvents.  Importantly, 11 had a more 
polar Rf value on TLC than 10.  Since unreacted 9 from the Pd(0) catalyzed cross-coupling step 
did not undergo hydrogenation, traces of 9 were easily separated from 11 using Biotage silica gel 
chromatography.  Importantly for the synthesis of 2, the 5’-O-TBDPS group in 10 was stable 
with respect to hydrogenation, and thus the ethanyl-linked product 11 remained soluble in 
MeOH/EtOAc solution. 
2.3.6.  Phosphorylation of 11 and Two Subsequent Deprotections to Form 2 
5’-O-tert-Butyldiphenylsilyl-8-[2-(anthraquinone-2-yl)ethyl]-2’-deoxyadenosine 3’-
dibenzyl phosphate (12) was prepared by phosphorylation of 11 using 1.2 equivalents of 
(BnO)2PN(iPr)2 and 2.2 equivalents of Me-tetrazol in THF, followed by oxidation with m-
CPBA.  Phosphorylation of the ethanyl-linked AQ-dA conjugate 11 showed five product spots in 
addition to a minor amount of unreacted 11 on TLC compared to a single spot found earlier 
when phosphorylating 4.  The major TLC spot corresponded to 12, while the side products were 
not identified.  Nevertheless, silica gel column chromatography easily purified 12 in 82% yield. 
The desilylated product 8-[2-(anthraquinone-2-yl)ethyl]-2’-deoxyadenosine 3’-dibenzyl 
phosphate (13) was produced in 88% yield by treatment of 12 with NH4F in THF/MeOH (1:6.7) 
at 60 °C.  The amount of NH4F added to this reaction was 11.5 equivalents with respect to 12, 
but this amount of NH4F was not fully soluble in the reaction solvent.  Nevertheless, after 
reaction completion the solvent was reduced in volume, and the residue was purified via silica 
gel chromatography on a Biotage column (without prior separation NH4F by filtration or water 
workup).  Finally, the monobenzyl-deprotected product 2 was formed from the 3’-dibenzyl 
phosphate intermediate 13 by catalytic hydrogenation using 10% Pd/C and H2 (40 psi) at room 
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temperature for 31 h in MeOH/EtOAc (8:1).  Although, Pd/C hydrogenolysis has been reported 
many times to cleavage both benzyls on a phosphate group,55-57,59,71,81 hydrogenolysis of 13 
produced only monobenzyl deprotection.  Analytical reverse phase HPLC of the crude product 
mixture showed 71% yield of 2.  Purification by preparative reverse phase HPLC, however, gave 
2 in 22% yield. 
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Scheme 2.3.  Reagents and conditions:  (a) i. HCl, NaNO2, THF/H2O, 0 ºC; ii. KI, 0 ºC, 75 min; 
(b) Pd(Ph3P)2Cl2, CuI, Et3N, THF, TMSA, rt, 10 min; (c) KF, THF/MeOH, rt, 1h. 
2.3.7.  Syntheses of Two Substituted-anthraquinones:  2-Iodoanthraquinone (15) and 2-
Ethynylanthraquinone (6) 
Early steps in the syntheses of both 1 and 2 involve Pd(0) catalyzed cross-coupling 
between a 5’-O protected 2’-deoxyadenosine (5 or 9) and 2-ethynylanthraquinone (6).  
Compound 6 in turn is prepared in two steps beginning with 15 as shown in Scheme 3.  In the 
first step, Pd(Ph3P)2Cl2 catalyzed cross-coupling of trimethylsilylacetylene (TMSA) with 15 
gives 2-(trimethylsilylethynyl)anthraquinone (16); then the terminal alkyne of 16 is deprotected 
with KF to give 6.  Although 2-chloroanthraquinone is commercially available, its Pd(0) 
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catalyzed cross-coupling reaction is likely to occur less readily than those for either 2-bromo or 
2-iodoanthraquinone.  Also, direct bromination of commercially available anthraquinone yields a 
mixture of polybromoanthraquinones that is difficult to separate.82  Other reported syntheses of 
2-bromoanthraquinone either have low yields83 or require harsh conditions.84  Thus, for these 
reasons as well as the fact that iodide is a better leaving group than bromide, 2-
iodoanthraquinone (15) appears to be a good precursor for forming first 16 and finally 6.   
2.3.8.  Synthesis of 2-Iodoanthraquinone (15) 
To form 15, 2-aminoanthraquinone (14) was diazotised with nitrous acid that was 
prepared in situ from hydrochloric acid and sodium nitrite, and then substituted with iodide in a 
manner similar to the Sandmeyer reaction.  First, compound 14 was suspended in THF, and HCl 
was added while stirring until the color of the suspension changed from reddish brown to rosy 
beige.  Addition of water and more THF reduced the thickness of the suspension and returned the 
suspension’s color to reddish brown.  Next, addition of more HCl restored the rosey beige color.  
The mixture was then stirred at 40 °C for 24 h to produce a thick suspension.  An aqueous 
solution of NaNO2 was added dropwise at 0 °C, followed by addition of an aqueous solution of 
KI also at 0 °C.  Addition of KI caused gas evolution.  The reaction mixture was then heated 
gradually to 60 °C until the gas evolution stopped.  Neutralization of the reaction mixture with 
Na2CO3 was avoided due to the large amount of base that would have been required.  Instead, 
THF was evaporated from the mixture, and HCl was removed by filtering the residue and 
washing it with water first, and then with a saturated solution of aqueous Na2CO3.  TLC of the 
product mixture, however, showed a less polar, minor product very close to 15.  Thus, although 
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15 was difficult to purify by silica gel column chromatography, three separations using 30% 
CH2Cl2 in hexane as the mobile phase produced 3.4 g of 15 in 75% yield. 
2.3.9.  Synthesis of 2-Ethynylanthraquinone (6) 
Following a general procedure for Pd catalyzed cross-coupling between an aryl halide 
and trimethylsilylacetylene (TMSA),85 15 was readily converted to 16 via cross-coupling with 
TMSA using dichlorobis(triphenylphosphine)palladium(II) (Pd(Ph3P)2Cl2) as the catalyst.  This 
reaction was complete within 10 minutes in tetrahydrofuran (THF) at room temperature.  
However, the above difficulty in purifying 15 made using commercially available 2-
chloroanthraquinone to produce 16 attractive.  Unfortunately, both of our attempts to do so by 
substituting 2-chloroanthraquinone for 15 a) under the same reaction conditions and also b) by 
heating the reaction mixture at 60 ˚C for 24 hrs failed.  Thus, at present, the best route for 
producing 6 appears to be via precursors 14 and 15.   
All of the anthraquinones in Scheme 3 had low solubility in organic solvents.  For 
example, 26 mL of THF/MeOH (1:1 v:v) along with 30 minutes of stirring were required to 
dissolve 200 mg of 16 for deprotection by potassium fluoride to produce 6, and it was harder to 
dissolve 6 than 16 in CH2Cl2, CHCl3, THF, MeOH, or EtOAc.  Additionally, the low solubility 
of 6 made difficult purification of its crude reaction mixture by silica gel chromatography.  Thus 
initially the crude product was extracted with CHCl3, and the extract’s dark color was reduced 
with active charcoal.  Then 6 was recrystallized from CHCl3 as a brown solid, and the 
recrystalized product was used for Pd catalyzed cross-coupling reactions with the 8-bromo-2’-
deoxyadenosines 5 and 9.  TLC analysis of the precipitated crystals showed very faint spots with 
higher polarity than 6, and 1H NMR of the crystals showed extra proton resonances.  To 
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eliminate the extra resonances in NMR, 100 mg of 6 was purified further on a 20 cm long by 5 
cm dia. silica gel column.  Late in our work, we found that 6 was sensitive to light below 370 
nm.  In particular, 6 changed its color from pale yellow to brown soon after silica gel purification 
when exposed to fluorescent laboratory light. 
2.4.  Conclusions   
Working with 6 as described in Schemes 1 and 2 to make, respectively, the 3’-benzyl 
phosphates 1 and 2 imposes synthetic constrains due to the poor solubility and photo-instability 
of 6.  Nevertheless, careful control of reaction conditions, including avoidance of short 
wavelength light (<370 nm) when using 6, allows synthesis of 1 and 2 and their precursors on a 
few-gram scale.  Based on our experience with the chemistry in Schemes 1-3, a common 
modification to Schemes 1 and 2 appears worth investigating in the future as a means of possibly 
making the 3’-phosphate conjugates 1 and 2 and related AQ-dA nucleosides with less effort and 
in larger quantities.  This alternate chemistry would switch the order of the alkynylation steps in 
each scheme.  Schemes 1 and 2 alkynylate 2-iodoanthraquinone (15) with TMSA first and then 
Pd cross-couple the resulting 6 with the 5’-protected-8-bromo-2’-deoxyadensines, respectively, 5 
and 9.  An interesting modification of these two schemes would alkynylate their 5’-protected-8-
bromo-2’-deoxyadensines with TMSA first and then Pd cross-couple the resulting 5’-protected-
8-ethynyl-2’-deoxyadensines with 15.  One clear advantage of such a switched reaction order 
would be that use of photo-chemically unstable 6 would be avoided.  A second and also 
important advantage would be that 5’-protected-8-ethynyl-2’-deoxyadensine intermediates 
would replace the 5’-protected-8-bromo-2’-deoxyadensines 5 and 9.  Thus, in these two cases the 
vexing coincidence of Rf values for intermediates 5 and 7 and 9 and 10 would also be eliminated.  
In short, the work presented here provides a sound basis for synthesizing the 3’-benzyl 
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phosphates 1 and 2 for investigation of their electrochemical reduction and photoinduced 
intramolecular ET properties in water.  Lacking the solubilizing effect of the 3’-benzyl phosphate 
group, the nucleosides 1a and 2a are insoluble in water, and thus these physical chemical 
experiments cannot be done on them.  Finally, future synthesis of AQ-dA substituted DNA 
oligomers based on standard solid-phase synthetic protocols appears achievable based either on 
the chemistry of Schemes 1-3 themselves or on variations of Schemes 1 and 2 that use a 
switched order of alkynylation. 
2.5.  Experimental 
2.5.1.  Materials and General Synthetic Methods 
2’-Deoxyadenosine monohydrate was purchased from TCI America as white a powder.  
TMSA obtained from GFS Chemicals was used after vacuum transfer from CaH2.  DMTrCl and 
Br2 were obtained from Alfa-Aesar.  10% Pd on activated carbon catalyst (Pd/C) and 
Pd(Ph3P)2Cl2 were obtained from Strem Chemicals and used as received.  2-Amino-
anthraquinone was purchased from Aldrich as a brown powder (93% pure) and was used as 
received.  Other remaining reagents used were purchased from Aldrich or VWR.  2-
Ethynylanthraquinone (6) was synthesized as described in Scheme 3.  Pd(Ph3P)4 was prepared 
according to the literature86 and stored between uses in our glove-box’s freezer at -20 °C.  
Anhydrous DMF was purchased from Aldrich and stored in our Vacuum Atmospheres M040-2 
glove-box that was pressurized with nitrogen boil-off gas from a liquid nitrogen tank.  All 
starting materials for anhydrous reactions were dried prior to use on a vacuum line (1-4 × 10-4 
torr) for at least 12 h.  Two to three co-evaporation cycles were also used for drying compounds 
as indicated below.  Solvents for synthesis were dried and redistilled in continuous circulation 
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distillation apparati:  THF was dried with benzophenone /Na0 and stored over activated 
molecular sieves in our glove-box.  Pyridine was always freshly distilled over CaH2 before use.  
Water was deionized by a Millipore (Milli-Q Plus) ultrapure water system (18.0 MΩ).  All 
manipulations of DMTrCl, TBDPSCl, Pd(Ph3P)4, Pd(Ph3P)2Cl2,and (BnO)2PN(iPr)2 were 
performed in our glove-box.  Most of the reactions were monitored with glass-backed TLC 
Plates precoated with silica gel 60 F254 (EMD Chemicals).  TLC was run using 5-7 % MeOH in 
CH2Cl2 as the eluent.  HPLC grade solvents were used for chromatographic purifications.  Flash 
column chromatography was carried out on either a Biotage Flash-40™ system using 
prepackaged KP-Sil™ cartridges, or on Whatman™ flash silica (60Å pore, 230-400 mesh) that 
was packed in glass columns and pressurized with boil-off nitrogen.  NMR Spectra were 
recorded at GSU on three spectrometers, a Varian Unity +300, a Varian Unity Inova 500, and a 
Brucker Avance 400, using either CDCl3 or DMSO-d6 as solvents.  Chemical shifts for 1H NMR 
in these solvents were referenced, respectively, relative to tetramethylsilane (0.00 ppm) and 
DMSO (2.49 ppm).  31P NMR spectra were recorded using orthophosphoric acid (85%) as an 
external standard in a capillary tube inside of the NMR tube.  Low resolution (LR) MS were 
obtained at GSU:  for substituted anthraquinones EI (electron impact) MS were recorded in 
positive ion mode on a Shimadzu 5050A MSD single quadrupole spectrometer with one amu 
resolution, and for substituted 2’-deoxyadenosines ESI (electrospray ionization) MS were 
recorded in either positive or negative ion modes on a Waters Micromass Q-TOFTM with 50 
ppm error. 
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2.5.2.  8-Bromo-2’-deoxyadenosine (3) 
2’-Deoxyadenosine monohydrate (6 g, 22.28 mmol) was dissolved in 800 mL of 1 M 
acetate buffer at pH 4.0 (prepared by adding glacial acetic acid to 700 mL of 1 M sodium acetate 
and adjusting the pH).  Br2 (2.3 mL, 44.43 mmol, 2 equiv) was added, and the reaction mixture 
was stirred at room temperature for 4 h in the dark.  The reaction was quenched by gradual 
addition of a saturated aqueous solution of NaHSO3 until the red color of Br2 disappeared.  The 
product was extracted by shaking with CHCl3 (8 × 500 mL) in a separatory funnel; the combined 
extracts were dried over anhydrous MgSO4 and evaporated to yield a solution of the product in 
acetic acid.  Co-evaporation with toluene (2 × 200 mL) provided 3 as a pale yellow powder that 
was used without further purification (5.96 g, 79% yield).  1H and 13C NMR spectra for 3 were 
identical to ones published in the literature. 
2.5.3.  5’-O-Dimethoxytrityl-8-bromo-2’-deoxyadenosine (4) 
Compound 3 (640 mg, 1.94 mmol) was dried 3 times by co-evaporation with dry pyridine 
and suspended in dry pyridine (5 mL).  To the suspension was added TEA (0.37 mL, 2.72 mmol, 
1.4 equiv) and 4-DMAP (13 mg, 0.1 mmol, 0.05 equiv) in our glove-box.  The mixture was next 
removed from our glove-box, and DMTrCl (789 mg, 2.33 mmol, 1.2 equiv) was dissolved in dry 
pyridine and added dropwise at 0 °C to the reaction mixture with 3 under a nitrogen atmosphere 
using a cannula.  The orange reaction mixture was stirred at room temperature under a nitrogen 
atmosphere for 4 h after which time the mixture was homogeneous, and TLC showed complete 
consumption of 3.  The reaction was quenched with a saturated aqueous solution of NaHCO3, 
and the solvent was evaporated.  The residue was dissolved in CH2Cl2 (50 mL) and water (20 
mL); the organic layer was separated, washed with water (2 × 20 mL), and dried over MgSO4.  
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The crude product was purified by silica gel chromatography on a column that had been pre-
equilibrated with 1% TEA in CH2Cl2 and eluted with MeOH/CH2Cl2 (0:100-3:97). Evaporation 
of the eluting solvent afforded 4 as pale yellow foam (940 mg, 72% yield).  The 1H NMR 
spectrum given here is very similar to ones previously reported in CD2Cl268 and CDCl3.67  1H 
NMR (300 MHz, CDCl3):  δ (ppm) 2.31-2.4 (1H, m, H-2’), 3.39 (2H, d, J = 5.7 Hz, H-5’, H-5’), 
3.51-3.60 (1H, m, H-2’), 3.77 [6H, s, OCH3 (DMTr)], 4.12 (1H, dd, J = 5.7 and 10.2 Hz, H-4’), 
4.95 (1H, dd, J = 4.8 and 10.2 Hz, H-3’), 5.78 (2H, br s, NH2), 6.4 (1H, t, J = 6.7 Hz, H-1’), 7.66 
[4H, dd, J = 4.2 and 8.7 Hz, OPh-meta (DMTr)], 7.16-7.28 [7H, m, OPh-ortho (DMTr, 4H) and 
Ph-meta and para (DMTr, 3H)], 7.37 [2H, d, J = 7.5 Hz, Ph-ortho (DMTr)], and 8.06 [1H, s, H-2 
(dA)].  
2.5.4.  5’-O-Dimethoxytrityl-8-bromo-2’-deoxyadenosine 3’-Dibenzyl Phosphate (5) 
To 4 (440 mg, 0.70 mmol), previously dried 2 times by co-evaporation with anhydrous 
THF, was added Me-tetrazole (130 mg, 1.54 mmol, 2.2 equiv) and anhydrous THF (5 mL) in our 
glove-box.  The mixture was removed from our glove-box and cooled to 0 °C using an ice-water 
bath, and (BnO)2PN(iPr)2 (0.28 mL, 0.84 mmol, 1.2 equiv) was added dropwise under nitrogen 
with a syringe.  The reaction mixture was stirred under a nitrogen atmosphere for 10 minutes at 0 
°C; then it was warmed to room temperature, and the reaction progress was monitored by TLC.  
A white precipitate began to form after 20 min, and TLC showed complete consumption of 4 
after a total reaction time of 1.5 h.  The suspension obtained was cooled to -78 °C using a dry 
ice-acetone bath, and a solution of m-CPBA (250 mg) in CH2Cl2 (5 mL) was added gradually to 
the chilled mixture.  After 15 minutes of stirring at -78 °C, the mixture became homogeneous, 
and TLC showed conversion of an intermediate spot to a more polar one.  The mixture was next 
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warmed to room temperature, and saturated aqueous NaHCO3 was added.  More CH2Cl2 (30 mL) 
and water (15 mL) were added; the organic layer was separated, washed with water, dried with 
anhydrous MgSO4, and evaporated to dryness.  The syrup obtained was purified using silica gel 
chromatography on a Biotage column that had been pre-equilibrated with 1% TEA and eluted 
with MeOH/CHCl3 (0:100-3:97).  Evaporation of the eluting solvent afforded 5 as white foam 
(469 mg, 75% yield).  1H NMR (500 MHz, CDCl3):  δ (ppm) 2.39 (1H, ddd, J = 2, 6.5 and 13.5 
Hz, H-2’), 3.30 (1H, dd, J = 5.5 and 10 Hz, H-5’) , 3.39 (1H, dd, J = 6.5 and 10 Hz, H-5’), 3.75-
3.81 [7H, m, H-2’ and OCH3 (DMTr)], 4.33-4.35  (1H, m, H-4’), 5.05 [4H, m, CH2 (Bn)], 5.35-
5.37 (1H, m, H-3’), 5.65 (2H, br s, NH2),  6.4 (1H, t, J = 7 Hz, H-1’), 6.72 [4H, dd, J = 7 and 9 
Hz, OPh-meta (DMTr)], 7.16-7.25 [7H, m, OPh-ortho (DMTr, 4H) and Ph-meta and para 
(DMTr, 3H)], 7.31 (10 H, s, Ph (Bn)), 7.36 [2H, d, J = 6.5 Hz, Ph-ortho (DMTr)], and 7.94 [1H, 
s, H-2 (dA)].  13C NMR (75 MHz, CDCl3):  δ (ppm) 43.26 (C-2’), 55.15 [OCH3 (DMTr)], 62.93 
(C-5’), 69.55 [d, JC - P = 5.7 Hz, CH2 (Bn)], 84.68 , 86.19 , 88.75 [C-1’, C-4’ and CAr3 (DMTr)], 
112.94, 120.41 [OPh-meta (DMTr), and C-5 (dA)], 126.67 [C-8 (dA)], 127.66, 128, 128.11, 
128.62, 130, 135.56, 135.81, 144.61 [Ar (DMTr and Bn)], 150.82 [C-4 (dA)], 152.49 [C-2 (dA)], 
154.07 [C-6 (dA)] and 158.35 [OPh-C-4 (DMTr)].  31P NMR (121 MHz, CDCl3): δ (ppm) –1.19.  
Low resolution ESI MS m/z (M+H)+: calc’d. 892.21, found 892.18. 
2.5.5.  5’-O-Dimethoxytrityl -8-[(anthraquinone-2-yl)ethynyl]-2’-deoxyadenosine 3’-
Dibenzyl Phosphate (7)  
To 5 (410 mg, 0.46 mmol) was added in our glove-box Pd(Ph3P)4 (24 mg, 0.02 mmol, 
0.05 equiv), CuI (9 mg, 0.05 mmol, 0.1 equiv), TEA (0.13 mL, 0.92 mmol, 2 equiv), compound 
6 (130 mg, 0.56 mmol, 1.3 equiv), and anhydrous DMF (5 mL).  The mixture was removed from 
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our glove-box and stirred under a nitrogen atmosphere for 6 h at 65 °C in an oil bath, after which 
time DMF was removed under reduced pressure.  The residue was dissolved in CH2Cl2 and 
filtered over Celite to remove insoluble materials.  After evaporation of solvent, the crude 
product was applied to a silica gel column that had been pre-equilibrated with 1% TEA in 
CHCl3, and eluted with MeOH/CHCl3 (0:100-3:97).  Evaporation of the eluting solvent afforded 
6 as a yellow foam (469 mg, 57% yield).  1H NMR (300 MHz, CDCl3):  δ (ppm) 2.53 (1H, ddd, 
J = 2.7, 6.6 and 14.1 Hz, H-2’), 3.36-3.49 (2H, m, H-5’ and H-5’), 3.66-3.75 [7H, m, H-2’ and 
OCH3 (DMTr)], 4.39-4.43  (1H, m, H-4’), 5.06 [4H, d, JH-P = 8.4 Hz, CH2 (Bn)], 5.39-5.43 (1H, 
m, H-3’), 5.73 (2H, br s, NH2),  6.57 (1H, t, J = 6.9 Hz, H-1’), 6.71 [4H, dd, J = 4.2 and 8.7 Hz, 
OPh-meta (DMT)], 7.15-7.39 [19H, m, OPh-ortho (DMT, 4H), Ph (DMT, 5H), and Ph (Bn, 
10H)], 7.82-7.85 [2H, m, H-6 (AQ) and H-7 (AQ)], 7.94 [1H, dd, J = 1.5 and 8.1 Hz, H-3 (AQ)],  
8.04 [1H, s, H-2 (dA)], 8.30-8.36 [3H, m, H-4 (AQ), H-5 (AQ) and H-8 (AQ)] and 8.53 [1H, d, J 
= 1.5 Hz, H-1 (AQ)].   
2.5.6.  8-[(Anthraquinone-2-yl)ethynyl]-2’-deoxyadenosine 3’-Dibenzyl Phosphate (8) 
Compound 7 (250 mg, 0.24 mmol) was dissolved in a 30% DCA in CH2Cl2 mixture (7.5 
mL), and the resulting red solution was stirred at room temperature for 30 min.  (Note that many 
times it was convenient to perform this detritylation step directly on the crude product 7 without 
silica gel purification.)  The reaction was quenched by addition of saturated aqueous NaHCO3 
until the red color of the DMTr cation disappeared.  More CH2Cl2 (25 mL) and water (10 mL) 
were added, and the organic layer was separated, washed with water, dried with anhydrous 
MgSO4, and evaporated to dryness.  The syrup obtained was purified using flash silica gel 
chromatography on a biotage column with MeOH/CHCl3 (0:100-3:97) as the eluting system to 
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yield yellow foam after evaporating the eluting solvent.  This foam was dissolved in a minimum 
amount of CH2Cl2 and precipitated by adding hexane.  Evaporation of CH2Cl2/hexane from the 
precipitate afforded 8 as a bright yellow solid (135 mg, 76% yield).  1H NMR (300 MHz, 
CDCl3):  δ (ppm) 2.46 (1H, dd, J = 5.7 and 14.1 Hz, H-2’), 3.08-3.15 (1H, m, H-2’), 3.37-3.65 
(1H, m, H-5’) 3.86-3.91 (1H, m, H-5’), 4.33 (1H, s, H-4’), 5.04-5.18 [4H, m, CH2 (Bn)], 5.20-
5.24 (1H, m, H-3’), 6.17 (2H, br s, NH2),  6.56-6.62 (2H, m, H-1’ and OH-5’), 7.29-7.37 [10H, 
m, Ph (Bn)], 7.72-7.83 [2H, m, H-6 (AQ) and H-7 (AQ)], 7.92 [1H, d, J = 8.1 Hz, H-3 (AQ)],  
8.23-8.26 [3H, m, H-2 (dA), H-5 (AQ) and H-8 (AQ)], 8.32 [1H, d, J = 8.1 Hz, H-4 (AQ)], and 
8.56 [1H, s, H-1 (AQ)].  1H NMR (500 MHz, CDCl3 + D2O):  δ (ppm) 2.45 (1H, dd, J = 5 and 14 
Hz, H-2’), 3-3.14 (1H, m, H-2’), 3.59 (1H, d, J = 12.5 Hz, H-5’), 3.87 (1H, d, J = 12.5 Hz, H-5’), 
4.33 (1H, s, H-4’), 5.05-5.16 [4H, m, CH2 (Bn)], 5.21-5.23 (1H, m, H-3’), 6.59 (1H, dd, J = 5 
and 9 Hz, H-1’), 7.31-7.38 [10H, m, Ph (Bn)], 7.76-7.82 [2H, m, H-6 (AQ) and H-7 (AQ)], 7.93 
[1H, d, J = 8 Hz, H-3 (AQ)],  8.23-8.25 [3H, m, H-2 (dA), H-5 (AQ) and H-8 (AQ)], 8.32 [1H, d, 
J = 8 Hz, H-4 (AQ)], and 8.56 [1H, s, H-1 (AQ)].  31P NMR (121 MHz, CDCl3):  δ (ppm) –1.55.  
13C NMR (100 MHz, CDCl3):  δ (ppm) 38.67 (C-2’), 63.10 (C-5’), 69.79 [d, JP-C = 6 Hz, CH2 
(Bn)], 80.05 (d, JP-C = 6 Hz, C-3’), 80.86 [dA-C (ethynyl)], 87.19, 88.04 (C-1’ and C-4’), 94.48 
[AQ-C (ethynyl)], 120.85 [C-5 (dA)], 126.11 [C-8 (dA)], 127.40, 127.60, 128.19, 128.71, 128.87, 
131.08 [AQ and Ph (Bn)], 132.05, 133.25, 133.40, 133.54, 133.63 (AQ), 134.44 (d, JP-C = 3.1 
Hz, Ph-C-1 (Bn)], 135.50, 136.78 [AQ and Ph (Bn)], 148.40 (AQ), 152.20 [C-4 (dA)], 153.36 
[C-2 (dA)], 155.67 [C-6 (dA)], 181.89 (CO), and 182.15 (CO).  Low resolution ESI MS m/z 
(M+H)+:  calc’d 742.21, found 742.18. 
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2.5.7.  8-[(Anthraquinone-2-yl)ethynyl]-2’-deoxyadenosine 3’-Benzyl Hydrogen Phosphate 
(1)   
Compound 8 (59 mg, 0.08 mmol) was dissolved in anhydrous 1,4-dioxane (8 mL) by 
heating to 60 °C.  DABCO (24 mg, 0.22 mmol, 2.7 equiv) was added to this solution in our 
glove-box, and the homogeneous mixture was refluxed on the bench top for 2 h under a nitrogen 
atmosphere.  The solvent was evaporated, and the crude product was separated by analytical 
HPLC to give ca. 95% yield of 1.  The crude product was then purified by preparative HPLC 
using a Varian Microsorb C-18 reverse phase column (250 mm × 41.4 mm dia.).  The column 
was eluted with a flow rate of 40 mL/min, and the fractions were monitored by UV detection at 
260 nm.  The mobile phase consisted of a programmed gradient of solution A (70% MeCN in 
water) and solution B (water): from 0% A/100% B to 50% A/50% B over 15 min; then to 100% 
A/0% B over 5 min, and finally at 100% A/0% B for another 10 min.  Evaporation of the eluent 
was facilitated by co-evaporation with MeOH to afford 1 as yellow plates (30 mg, 58% yield).  
1H NMR (500 MHz, DMSO-d6):  δ (ppm) 2.52-2.56 (1H, m, H-2’), 3.08-3.14 (1H, m, H-2’), 
3.35 (1H, br s, OH-5’), 3.52-3.54 (1H, m, H-5’), 3.64-3.66 (1H, m, H-5’), 4.14 (1H, s, H-4’), 
4.80 [2H, d, JH-P = 5.5 Hz, CH2 (Bn)], 5.03 (1H, s, H-3’), 6.55 (1H, t, J = 7 Hz, H-1’), 7.17 [1H, 
t, J = 7.5 Hz, Ph-para (Bn)], 7.24 [2H, t, J = 7.5 Hz, Ph-meta (Bn)], 7.33 [2H, d, J = 7.5 Hz, Ph-
ortho (Bn)], 7.68 (2H, br s, NH2), 7.94 [2H, dd, J = 5.5 and 3.5 Hz, H-6 (AQ) and H-7 (AQ)], 
8.13 [1H, s, H-2 (dA)], 8.17 [1H, d, J = 8 Hz, H-3 (AQ)], 8.20-8.22 [3H, m, H-4 (AQ), H-5 (AQ) 
and H-8 (AQ)], and 8.32 [1H, s, H-1 (AQ)].  1H NMR (500 MHz, DMSO-d6 + D2O):  δ (ppm) 
2.52-2.56 (1H, m, H-2’), 3.11 (1H, s, H-2’), 3.50-3.53 (1H, m, H-5’), 3.65-3.67 (1H, m, H-5’), 
4.15 (1H, s, H-4’), 4.79 [2H, s, CH2 (Bn)], 5.0 (1H, s, H-3’), 6.55 (1H, s, H-1’), 7.18 [1H, d, J = 
6 Hz, Ph-para (Bn)], 7.24 [2H, t, J = 6 Hz, Ph-meta (Bn)], 7.32 [2H, d, J = 6 Hz, Ph-ortho (Bn)], 
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7.94 [2H, d, J = 2.5 Hz, H-6 (AQ) and H-7 (AQ)], 8.11 [1H, s, H-2 (dA)], 8.14 [1H, d, J = 8.5 
Hz, H-3 (dA)],  8.19-8.21 [3H, m, H-4 (AQ), H-5 (AQ) and H-8 (AQ)] and 8.30 [1H, s, H-1 
(AQ)].  13C NMR (125 MHz, DMSO-d6):  δ (ppm) 45.22(C-2’), 62.38 (C-5’), 66.07 [d, JC-P = 4.6 
Hz, CH2 (Bn)], 75.31 (d, J = 20 Hz, C-3’), 82.22 [dA-C (ethynyl)], 84.92, 86.96 (C-1’ and C-4’), 
92.73 [AQ-C (ethynyl)], 119.85 [C-5 (dA)], 125.57 [C-8 (dA)], 126.87, 127.07, 127.30, 128.07, 
129.65, 132.07 [AQ and Ph (Bn)], 132.83, 132.97, 133.05, 133.16, 136.96, 134.75 (AQ) 139.28 
[d, JC-P = 8.3 Hz, Ph-C-1 (Bn)], 148.48 [C-4 (dA)], 153.75 [C-2 (dA)], 156.16 [C-6 (dA)], 181.55 
(CO), and 181.66 (CO). 31P NMR (202 MHz, DMSO-d6):  δ (ppm) –0.35.  Low resolution ESI 
MS m/z (M-H)-:  calc’d 650.14, found 650.11. 
2.5.8.  5’-O-tert-Butyldiphenylsilyl-8-bromo-2’-deoxyadenosine (9) 
Compound 3 (5 g, 15 mmol) was dried two times by co-evaporation with anhydrous 
pyridine, and then suspended in anhydrous pyridine (40 mL); imidazol (1.02 g, 15 mmol, 1 
equiv) was added to this suspension in our glove-box.  The mixture was removed from the glove-
box and cooled to 0 °C using an ice-water bath.  TBDPSCl (4.09 mL, 15.7 mmol, 1.05 equiv) 
was added dropwise (over 27 min) under nitrogen with a syringe.  The pale yellow reaction 
mixture was warmed to room temperature, at which time the mixture became homogeneous.  
Stirring continued at room temperature under a nitrogen atmosphere, and the reaction progress 
was monitored with TLC.  The starting materials were completely consumed after a total 
reaction time of 3 h.  The reaction was quenched with MeOH (5 mL), and the solvent was 
evaporated.  The residue was dissolved in EtOAc (500 mL) and washed with water (2 × 200 
mL); the organic phase was dried over MgSO4.  The crude product was purified on a silica gel 
column that was eluted with MeOH/CH2Cl2 (0:100-3:97).  Evaporation of the eluting solvent 
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afforded 9 as white foam (7.755 g, 91% yield).  1H NMR (300 MHz, CDCl3):  δ (ppm) 1.02 [9H, 
s, t-Bu (TBDPS)], 2.3-2.41 (2H, m, H-2’ and OH-3’), 3.53-3.62 (1H, m, H-2’), 3.84 (1H, dd, J = 
8.1 and 10.2 Hz, H-5’), 3.98 (1H, dd, J = 7.5 and 10.2 Hz, H-5’), 4.04-4.1 (1H, m, H-4’), 4.99-
5.08 (1H, m, H-3’), 5.6 (2H, br s, NH2), 6.38 (1H, dd, J = 6.3 and 7.2 Hz, H-1’), 7.29-7.43 [6H, 
m, Ph-ortho and para (TBDPS)], 7.62 [4H, dt, J = 1.5 and 8.1 Hz, Ph-meta (TBDPS)], and 8.09 
[1H, s, H-2 (dA)].  13C NMR (75 MHz, CDCl3):  δ (ppm) 19 [CMe3 (TBDPS)], 26.67 [CH3 
(TBDPS)], 36.37 (C-2’), 63.68 (C-5’), 72.09 (C-3’), 86.04, 87.05 (C-4’ and C-1’), 120.15 [C-5 
(dA)], 127.51 [Ph-meta (TBDPS)], 127.66 [C-8 (dA)], 129.63 [Ph-para (TBDPS)], 133 [Ph-C-1 
(TBDPS)], 135.38 [Ph-ortho (TBDPS)], 150.55 [C-4 (dA)], 152.38 [C-2 (dA)], and 154.28 [C-6 
(dA)].  Low resolution ESI MS m/z (M+H)+:  Calc’d 568.14, found 568.13. 
2.5.9.  5’-O-tert-Butyldiphenylsilyl-8-[(anthraquinone-2-yl)ethynyl]-2’-deoxyadenosine (10) 
To 9 (1.914 g, 3.37 mmol) was added in our glove-box Pd(Ph3P)4 (194 mg, 0.17 mmol, 
0.05 equiv), CuI (65 mg, 0.34 mmol, 0.1 equiv), TEA (0.94 mL, 6.7 mmol, 2 equiv), compound 
6 (1.016 g, 4.38 mmol, 1.3 equiv), and anhydrous DMF (29 mL).  The mixture was removed 
from our glove-box and stirred under a nitrogen atmosphere in the dark for 6 h at 65 °C in an oil 
bath.  DMF was removed under reduced pressure, and the residue was dissolved in 10% MeOH 
in CH2Cl2; insoluble materials were removed by filtration over CeliteCelite.  After evaporation 
the crude product was purified with two silica gel columns using MeOH/CH2Cl2 (0:100-3:97) as 
the eluting system to yield yellow foam after evaporation of the eluting solvent.  This foam was 
dissolved in a minimum amount of CH2Cl2 and precipitated by adding hexane. Evaporation of 
CH2Cl2/hexane from the precipitate afforded 10 as a bright yellow solid (2.19 g, 90%).  1H NMR 
(300 MHz, CDCl3):  δ (ppm) 1.03 [9H, s, t-Bu (TBDPS)], 2.45-2.53 (1H, m, H-2’), 2.63 (1H, d, 
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J = 3 Hz, OH-3’), 3.5-3.59 (1H, m, H-2’),  3.89 (1H, dd, J = 5.1 and 10.2 Hz, H-5’), 4.03 (1H, 
dd, J = 7.8 and 10.2 Hz, H-5’), 4.13-4.19 (1H, m, H-4’), 5-5.08 (1H, m, H-3’), 5.96 (2H, br s, 
NH2), 6.32 (1H, t, J = 6.9 Hz, H-1’), 7.29-7.42 [6H, m, Ph-ortho and para (TBDPS)], 7.63 [4H, 
t, J = 6.6 Hz, Ph-meta (TBDPS)],  7.79 [2H, t, J = 3.6 Hz, H-6 (AQ) and H-7 (AQ)], 7.88 [1H, d, 
J = 8.1 Hz, H-3 (AQ)],  8.12 [1H, s, H-2 (dA)], 8.25 [1H, d, J = 8.1 Hz, H-4 (AQ)], 8.27-8.32 
[2H, m, H-5 (AQ) and H-8 (AQ)], and 8.48 [1H, s, H-1 (AQ)].  13C NMR (100 MHz, CDCl3):  δ 
(ppm) 19.17 [CMe3 (TBDPS)], 26.80 [CH3 (TBDPS)], 37.02 (C-2’), 64.12 (C-5’), 73.05 (C-3’), 
81.78 [dA-C (ethynyl)], 85.19, 87.02 (C-4’ and C-1’), 93.74 [AQ-C (ethynyl)], 120.01 [C-5 
(dA)], 126.32 [C-8 (dA)], 127.30 and 127.67 [Ph-meta (TBDPS), and AQ], 129.74 [Ph-para 
(TBDPS)], 130.80 (AQ), 133.10, 133.30, 134.02, 134.27, 134.32 [Ph-C-1 (TBDPS) and AQ], 
135.48 [Ph-ortho (TBDPS)], 136.47 (AQ), 149.12 [C-4 (dA)], 153.69 [C-2 (dA)], 155.24 [C-6 
(dA)], 181.89 (CO), and 182.06 (CO).  ESI MS m/z for C42H42N5O5Si (M+1): calc’d 724.90, 
found 724.20.  Low resolution ESI MS m/z (M+H)+:  Calc’d 720.26, found 720.25. 
2.5.10.  5’-O-tert-Butyldiphenylsilyl-8-[2-(anthraquinone-2-yl)ethyl]-2’-deoxyadenosine (11) 
Compound 10 (940 mg, 1.3 mmol) was dissolved in EtOAc (60 mL) by slight heating 
while stirring; MeOH (90 mL) was then added to the solution.  The resulting solution was 
transferred to a hydrogenation vessel containing 10% Pd/C (500 mg) that had been activated by 
stirring under H2 (40 psi) in MeOH (20 mL) for 30 min at room temperature.  The vessel was 
next charged with H2 gas and then degassed using an aspirator in a cycle that was repeated 5-6 
times.  The vessel was finally charged with hydrogen gas at 40 psi and stirred at room 
temperature for 24 h, by which time TLC showed complete conversion of an initial spot to a 
more polar spot.  The Pd/C catalyst was then removed by filtration over Celite, and adsorbed 
nucleoside residue was extracted from the catalyst by washing with boiling 10% MeOH in 
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CHCl3.  The crude product was applied to a silica gel column and eluted with MeOH/CH2Cl2 
(0:100-3:97).  Evaporation of the eluting solvent afforded 11 as a pale yellow foam (810 mg, 
86% yield).  1H NMR (300 MHz, CDCl3):  δ (ppm) 0.98 [9H, s, t-Bu (TBDPS)], 2.28 (1H, ddd, J 
= 3.9, 6.9 and 13.2 Hz, H-2’), 3.03 (1H, br s, OH-3’), 3.19-3.4 (4H, m, ethylene), 3.58-3.68 (1H, 
m, H-2’),  3.8 (1H, dd, J = 4.8 and 10.5 Hz, H-5’), 3.96 (1H, dd, J = 6.9 and 10.5 Hz, H-5’), 
4.05-4.1 (1H, m, H-4’), 4.92-4.98 (1H, m, H-3’), 5.67 (2H, br s, NH2), 6.25 (1H, t, J = 6.9 Hz, H-
1’), 7.26-7.38 [6H, m, Ph-ortho and para (TBDPS)], 7.52-7.66 [5H, m, Ph-meta (TBDPS) and 
H-3 (AQ)],  7.79 [2H, t, J = 4.5 Hz, H-6 (AQ) and H-7 (AQ)], 8.09 [1H, s, H-2 (dA)], 8.16 [1H, 
d, J = 7.8 Hz, H-4 (AQ)], 8.2 [1H, d, J = 1.8 Hz, H-1 (AQ)], and 8.24-8.3 [2H, m, H-5 (AQ) and 
H-8 (AQ)]. 13C NMR (125 MHz, CDCl3):  δ (ppm) 19.17 [CMe3 (TBDPS)], 26.79 [CH3 
(TBDPS)], 29.16 [dA-CH2 (ethyl)], 33.35 [AQ-CH2 (ethyl)], 36.86 (C-2’), 64.02 (C-5’), 72.69 
(C-3’), 84.18, 86.76 (C-4’ and C-1’), 118.96 [C-5 (dA)], 127.17 [C-8 (dA)], 127.65 [Ph-meta 
(TBDPS)], 129.73 [Ph-para (TBDPS)], 131 (AQ), 133.2, 133.52, 133.63 [Ph-C-1 (TBDPS) and 
AQ], 135.49 [Ph-ortho (TBDPS)], 147.52 (AQ), 150.84 [C-4 (dA)], 151.92 [C-2 (dA)], 154.62 
[C-6 (dA)], 182.75 (CO), and 183.14 (CO).  Low resolution ESI MS m/z (M+H)+: Calc’d 724.30, 
found 724.25. 
2.5.11.  5’-O-tert-Butyldiphenylsilyl-8-[2-(anthraquinone-2-yl)ethyl]-2’-deoxyadenosine 3’-
Dibenzyl Phosphate (12)   
To 11 (750 mg, 1.036 mmol), previously dried two times by co-evaporation with 
anhydrous THF, was added Me-tetrazole (193 mg, 2.28 mmol, 2.2 equiv) and anhydrous THF (7 
mL) in our glove-box.  The mixture was removed from our glove-box and cooled to 0 °C using 
an ice-water bath, and (BnO)2PN(iPr)2 (0.41 mL, 1.24 mmol, 1.2 equiv) was added dropwise 
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under nitrogen with a syringe.  The reaction mixture was stirred under a nitrogen atmosphere for 
10 minutes at 0 °C and then allowed to warm to room temperature with continued stirring for a 
total reaction time of 1 h. A white precipitate began to form after 20 min of stirring, and TLC 
showed formation of a spot that was less polar than the starting material.  This new TLC spot did 
not increase with additional stirring.  The suspension was cooled to -78 °C using a dry ice-
acetone bath, and a solution of m-CPBA (375 mg) in CH2Cl2 (7 mL) was added gradually to the 
chilled mixture.  After 15 minutes of stirring at -78 °C, the mixture became homogeneous, and 
TLC showed conversion of an initial spot to a more polar one.  The mixture was next warmed to 
room temperature, and saturated aqueous NaHCO3 (8 mL) was added.  More CH2Cl2 (50 mL) 
and water (20 mL) were then added.  Finally, the organic layer was separated, washed with 
water, dried with anhydrous MgSO4, and evaporated to dryness.  The syrup obtained was 
purified on silica gel column (16 cm x 2.5 cm dia.) that was eluted with MeOH/CHCl3 (0:100-
3:97).  Evaporation of the eluting solvent afforded 12 as pale yellow foam (833 mg, 82% yield).  
1H NMR (300 MHz, CDCl3):  δ (ppm) 0.99 [9H, s, t-Bu (TBDPS)], 2.4 [1H, ddd, J = 2.1, 6 and 
13.8 Hz, H-2’], 3.18-3.37 (4H, m, ethylene), 3.70 (1H, dd, J = 5.4 and 11.1 Hz, H-5’), 3.82-3.90 
(1H, m, H-2’), 3.96 (1H, dd, J = 6.6 and 11.1 Hz, H-5’), 4.23-4.28 (1H, m, H-4’), 5-5.12 [4H, m, 
CH2 (Bn)], 5.35-5.39 (1H, m, H-3’), 5.54 (2H, br s, NH2),  6.4 (1H, dd, J = 6 and 7.8 Hz, H-1’), 
7.23-7.4 [16H, m, Ph-ortho and para (TBDPS, 6H) and Ph (Bn, 10H)], 7.54-7.59 [4H, m, Ph-
meta (TBDPS)], 7.62 [1H, dd, J = 1.8 and 8.1 Hz, H-3 (AQ)],  7.76-7.82 [2H, m, H-6 (AQ) and 
H-7 (AQ)], 7.98 [1H, s, H-2 (dA)], 8.21 [1H, d, J = 8.1 Hz, H-4 (AQ)], 8.2 [1H, d, J = 1.8 Hz, H-
1 (AQ)], and 8.23-8.32 [2H, m, H-5 (AQ) and H-8 (AQ)].  13C NMR (125 MHz, CDCl3):  δ 
(ppm) 19.13 [CMe3 (TBDPS)], 26.69 [CH3 (TBDPS)], 29.05 [dA-CH2 (ethyl)], 33.07 [AQ-CH2 
(ethyl)], 34.68 (C-2’), 63.04 (C-5’), 69.31-69.68 [m, CH2 (Bn)], 78.66 (C-3’), 84.18, 86.76 (C-4’ 
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and C-1’), 118.85 [C-5 (dA)], 127.13 [C-8 (dA)], 127.58 [Ph-meta (TBDPS)], 128.02, 128.6 [Ph 
(Bn)], 129.68 [Ph-para (TBDPS)], 131.88 (AQ), 132.95 [d, JP-C = 6.1, Ph-C-1 (Bn)], 133.43, 
133.44, 133.52 [Ph-C-1 (TBDPS) and AQ], 134.04, 134.3 [Ph (Bn)], 135.48 [Ph-ortho 
(TBDPS)], 147.42 (AQ), 150.86 [C-4 (dA)], 151.80 [C-2 (dA)], 154.48 [C-6 (dA)], 182.82 (CO), 
and 183.16 (CO).  31P NMR (121 MHz, CDCl3):  δ (ppm) –1.19.  Low resolution ESI MS m/z 
(M+H)+:  Calc’d 984.36, found 984.31. 
2.5.12.  8-[2-(Anthraquinone-2-yl)ethyl]-2’-deoxyadenosine 3’-Dibenzyl Phosphate (13) 
Compound 12 (375 mg, 0.38 mmol) was dissolved in THF (1.5 mL) by stirring at 60 °C 
for 1 min, and then MeOH (10 mL) was added.  To this solution was added NH4F (162 mg, 4.38, 
11.5 equiv), and the reaction mixture was stirred at 60 °C for 6 h by which time TLC showed 
nearly complete consumption of the starting material.  The solvent was reduced in volume, and 
the residue was adsorbed on silica gel.  The adsorbed residue was applied to flash silica gel on a 
biotage column that was eluted with MeOH/CHCl3 (0:100-5:95).  Evaporation of the eluting 
solvent yielded pale yellow foam.  This foam was dissolved in a minimum amount of CH2Cl2 and 
precipitated by adding hexane.  Evaporation of CH2Cl2/hexane from the precipitate afforded 13 
as pale yellow powder (250 mg, 88% yield).  1H NMR (300 MHz, CDCl3):  δ (ppm) 2.22 (1H, 
dd, J = 5.4 and 14.1 Hz, H-2’), 3.02-3.38 (5H, m, ethylene, and H-2’), 3.55 (1H, d, J = 12.9 Hz, 
H-5’), 3.8 (1H, d, J = 12.9 Hz, H-5’), 4.21 (1H, s, H-4’), 5.0-5.17 [5H, m, CH2 (Bn), and H-3’], 
5.77 (2H, br s, NH2),  6.13 (1H, dd, J = 5.1 and 9.9 Hz, H-1’), 6.73 (1H, br s, OH-5’), 7.31-7.38 
[10H, m, Ph (Bn)], 7.65 [1H, dd, J = 1.5 and 7.8 Hz, H-3 (AQ)], 7.78-7.82 [2H, m, H-6 (AQ) and 
H-7 (AQ)], 8.22-8.33 [5H, m, H-2 (dA), H-4 (AQ), H-1 (AQ), H-5 (AQ), and H-8 (AQ)].  13C 
NMR (125 MHz, CDCl3):  δ (ppm) 29.01 [dA-CH2 (ethyl)], 33.01 [AQ-CH2 (ethyl)], 38.16 (C-
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2’), 63.01 (C-5’), 69.71 [d, JP-C = 1 Hz, CH2 (Bn)], 80.21 (C-3’), 85.67, 87.60 (C-1’ and C-4’), 
119.38 [C-5 (dA)], 127.22 [C-8 (dA)], 127.83, 128.20, 128.7, 128.83 [AQ and Ph (Bn)], 132.05 
(AQ), 133.45 [d, JP-C = 3.1, Ph-C-1 (Bn)], 133.63 (AQ), 134.09, 134.20, 134.32, 135.41, 135.46 
[AQ and Ph (Bn)], 147.01, 149.78 (AQ), 150.62 [C-4 (dA)], 151.75 [C-2 (dA)], 155.08 [C-6 
(dA)], 182.82 (CO), and 183.17 (CO).  31P NMR (162 MHz, CDCl3):  δ (ppm) -1.23.  Low 
resolution ESI MS m/z (M+H)+:  Calc’d 746.24, found 746.24. 
2.5.13.  8-[2-(Anthraquinone-2-yl)ethyl]-2’-deoxyadenosine 3’-Benzyl Hydrogen Phosphate 
(2) 
Compound 13 (210 mg, 0.28 mmol) was dissolved in a mixture of EtOAc (10 mL) and 
MeOH (80 mL).  The resulting solution was transferred to a hydrogenation vessel containing 
10% Pd/C (30 mg) that had been activated by stirring under H2 (40 psi) in MeOH (20 mL) for 30 
min at room temperature.  The vessel was next charged with H2 gas and then degassed using an 
aspirator in a cycle that was repeated 5-6 times.  The vessel was finally charged with hydrogen 
gas at 40 psi and stirred at room temperature for 24 h at which time TLC showed that some 13 
was still present.  More 10% Pd/C (20 mg) was added, and the hydrogenation vessel was 
recharged with H2 as described above.  The mixture was stirred at room temperature for an 
additional 7 h under H2 gas (45 psi) by which time TLC showed complete consumption of 13.  
The Pd/C catalyst was then removed by filtration over Celite, and adsorbed nucleotide residue 
was extracted from the catalyst by washing with boiling MeOH.  The crude product was then 
purified by preparative HPLC using a Varian Microsorb C-18 reverse phase column (250 mm × 
41.4 mm dia.).  The column was eluted with a flow rate of 40 mL/min, and the fractions were 
monitored with UV detection at 260 nm.  The mobile phase consisted of a programmed gradient 
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of solution A (70% MeCN in water) and solution B (water): from 0% A/100% B to 50% A/50% 
B over 15 min; then to 100% A/0% B over 5 min, and finally at 100%A/0% B for another 10 
min.  Evaporation of the eluent was facilitated by co-evaporation with MeOH and afforded 2 as 
yellow plates (30 mg, 22% yield).  1H NMR (500 MHz, DMSO-d6):  δ (ppm) 2.33 (1H, ddd, J = 
3.5, 6.5 and 13 Hz, H-2’), 2.98-3.04 (1H, m, H-2’), 3.25-3.4 (4H, m, ethylene), 3.45-3.49 (1H, 
m, H-5’), 3.5-3.58 (1H, m, H-5’), 4.01 (1H, d, J = 3 Hz, H-4’), 4.71 [2H, d, JH-P = 5 Hz, CH2 
(Bn)], 4.87-4.96 (1H, m, H-3’), 6.12 (1H, br d, J = 7 Hz, OH-5’), 6.28 (1H, t, J = 7 Hz, H-1’), 
7.15 (2H, br s, NH2), 7.18 [1H, t, J = 7.5 Hz, Ph-para (Bn)], 7.25 [2H, t, J = 7.5, Ph-meta (Bn)], 
7.33 [2H, d, J = 7.5 Hz, Ph-ortho (Bn)], 7.87 [1H, d, J = 8 Hz, H-3 (AQ)], 7.91-7.93 [2H, m, H-6 
(AQ) and H-7 (AQ)], 8.05 [1H, s, H-2 (dA)], 8.12-8.14 [2H, m, H-1 (AQ) and H-4 (AQ)], and 
8.18-8.22 [2H, m, H-5 (AQ) and H-8 (AQ)].  1H NMR (500 MHz, DMSO-d6 + D2O):  δ (ppm) 
2.3-2.38 (1H, m, H-2’), 2.98-3.04 (1H, m, H-2’), 3.25-3.4 (4H, m, ethylene), 3.52-3.6 (2H, m, H-
5’), 4.05 (1H, s, H-4’), 4.71 [2H, d, JH-P = 5 Hz, CH2 (Bn)], 4.86 (1H, s, H-3’), 6.27 (1H, t, J = 7 
Hz, H-1’), 7.18 [1H, t, J = 7.5 Hz, Ph-para (Bn)], 7.25 [2H, t, J = 7.5, Ph-meta (Bn)], 7.32 [2H, 
d, J = 7.5 Hz, Ph-ortho (Bn)], 7.87 [1H, d, J = 8 Hz, H-3 (AQ)], 7.91 [2H, s, H-6 (AQ) and H-7 
(AQ)], 8.04 [1H, s, H-2 (dA)], 8.1-8.13 [2H, m, H-1 (AQ) and H-4 (AQ)], and 8.19 [2H, m, H-5 
(AQ) and H-8 (AQ)].  13C NMR (125 MHz, DMSO-d6):  δ (ppm) 28.34 [dA-CH2 (ethyl)], 32.72 
[AQ-CH2 (ethyl)], 37.15 (C-2’), 62.42 (C-5’), 65.96 [d, JC-P = 1 Hz, CH2 (Bn)], 75.4 (d, J = 20.3 
Hz, C-3’), 84.16 (C-4’), 86.79 (C-1’), 118.18 [C-5 (dA)], 126.71 [C-8 (dA)], 127.03, 128.05, 
131.28 [AQ and Ph (Bn)], 132.98, 133, 134.52, 134.92 (AQ), 139.5 [d, JC-P = 7.4, Ph-C-1 (Bn)], 
148.15, 149.79 (AQ), 150.82 [C-4 (dA)], 151.63 [C-2 (dA)], 155.49 [C-6 (dA)], 182.22 (CO), 
and 182.53 (CO). 31P NMR (202 MHz, DMSO-d6):  δ (ppm) 0.77.  Low resolution ESI MS m/z 
(M-H)-:  Calc’d 654.18, found 654.20. 
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2.5.14.  2-Iodoanthraquinone (15)  
To a suspension of 14 (3.06 g, 0.137 mol) in THF (21 mL) was added HCl (28 mL) and 
water (7 mL).  The mixture was stirred at 40 °C for 24 h to give a thick, rosey beige suspension.  
This suspension was cooled to 0 °C using an ice-water bath, and a solution of NaNO2 (1.90 g, 
0.027 mol, 2 equiv) in H2O (6.5 mL) was added dropwise with a syringe.  A solution of KI (5.69 
g, 0.034 mol, 2.5 equiv) in H2O (12.5 mL) was added gradually to the reaction mixture while 
stirring at 0 °C.  The reaction mixture was then stirred for an additional 15 min at 0 °C, for 30 
min at room temperature, and finally for 30 min at 60 °C.  THF was evaporated from the 
mixture, and the residue was filtered.  The precipitate was collected and washed first with water 
and then with a saturated solution of aqueous Na2CO3.  The residue was dissolved in CHCl3 (54 
mL), and the solution was shaken with an aqueous solution of Na2S2O3.  The CHCl3 layer was 
separated, dried with anhydrous MgSO4, and evaporated to dryness.  Three consecutive silica gel 
columns eluted with CH2Cl2/hexane (10:90-30:70) afforded 15 as yellow powder (3.42 g, 75% 
yield).  1H NMR (300 MHz, CDCl3):  δ (ppm) 7.83 (2H, m, H-7), 8.01 (1H, d, J= 8.4 Hz, H-4), 
8.16 (1H, dd, J= 8.4 and 1.5 Hz, H-3), 8.30-8.33, (2H, m, H-5, and H-8), and 8.66 (1H, s, H-1).  
13C NMR (75 MHz, CDCl3):  δ (ppm) 127.30, 128.6, 132.5, 133, 133.27, 134, 134.34, 136.23, 
143.06, 181.87, and 182.58.  Low resolution EI MS m/z (M+):  334. 
2.5.15.  2-(Trimethylsilanylethynyl)anthraquinone (16)  
Pd(Ph3P)2Cl2 (24 mg, 0.03 mmol, 0.05 equiv), CuI (13.1 mg, 0.07 mmol, 0.1 equiv), TEA 
(0.19 mL, 1.38 mmol, 2 equiv), and 15 (229.8 mg, 0.69 mmol) were combined and stirred in dry 
THF (4.6 mL) under a nitrogen atmosphere until dissolved; then TMSA (0.23 mL, 2.064 mmol, 
3 equiv) was added.  After 10 minutes of stirring at room temperature, TLC (CH2Cl2/hexanes, 
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1:1 v:v) showed complete consumption of 15.  The solvent was evaporated in vaccuo, and the 
crude material was purified by flash silica gel chromatography (CH2Cl2/hexanes, 0:100-20:80 
v:v) to give 16 as pale yellow solid (210 mg, 96% yield).  1H NMR (300 MHz, CDCl3):  δ (ppm) 
0.3 (9H, s, 3 × CH3), 7.84-7.77 (3H, m, H-4, H-6, and H-7), 8.234 (1H, dd, J= 8.1 and 0.3 Hz, H-
3), 8.319-8.268 (2H, m, H-5, and H-8), and 8.35 (1H, dd, J= 1.5 and 0.3 Hz, H-1).  13C NMR (75 
MHz, CDCl3):  δ (ppm) -0.27, 100.11, 103.14, 126.21, 127.26, 127.29, 129.30, 130.62, 132.44, 
133.26, 133.33, 133.45, 134.17, 134.26, 136.80, 182.43, and 182.47.  Low resolution EI MS m/z 
(M+):  304. 
2.5.16.  2-Ethynylanthraquinone (6) 
To a solution of 16 (200 mg, 0.657 mmol) in THF/ MeOH (1:1 v:v, 26 mL) was added 
potassium fluoride (57.26 mg, 0.985 mmol, 1.5 equiv) at room temperature.  After 1 hour the 
solvent was evaporated; the product was extracted with CHCl3, shaken with charcoal, and 
recrystallized from CHCl3 to afford 6 as brown solid (150 mg, 99% yield).  NMR spectra were 
run on a pale yellow, silica-gel purified portion of this product.  1H NMR (300 MHz, CDCl3):  δ 
(ppm) 3.37 (1H, s, ≡C-H), 7.82 (2H, dd, J= 5.7 and 3.3 Hz, H-6, H-7), 7.67 (1H, dd, J= 8.1 and 
1.8 Hz, H-3), 8.34-8.27 (3H, m, H-4, H-5 and H-8), and 8.41 (1H, d, J= 1.5 Hz, H-1).  13C NMR 
(75 MHz, CDCl3):  δ (ppm) 81.88, 127.33, 130.85, 134.3, 134.36, 137.1, and 182.42.  EI MS m/z 
(M+):  232. 
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Chapter 3 
Synthesis and Electrochemical Evaluation of Conjugates between 2'-Deoxyadenosine and 
Modified Anthraquinone:  New Probes for Hole Transfer Studies in DNA 
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3.1.  Abstract   
Photoexcitation of anthraquinones (AQ) in association with DNA results in DNA damage 
mainly at guanine residues, with products from thymine oxidation also observed.  Studies of 
adenine (A) oxidation will be aided by systems with an increased driving force for charge 
transfer, achieved by adding electron withdrawing groups to the AQ ring.  Attaching AQ 
derivatives to A via two carbon atom linkers should enable the intended regiocontrol within the 
DNA duplex structure.  Herein we report the synthesis of new conjugates between AQ and A, in 
which the AQ moieties have been modified with a formyl, a trifluoroacetyl and two methyl ester 
groups.  These have been synthesized by palladium coupling of tert-butyldiphenylsilyl 5’-
protected 8-ethynyl-2’-deoxyadenosine with the corresponding bromoanthraquinone 
intermediates.  Bromo intermediates bearing formyl or trifluoroacetyl were prepared by 
L = C≡C, R1 = H, R2 = CHO 
L = C≡C, R1 = H, R2 = COCF3 
L = C≡C, R1 = R2 = CO2Me 
L = CH2CH2, R1 = R2 = CO2Me
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monolithiation of 2,6-dibromoanthraquinone, a step that required protection of the anthraquinone 
carbonyls.  A bromo intermediate bearing two methyl ester groups was obtained from 1,2,4-
trimethylbenzene by Friedel-Crafts acylation with 4-bromobenzoyl chloride followed by 
oxidation to the tricarboxylic acid, cyclization to form the anthraquinone  ring, and finally 
esterification.  Hydrogenation of the ethynyl linker gave the ethanyl linker.  Cyclic voltammetry 
showed that the conjugate with the two ester groups and ethynyl linker was the most easily 
reduced of the derivatives synthesized.   
3.2.  Introduction 
 Oxidation of guanine (G) to 8-oxoguanine is the major oxidative damage in DNA that is 
implicated in mutagenesis, carcinogenesis and ageing.1,2  This DNA lesion occurs predominantly 
at G clusters,3 because initial cation radical (hole) on G migrates to GG and GGG sequences.  
Many studies have been conducted in order to investigate the details of this important 
phenomenon.3-12  In many instances anthraquinone (AQ) has been used as an electron acceptor 
chromophore to initiate DNA oxidation, when photoexcited by UV light.13-15  In these systems, 
because the singlet excited state of AQ lives for less than 1 ps,16 it is the triplet excited state of 
AQ that gives charge transfer (CT) product: a radical anion on AQ and a hole on a DNA base.  In 
this aspect, AQ is advantageous over other chromophores in that it can give an initial triplet CT 
product.  All things being equal, a triplet CT product will live considerably longer than a singlet 
CT product.  This would facilitate a higher yield of secondary hole transfer along DNA.16   
If the position of the initial radical on DNA is to be pinpointed, it is necessary to have the 
AQ covalently bound to the DNA.  This should minimize side reactions such as oxidation of 
distant bases and charge recombination during hole migration along the DNA duplex.  A variety 
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of AQ derivatives linked to DNA have been synthesized, including those attached to the 5’-end 
phosphate group,17,18 the C-2’ of a sugar,19,20 a phosphate of the DNA backbone,21 and individual 
bases in the DNA strand.22,23  This last class of derivatives has the greatest potential for creation 
of a hole at a well-defined position on the DNA duplex provided that the linker between the base 
and AQ is very short.  Long linkers permit a variety of options for the position of AQ with 
respect to the DNA, including intercalation between adjacent base pairs in the DNA.22,24,25 
In general, oxidized DNA gives final products due to reactions at a G radical cation (G•+) 
site.  However, a recent study on one-electron oxidation of DNA linked to AQ showed not only 
the expected reaction at GG doublets, but also products from thymine (T) residues.21  Another 
study also on DNA linked to AQ, in which the DNA had only adenine (A) and thymine residues, 
found that T formed oxidation products in preference to A.26,27  Since A is easier to oxidize than 
T,28,29 this finding was unexpected.  These observations were attributed to the significantly 
higher reactivity of the T radical cation (T•+) compared to that of the A radical cation (A•+).  On 
the other hand, it has been shown that oxidation of A in a consecutive A stretch, rather than 
oxidation of G, results in a higher yield of DNA damage.30 
Our previous work showed that A•+ can be formed by photolysis of a system containing 
both A and AQ.16  Whether or not an AQ-A conjugate forms the AQ•−/A•+ CT photoproduct 
depends on the details of the system studied.  For example, irradiation of the AQ-A conjugates 
AQYdA or AQEdA in methanol31 or AQYdAP or AQEdAP32 in water33 did not give the 
AQ•−/A•+ photoproduct.  On the other hand, photoexcitation of AQCOdA did give the AQ•−/A•+ 
in MeOH and DMSO.16  In addition, photoexcitation of a bimolecular solution of 2’-
deoxyadenosine (dA) and anthraquinone-2-sulfonate (AQS) in water produced the AQ•−/A•+ CT 
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product.31  One possibility for these observations is that AQ•−/A•+ is formed only when the 
anthraquinone is substituted with an electron withdrawing group, which would be expected to 
result in a greater driving force for the CT reaction.  Indeed, most literature examples of DNA 
oxidation with AQ have employed derivatives with an amide carbonyl17,18,21,22,34 or sulfonyl35,36 
attached to the AQ. 
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Future studies in the area of A oxidation would be greatly aided by access to a series of 
AQ-dA derivatives with different driving forces for CT.  Our work and literature studies indicate 
that these AQ derivatives should have electron withdrawing substituents on the AQ ring.  In such 
systems, the AQ can oxidize its covalently attached A, giving a precise point of initial DNA 
oxidation.  Herein, we report the synthesis of AQ-dA conjugates (1-4) bearing formyl, 
trifluoroacetyl or methyl ester groups as carbonyl containing substituents.  In view of the 
probable importance of the linker in studies of AQ-A conjugates, the diester has been prepared 
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with both ethanyl and ethynyl linkers.  Electrochemical potentials of these conjugates were 
measured in acetonitrile versus saturated calomel electrode (SCE).   
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3.3.  Results and Discussion 
Our choice of the substituents to modify AQ was not based only on the feasibility of their 
preparations, but also on the compatibility of such substituents toward a variety of conditions 
used in the conventional DNA synthesis protocols.  The final target conjugates required 
protection of at least one hydroxyl on dA to improve solubility in acetonitrile to the necessary 
concentrations for electrochemical measurements.  Hence, dA 5’-protected with a tert-
butyldiphenylsilyl (TBDPS) group was used as the starting material.  This protection was also 
important to increase the solubility of the synthetic intermediates. 
3.3.1.  Synthesis of deoxyadenosine substrate 
In our previous work32 we joined AQ to dA via an alkyne linker by first allowing 2-
iodoanthraquinone to react with trimethylsilylacetylene (TMSA) using Pd catalyzed cross-
coupling chemistry.  Deprotection of the trimethylsilyl group on the resulting 2-
ethynylanthraquinone permitted a second Pd coupling with 5’-protected 8-bromo-dA to form the 
desired AQ-dA conjugates.  However, working with the ethynylanthraquinone imposed synthetic 
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constraints due to its poor solubility, photoinstability, and the chromatographic similarity of the 
protected bromo-dA starting material and AQ-dA products. 
SCHEME 1 
N
N N
N
NH2
O
OH
TBDPSO
N
N N
N
NH2
O
OH
TBDPSO
TMSN
N N
N
NH2
O
OH
TBDPSO
Br
TMSA, CuI, TEA, 
PdCl2(PPh3)2, THF, 
60 °C, 0.5 h
85%
K2CO3, CH2Cl2/MeOH, 
rt, 0.5 h
quant
5 6 7
 
Therefore, in our present work, we switched the order of the alkynylation steps.  
Protected 8-bromo-2’-deoxyadenosine 532 was first coupled with TMSA using Pd-based 
chemistry as illustrated in Scheme 1 to give the protected alkyne 6.  The yield of this step was 
greatly affected by the interval between the addition of the reagents.  For example, when TMSA 
was added 2 min after triethylamine (TEA) addition, the yield was 57%.  On the other hand, 
immediate addition of TMSA after TEA improved the yield to 85%.  The silyl group on the 
ethynyl of 6 was removed quantitatively by using K2CO3 as an oxide37 leaving the silyl 
protection on 5’-O intact to yield the free alkyne 7.  This in turn was Pd-coupled with 
bromoanthraquinone derivatives bearing a formyl, a trifluoroacetyl or two methyl ester groups. 
3.3.2.  Modification of AQ moiety with a formyl group 
We chose to introduce the formyl group via lithiation of a bromide on AQ using butyl 
lithium.  Because the AQ carbonyls are susceptible to addition of such a strongly nucleophilic 
reagent, protection of the AQ quinone function was necessary.  A second bromide on AQ was 
needed to couple AQ with the terminal alkyne on 7 using Pd-based coupling.  Thus, our synthetic 
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strategy started with 2,6-dibromoanthraquinone.  Other strategies based on electrophilic aromatic 
substitutions38-40 or Diels-Alder reactions41 were avoided in order to circumvent obtaining 
regioisomers.  The feasibility of monolithiation of 2,6-dihaloanthraquinone was key in this 
synthesis. 
SCHEME 2 
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ii. NaOH, rt, 15 min
iii. CF3SO3Bu, rt, 2 h
i. n-BuLi, THF,
  −72 °C,10 min
ii. CF3CO2Et or DMF, 
  −72 °C - rt, 1 h
AgO, 6 N HNO3, 
dioxane, rt, 5 min
7, Pd(PPh3)4, CuI, 
TEA, DMF, 65 °C, 3 h
10% Pd/C, H2, 45 psi, 
MeOH, rt, 24 h
R
8 9 10
13: R = CHO
14: R = COCF3
1: R = CHO
2: R = COCF3
 
As illustrated in Scheme 2, the initial step was transformation of 2,6-
diaminoanthraquinone (8) to the dibromo derivative 9 as described in the literature42 with minor 
modifications in the procedure.  In general, protection of the quinone functionality is most 
commonly done by reductive methylation to form the dimethoxyanthracene derivatives.42-45  
However, a number of different modifications of this reaction all gave mixtures with low 
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solubility including a substantial amount of unreacted 9, which made chromatographic 
purification troublesome.  To solve this problem, use of a larger alkyl group was necessary.  
Even though the literature42 has reported good yields of reductive propylation of 9 using n-propyl 
bromide, only trace amounts of the propylated product were obtained in our hands.  However, 
use of butyl triflate as a more reactive alkylating agent in the one pot reductive alkylation 
employing Na2S2O4 in phase transfer catalysis gave the dibutylanthracene derivatives 10 in 88% 
yield.  Strict anaerobic conditions were essential to obtain the product in good yield.  A solution 
of the protected 10 in tetrahydrofuran (THF) was successfully monolithiated with 1.05 equiv of 
n-BuLi at –72 °C; subsequent quenching with DMF afforded the desired bromo intermediate 11.  
The optimal yield was obtained when 15 mg/mL as a concentration of 10 in THF was used; 
higher concentrations led to precipitation of 10 when the solution was cooled to –72 °C, resulting 
in reduced yields of monosubstitution with the formyl group. 
Oxidative dealkylation of 11 to the anthraquinone aldehyde 13 was effected using 
AgO/HNO3 in dioxane46 for 5 min or PhI(OCOCF3)2 in water47 and THF for 7 h.  The former 
reagent was preferred because filtration and water workup removed all side products and 
chromatography was not required.  The AQ-dA conjugate 1 was obtained in a moderate yield via 
Pd-catalyzed coupling between 13 and 7, with 13 used in a higher molar ratio than 7 to ease 
purification.  Hydrogenation of 1 using 10% Pd/C in methanol resulted in the reduction of the 
alkyne linker, with the product isolated as the corresponding dimethyl acetal 15 in 86% yield. 
Literature studies indicate that the formyl group can be incorporated into DNA.  For 
instance, the formyl group has been protected before incorporation into DNA, with later acidic 
hydrolysis to afford unprotected formyl.48  The formyl group has also been introduced into DNA 
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using the phosphorimidite of 3-formylindole 2’-deoxynucleoside directly without protection,49 
indicating that this group can survive DNA synthesis conditions. 
3.3.3.  Modification of AQ moiety with a trifluoroacetyl group 
The bromo trifluoroacetate 12 was synthesized as described above for 11, except that 
ethyl trifluoroacetate was used instead of DMF as the quenching electrophile after lithiation.  
Oxidative dealkylation of 12 with AgO/HNO3 gave the desired product 14, and was preferable to 
PhI(OCOCF3)2, which gave substantial amounts of a side product.  Compound 14 was obtained 
as a mixture of the ketone and its water adduct, the geminal diol, in a ratio of 2:1.  This was 
judged by 1H NMR resonances for H-5 at both 8.92 ppm (ketone) and 8.56 ppm (gem diol), and 
19F NMR resonances at both –72.34 (ketone) and –83.90 (gem diol) ppm.  COCF3 moieties are 
known to hydrate.50-53  Following a protocol in the literature,54 shaking of 14 in ethyl acetate with 
a solution of NaHCO3 in water, followed by removal of the ethyl acetate, gave the ketone 
exclusively as shown by NMR. 
Conjugate 2 was synthesized by Pd coupling of anthraquinone 14 to 7 as described 
above.  The product was isolated via silica gel purification using a MeOH/EtOAc/hexane solvent 
mixture. 19F NMR in CDCl3/CD3OD showed a single resonance at –83.57 ppm.  The mass 
spectrum indicated that the majority of the product was the geminal diol (rather than the 
hemiketal55 or ketal).  Treatment of the diol form of 2 with NaHCO3 as described for 14 did not 
result in reversion to the ketone form.  However, when conjugate 2 was dissolved in a saturated 
solution of K2CO3 in methanol and stirred overnight, treated with water, and extracted with 
chloroform, the ketone form was obtained.  This was confirmed by the 19F NMR peak at –72.54 
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ppm, and 1H NMR (CDCl3) peaks at 9.02, 8.53 and 8.49 ppm corresponding to the three protons 
(H-5, H-8 and H-7, respectively) of the AQ ring bearing the COCF3. 
3.3.4.  Modification of the AQ moiety with two methyl ester groups 
6-Bromoanthraquinone-2,3-dicarboxylic acid (18) was the key intermediate for making 
AQ-dA conjugates modified with two methyl ester groups.  As shown in Scheme 3, 18 was 
prepared analogously to the literature procedure for anthraquinone-2,3-dicarboxylic acid.56,57  
Friedel-Crafts acylation of 1,2,4-trimethylbenzene with 4-bromobenzoyl chloride afforded 
benzophenone derivative 16.  Following the original procedure, the desired 16 was often 
contaminated with significant amounts of a by-product that was difficult to remove by either 
fractional distillation or chromatography.  This by-product was isolated by crystallization from 
ethyl acetate and identified by NMR as a methyl homologue of 16 (methyl homologues result 
from a side reaction common under Friedel-Crafts conditions58,59).  To increase the yield of 16, 
we minimized this side reaction by preliminary mixing of AlCl3 and 4-bromobenzoyl chloride 
and dropwise addition of 1,2,4-trimethylbenzene at –20 °C.  Fractional crystallization of the 
crude product from ethyl acetate/methanol allowed separation of pure 16. 
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SCHEME 3 
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The tricarboxylic acid 17 was obtained by refluxing 16 in 20% aqueous HNO3 to give an 
alkali-soluble mixture of monocarboxylic acids60 that was further oxidized with KMnO4 in 4% 
NaOH.  To prevent any possible displacement of the bromide on the product by hydroxide, the 
crude product mixture was taken to pH ≈ 9 before concentration.  Cyclodehydration of 17 was 
effected by conc. H2SO4 to give the bromo anthraquinone 18.  Removal of all H2SO4 from the 
product 18 by washing with water was difficult due to its solubility in water.  Hence, the crude 
mixture of 18 was esterified in refluxing methanol using the H2SO4 present in this crude material 
as the catalyst to give the dimethyl ester 19.  Compound 19 in turn was coupled to 7 using Pd-
catalyzed chemistry to give conjugate 3 and then hydrogenated in a manner similar to that 
described above to give conjugate 4. 
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Solid phase DNA synthesis generally employs ammonia in the final deprotection step.  
However, ammonia can react with methyl esters to form amides61 which can further hydrolyze 
under basic conditions to the corresponding carboxylic acids.62  The ammonia step can be 
replaced by treatment with 0.05 M K2CO3 in methanol; the AQ dimethyl ester was stable to these 
milder conditions.  
3.3.5.  Electrochemical results 
Table 3.1.  Reduction potentials of AQ and AQdA conjugates in CH3CN. 
Compound Linker with dA substituent E1/2 (SCE) 
AQ none none –0.939 
AQYdA-5’-O-TBDPS C≡C none –0.810 
AQEdA-5’-O-TBDPS CH2CH2 none –0.935 
AQCOdA-3’,5’-di-O-Ac amide amide –0.734 
1 C≡C CHO –0.639 
3 C≡C di(CO2Me) –0.570 
4 CH2CH2 di(CO2Me) –0.703 
 
Reduction potentials for selected AQ-dA conjugates were measured in acetonitrile versus 
SCE (Table 1).  For these conjugates, the cyclic voltammogram (CV) is reported only for the 
first one electron reduction of the AQ, because the second was not reversible.  The conjugates 
synthesized herein were compared with previous conjugates AQYdA, AQEdA and AQCOdA, 
for which photophysical studies have been performed.16,31,33  To increase the solubility in 
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acetonitrile for the electrochemistry measurements, the AQYdA and AQEdA conjugates were 
studied as the 5’-O-TBDPS derivatives32 and AQCOdA conjugate was studied as the 3’,5’-di-O-
Ac derivative.16  AQCOdA-3’,5’-di-O-Ac had a reduction potential of –0.735 V, making it easier 
to reduce than AQ itself by 200 mV.  This ease of reduction is consistent with the observation 
that this conjugate undergoes charge transfer upon photoexcitation.16 
Two conjugates with ethanyl linkers were investigated.  The reduction potential of 
AQEdA-5’-O-TBDPS conjugate was –0.935 V, which was the same as that of AQ itself at –
0.939 V.  Thus, the ethanyl linker seems to isolate the AQ group effectively from the rest of the 
molecule.  With the same linker, diester substitution (4) gave a conjugate easier to reduce by 240 
mV.  The conjugate bearing a CH(OMe)2 group on the anthraquinone (15) did not show 
reversible electrochemistry. 
Comparison of the ethanyl and the ethynyl linkers showed that the conjugates with the 
ethynyl linker were more easily reduced.  Thus, AQYdA-5’-O-TBDPS was easier to reduce than 
AQEdA-5’-O-TBDPS and 3 was easier to reduce than 4 by approximately 130 mV.  The 
comparative ease of reduction of AQ in the conjugates with the ethynyl linker is consistent with 
the extended conjugation in these systems as well as the electron withdrawing nature of the 
ethynyl group.  
Two additional molecules with ethynyl linkers were evaluated.  Efforts to obtain 
reproducible reduction potential values for the conjugate 2 with the C(OH)2CF3 substituent were 
thwarted by the ease with which this compound converted between the ketone and geminal diol 
forms under the conditions of the electrochemistry experiments.  This has literature precedence 
in the electrochemistry of trifluoroacetylbenzophenone.63,64  We also looked at the formyl 
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conjugate 1.  This conjugate was more difficult to reduce than the diester conjugate 3 by 
approximately 70 mV.  Formyl conjugate 1 also showed some degradation on repeated cycles of 
reduction and reoxidation.  Thus, although the formyl group has been reported to be stable on 
DNA in aqueous solution,48,49,65 the somewhat more favorable reduction potential and the 
enhanced stability of the anthraquinone diester make 3 the molecule of choice for future 
photophysical studies. 
3.4.  Conclusion  
The syntheses of novel AQ-dA conjugates with the AQ bearing electron withdrawing 
formyl, trifluoroacetyl and dimethyl ester groups have been achieved.  In these conjugates, AQ 
was linked to adenine via ethanyl or ethynyl groups.  Electrochemical measurements of these 
conjugates revealed that the diester modification facilitates the reduction of AQ by 240 mV 
compared with the corresponding unmodified conjugates.  In addition, the ethynyl linkers further 
enhances the reduction potential of the AQ by 130 mV relative to ethanyl linkers.  Conjugates of 
AQ-dA with ethynyl linker and diester substituents on AQ would satisfy two advances required 
for achieving better yields for hole transfer in DNA.  The first is favorable oxidation of A by 
virtue of the electron withdrawing nature of the substituent groups.  The second is regiocontrol of 
the DNA secondary structure by the short and rigid linker between AQ and A.    
3.5.  Experimental 
3.5.1.  Materials and general synthetic methods   
n-Butyl triflate was purchased from TCI America.  Anhydrous and air-sensitive solvents 
and reagents were used and stored in between uses in a Vacuum Atmospheres Company (VAC) 
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M040-2 glove box that was pressurized with nitrogen boil-off gas from a liquid nitrogen tank or 
in a VAC CS-40 glove box freezer at –20 °C.  Solvents for synthesis were dried and redistilled 
using standard methods.  Ethyl trifluoroacetate was distilled over CaH2 prior to use.  Distilled 
solvents and reagents were transferred under nitrogen gas to the glove box immediately after 
distillation using an evacuated Schlenk tube or flask containing activated molecular sieves.  
Dichloromethane and methanol were freshly distilled over CaH2 and Mg0, respectively, before 
use.  All glassware used for anhydrous reactions was treated with hexamethyldisilazane and/or 
baked in an oven at 150 °C for at least 2 h.  All starting materials for anhydrous reactions were 
dried prior to use on a vacuum line (1 - 4 × 10–4 torr).  All reaction vessels were sealed with 
rubber septa and pressure change (due reagent addition or temperature change) inside the vessels 
was stabilized using a balloon filled with nitrogen gas.  The temperatures of the oil baths were 
controlled using a programmable Dataplate® 721P digital hotplate/stirrer.  Reactions were 
monitored with glass-backed TLC plates pre-coated with silica gel 60 F254 (EMD Chemicals).  
Flash column chromatography was carried out on either a Biotage Flash-40™ system using 
prepackaged KP-Sil™ cartridges, or on Whatman™ flash silica (60Å pore, 230-400 mesh) that 
was packed in glass columns and pressurized with nitrogen.  Melting points were corrected.  
NMR Spectra were recorded on a Varian Unity +300, Varian Unity Inova 500, or Brucker 
Avance 400 spectrometer, using either CDCl3 or DMSO-d6 as solvents.  Chemical shifts for 1H 
NMR in these solvents were referenced relative to tetramethylsilane (0.00 ppm), CDCl3 (7.24 
ppm) or DMSO (2.50 ppm).  Chemical shifts for 13C NMR were referenced relative to CDCl3 
(77.23 ppm) or DMSO (39.50 ppm).  13C NMR signals were assigned using 13C-APT technique.  
19F NMR spectra were recorded using trifluoroacetic acid (–76.55 ppm) as an external standard.  
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High resolution (HR) MS were either obtained with electrospray ionization (ESI) on a Q-
TOFTM Waters Micromass or with electron impact (EI) on a 70SE VG instrument. 
3.5.2.  5’-O-tert-Butyldiphenylsilyl-8-[(trimethylsilyl)ethynyl]-2’-deoxyadenosine (6) 
Compound 532 (2.5 g, 3.4 mmol), Pd(PPh3)2Cl2 (154 mg, 0.220 mmol, 0.0500 equiv) and 
CuI (84 mg, 0.44 mmol, 0.10 equiv) were combined and stirred in dry THF (25 mL) in a glove 
box.  Triethylamine (TEA) (1.23 mL, 8.80 mmol, 2.00 equiv) was added followed immediately 
by trimethylsilylacetylene (TMSA) (1.50 mL, 13.2 mmol, 3.00 equiv).  The dark brown mixture 
was removed from the glove box and stirred under a nitrogen atmosphere at 60 °C in an oil bath 
for 30 min.  The solvent was removed under reduced pressure, and the black foam residue was 
dried in vacuo at 45 °C for 2 h.  The dry crude material was purified two times with silica gel 
column chromatography.  The first column was eluted with MeOH/CH2Cl2 (0:100-3:97) and the 
second was eluted with EtOAc/CH2Cl2 (1:9-1:1).  Evaporation of the eluting solvent afforded 6 
as a light brown foam (2.20 g, 85% yield).  1H NMR (300 MHz, CDCl3):  δ (ppm) 0.03 [9H, s, 
CH3 (TMS)], 1.05 [9H, s, t-Bu (TBDPS)], 2.27 [1H, d, J = 3.3 Hz, OH-3’ (dA)], 2.41 [1H, ddd, J 
= 4.5, 7.5 and 13.5 Hz, H-2’ (dA)], 3.35-3.44 [1H, m, H-2’ (dA)],  3.89 [1H, dd, J = 4.8 and 9.6 
Hz, H-5’ (dA)], 3.99-4.10 [2H, m, H-5’ and H-4’ (dA)], 4.97-5.14 [1H, m, H-3’ (dA)], 5.66 (2H, 
br s, NH2), 6.52 [1H, dd, J = 3.3, 4.5 Hz, H-1’ (dA)], 7.26-7.45 [6H, m, Ph-ortho and para 
(TBDPS)], 7.61-7.64 [4H, m, Ph-meta (TBDPS)], and 8.14 [1H, s, H-2 (dA)].  13C NMR (125 
MHz, CDCl3):  δ (ppm) –0.6 [CH3 (TMS)], 19.2, 26.9, 37.3, 64.4, 73.4, 84.8, 86.7, 92.5 and 
103.7 (C≡C), 120.0, 127.7, 129.8, 133.2, 134.3, 135.6, 149.2, 153.6 and 155.1.  HRMS (ESI) 
calcd for C31H40N5O3Si2 [M + H]+ 586.2670, found 586.2646. 
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3.5.3.  5’-O-tert-Butyldiphenylsilyl-8-ethynyl-2’-deoxyadenosine (7) 
To a solution of 6 (0.29 g, 0.50 mmol) in CH2Cl2/ MeOH (1:5 v:v, 6 mL) was added 
K2CO3 (89 mg, 0.64 mmol, 1.5 equiv).  The mixture was stirred at rt for 30 min.  Water and 
more CH2Cl2 were added, and the mixture was transferred to a separatory funnel.  The organic 
layer was separated, dried with anhyd MgSO4 and evaporated to dryness.  The residue was 
purified by silica gel column eluted with MeOH/CH2Cl2 (0:100-4:96).  Evaporation of the 
eluting solvent afforded 7 as a white foam (252 mg).  1H NMR (400 MHz, CDCl3):  δ (ppm) 0.93 
[9H, s, t-Bu (TBDPS)], 2.29 [1H, ddd, J = 4, 7.2 and 13.6 Hz, H-2’ (dA)], 3.29 (1H, s, ≡C-H), 
3.34-3.42 [1H, m, H-2’ (dA)], 3.53 [1H, br s, OH-3’ (dA)], 3.79 [1H, dd, J = 5.2 and 10.4 Hz, H-
5’ (dA)], 3.93 [1H, dd, J = 7.6 and 10.4 Hz, H-5’ (dA)], 4.03-4.09 [1H, m, H-4’ (dA)], 4.86-4.89 
[1H, m, H-3’ (dA)], 6.29 (2H, br s, NH2), 6.49 [1H, t, J = 7.2 Hz, H-1’ (dA)], 7.18-7.34 [6H, m, 
Ph-ortho and para (TBDPS)], 7.51-7.57 [4H, m, Ph-meta (TBDPS)], and 8.07 [1H, s, H-2 (dA)].  
13C NMR (100 MHz, CDCl3):  δ (ppm) 19.4, 27.0, 37.1, 64.2, 72.8 and 72.9, 84.7 (C≡C), 85.2, 
87.3, 127.8, 127.9, 129.9, 129.9, 133.2, 133.5, 133.8, 135.7, 135.7, 149.3, 153.9 and 155.6.  
HRMS (ESI) calcd for C28H32N5O3Si [M + H]+ 514.2274, found 514.2271. 
3.5.4.  2,6-dibromoanthraquinone (9)42   
To 2,6-diaminoanthraquinone (10.0 g, 41.4 mmol) was added CuBr2 (20.8 g, 93.2 mmol, 
2.25 equiv) and anhyd acetonitrile (175 mL).  To the resulting suspension was added t-BuONO 
(12.35 mL, 93.20 mmol, 2.250 equiv) under nitrogen gas.  The mixture was heated to 63 °C, 
which led to evolution of a colorless gas that continued for 15 min.  The mixture was stirred at 
the same temperature for an additional 2 h, and then quenched by adding 20% HCl (98 mL) and 
stirring for 5 min.  Water (150 mL) was added and the light brown precipitate was separated by 
  
80
filtration, washed with water and air dried.  The crude product was dissolved in boiling dioxane 
and then active charcoal was added.  Recrystallization from dioxane (800 mL) afforded 9 as light 
yellow crystals (11.7 g, 78% yield), mp 285-287 °C.  1H NMR (400 MHz, CDCl3):  δ (ppm) 7.94 
(2H, dd, J = 2 and 8.4 Hz, H-3 and H-7), 8.17 (2H, d, J = 8.4 Hz, H-4 and H-8) and 8.44 (2H, d, 
J = 2 Hz, H-1 and H-5).  13C NMR (100 MHz, CDCl3):  δ (ppm) 129.4, 130.4, 130.6, 132.0, 
134.6, 137.7 and 181.6 (C-9 and C-10).  Low resolution EI MS m/z (M+):  366. 
3.5.5.  2,6-Dibromo-9,10-di-n-butoxyanthracene (10) 
A suspension of 9 (3.0 g, 8.1 mmol) and n-Bu4NBr (2.37 g, 7.30 mmol, 0.900 equiv) in 
CH2Cl2 (90 mL) was placed in a Synthware Glass 250-mL round bottom Schlenk flask with a 
side arm inlet controlled with a glass stopcock.  This Schlenk flask was equipped with a stirring 
bar and connected to the vacuum line through an adapter with a valve.  The contents of the flask 
were degassed by freezing the suspension and applying vacuum through the adapter until the 
pressure in the flask was ≤ 5 millitorr.  The vacuum was then disconnected and the mixture was 
allowed to thaw.  The freeze-vacuum-thaw cycle was repeated until the pressure remained 
constant in the flask when the mixture was frozen.  The vacuum adapter was closed and the 
space in the flask was filled with nitrogen gas through the side arm.  Sodium dithionite (4.92 g, 
24.3 mmol, 3.00 equiv) was added to frozen degassed water (23 mL) in a separate flask and then 
the water-dithionite mixture was degassed again.  The resulting solution was added to the 
suspension of 9 under nitrogen gas via a cannula.  After stirring for 1 min, a dark green color 
developed; the mixture was stirred for 5 min at rt.  A degassed solution of NaOH (1.65 g, 40.5 
mmol, 5.00 equiv) in water (15 mL) was added under nitrogen gas via a cannula.  After stirring 
for 15 min at rt, the dark red mixture was cooled to 0 °C using an ice-water bath; and n-butyl 
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triflate (13.2 mL, 81.0 mmol, 10.0 equiv) was added gradually (over 10 min).  The ice bath was 
removed, and the mixture was stirred at rt for 2 h to give two clear layers with a yellow 
fluorescent organic layer.  Saturated aqueous NaHCO3 was added until the mixture became 
basic.  The organic layer was separated, and the aqueous layer was extracted two times with 
CH2Cl2.  The combined organic layers were dried with anhyd MgSO4 and evaporated to dryness.  
The crude product was dissolved in a minimal amount of hot chloroform, loaded on silica gel 
and purified using silica gel chromatography on four Biotage columns (40+M cartridge) eluted 
with CH2Cl2/hexane (5:95 v:v).  Evaporation of the eluting solvent afforded 10 as bright yellow 
crystals (3.43 g, 88% yield), mp 125-127 °C.  1H NMR (400 MHz, CDCl3):  δ (ppm) 1.06 [6H, t, 
J = 7.2 Hz, CH3], 1.62-1.72 [4H, m, H-3 (Bu)], 1.94-2.02 [4H, m, H-2 (Bu)], 4.09 [4H, t, J = 6.4 
Hz, H-1 (Bu)], 7.49 (2H, dd, J = 2 and 9.2 Hz, H-3 and H-7), 8.09 (2H, d, J = 9.2 Hz, H-4 and 
H-8) and 8.36 (2H, d, J = 2 Hz, H-1 and H-5).  13C NMR (100 MHz, CDCl3):  δ (ppm) 14.0, 
19.4, 32.6, 76.4, 120.3, 124.1, 124.7, 124.8, 126.1, 129.3 and 147.0.  HRMS (ESI) calcd for 
C22H24Br2O2 [M]+ 478.0143, found 478.0195. 
3.5.6.  2-Bromo-6-formyl-9,10-di-n-butoxyanthracene (11) 
Compound 10 (0.12 g, 0.25 mmol) was dissolved in anhyd THF (8 mL), and cooled to –
72 °C (dry ice-ethanol bath).  n-BuLi (160 μL, 0.27 mmol, 1.1 equiv) was added dropwise (over 
5 min), and the homogeneous brown reaction mixture was stirred for an additional 10 min at the 
same temperature.  DMF (0.10 mL, 0.75 mmol, 1.5 equiv) was added, which led to the change of 
the brown color to yellow.  The reaction mixture was stirred for 30 min at –72 °C and for 30 min 
at rt.  A saturated aqueous solution of NH4Cl was added; this was followed by addition of water 
and CH2Cl2.  The organic layer was separated, dried over anhyd MgSO4 and evaporated to 
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dryness.  The crude product was applied to a silica gel column and eluted with CH2Cl2/hexane 
(0:100-35:65).  Evaporation of the eluting solvent afforded 11 as a bright intense yellow powder 
(65 mg, 70% yield), mp 116-118 °C.  1H NMR (400 MHz, CDCl3):  δ (ppm) 1.06 [3H, t, J = 7.2 
Hz, CH3], 1.07 [3H, t, J = 7.2 Hz, CH3], 1.63-1.72 [4H, m, H-3 (Bu)], 1.95-2.05 [4H, m, H-2 
(Bu)], 4.09 [2H, t, J = 6.4 Hz, H-1 (Bu)], 4.15 [2H, t, J = 6.4 Hz, H-1 (Bu)], 7.52 (1H, dd, J = 2 
and 9.2 Hz, H-3), 7.86 (1H, dd, J = 1.6 and 9.2 Hz, H-7), 8.11 (1H, d, J = 9.2 Hz, H-4), 8.24 
(1H, d, J = 9.2 Hz, H-8), 8.39 (1H, d, J = 2 Hz, H-1), 8.67 (1H, d, J = 1.6 Hz, H-5) and 10.15 
(1H, s, CHO).  13C NMR (100 MHz, CDCl3):  δ (ppm) 14.2, 19.6, 19.6, 32.8, 32.9, 76.4, 77.4, 
121.5, 122.0, 124.3, 124.3, 124.5, 125.2 and 125.2, 127.4, 128.5, 129.6, 132.1, 134.0, 147.0, 
150.4 and 192.1 (CHO).  HRMS (EI) calcd for C23H25BrO3 [M]+ 428.0987, found 428.0984. 
3.5.7.  2-Bromo-6-trifluoroacetyl-9,10-di-n-butoxyanthracene (12) 
Compound 10 (0.24 g, 0.50 mmol) was dissolved in anhyd THF (20 mL) and cooled to –
72 οC (dry ice-ethanol bath).  n-BuLi (0.330 mL, 0.530 mmol, 1.05 equiv) was added dropwise 
(over 5 min), and the homogeneous brown reaction mixture was stirred for an additional 10 min 
at the same temperature.  CF3COOEt (0.10 mL, 0.75 mmol, 1.5 equiv) was added, which led to 
the change of the brown color to orange.  The reaction mixture was stirred for 30 min at –72 οC 
and for 30 min at rt.  A saturated aqueous solution of NH4Cl was added; this was followed by 
addition of water and CH2Cl2.  The organic layer was separated, dried over anhyd MgSO4 and 
evaporated to dryness.  The crude product was purified using silica gel chromatography on a 
Biotage column (40+S cartridge) eluted with CH2Cl2/hexane (1:4 v:v).  Evaporation of the 
eluting solvent afforded 12 as an orange powder (169 mg, 68% yield), mp 105-107 °C.  1H NMR 
(400 MHz, CDCl3):  δ (ppm) 1.07 (3H, t, J = 7.2 Hz, CH3), 1.08 (3H, t, J = 7.2 Hz, CH3), 1.63-
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1.74 [4H, m, H-3 (Bu)], 1.96-2.04 [4H, m, H-2 (Bu)], 4.10 [2H, t, J = 6.4 Hz, H-1 (Bu)], 4.16 
[2H, t, J = 6.4 Hz, H-1 (Bu)], 7.55 (1H, dd, J = 2 and 9.2 Hz, H-3), 7.97 (1H, dd, J = 1.6 and 9.2 
Hz, H-7), 8.13 (1H, d, J = 9.2 Hz, H-4), 8.27 (1H, d, J = 9.2 Hz, H-8), 8.41 (1H, d, J = 2 Hz, H-
1) and 9.07 (1H, d, J = 1.6 Hz, H-5).  13C NMR (100 MHz, CDCl3):  δ (ppm) 14.2, 14.2, 19.6, 
19.6, 32.8, 32.8, 76.7, 77.9, 117.2 (q, J = 290 Hz, CF3), 122.6, 122.1 and 123.9, 124.4, 124.5, 
125.2 and 125.3, 126.8, 126.9 and 129.2, 129.9, 130.3 (q, J = 3 Hz, C-5), 146.9, 151.4 and 180.4 
(q, J = 34 Hz, COCF3).  19F NMR (282 MHz, CDCl3):  δ (ppm) -70.53.  High resolution ESI MS 
m/z [M+H]+:  Calc’d for C24H25BrF3O3 497.0939, found 478.0959. 
3.5.8.  2-Bromo-6-formylanthraquinone (13) 
Solid 11 (74 mg, 0.18 mmol) and AgO (34 mg, 0.27 mmol, 1.5 equiv) were combined 
and dried in vacuo for 30 min.  Anhyd dioxane (4 mL) was added under nitrogen gas, and the 
mixture was stirred until 11 was completely soluble (AgO was in suspension).  When viewed 
under long wavelength UV light, the solution was fluorescent.  HNO3 (6 N, 0.36 mL) was added 
via a syringe and the mixture was stirred at rt for 5 min, by which time all AgO was soluble and 
the mixture lost its fluorescence.  A saturated aqueous solution of NaHCO3 (4 mL) was added 
and the mixture was stirred for 1 min.  Hot EtOAc (120 mL) and water (50 mL) were added; the 
insoluble material in the mixture was removed by filtration over a layer of Celite and washed 
with hot EtOAc.  The organic layer was separated, dried with anhyd MgSO4 and evaporated.  
The residue was co-evaporated with toluene to afford 13 as a pale yellow powder (54 mg, 82% 
yield), mp 276-278 °C dec.  1H NMR (400 MHz, CDCl3):  δ (ppm) 7.95 (1H, dd, J = 2 and 8 Hz, 
H-3), 8.21 (1H, d, J = 8 Hz, H-4), 8.28 (1H, dd, J = 1.6 and 8 Hz, H-7), 8.46 (1H, d, J = 2 Hz, H-
1), 8.45 (1H, d, J = 8 Hz, H-8), 8.77 (1H, d, J = 1.6 Hz, H-5) and 10.22 (1H, s, CHO).  13C NMR 
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(100 MHz, DMSO-d6):  δ (ppm) 127.50, 127.53, 128.8, 129.0, 128.6, 131.8, 133.4, 133.5, 136.1, 
137.1, 139.8, 180.7, 181.0 (C-9 and C-10) and 192.0 (CHO).  HRMS (EI) calcd for C15H7BrO3 
[M]+ 313.9579, found 313.9603. 
3.5.9.  2-Bromo-6-trifluoroacetylanthraquinone (14) 
Solid 12 (95 mg, 0.19 mmol) and AgO (36 mg, 0.29 mmol, 1.5 equiv) were combined in 
a 25 mL flask and dried in vacuo for 30 min.  Anhyd dioxane (4 mL) was added under nitrogen 
gas, and the mixture was stirred until 12 was completely soluble (AgO was in suspension).  
When viewed under long wavelength light, the solution was fluorescent.  HNO3 (6.0 N, 0.38 mL) 
was added via a syringe and the mixture was stirred at rt for 5 min, by which time all AgO was 
soluble and the mixture lost fluorescence.  EtOAc (10 mL) and saturated aqueous solution of 
NaHCO3 (4 mL) were added and the mixture was stirred at rt for 30 min.  More EtOAc and 
water were added, and the mixture was filtered over a layer of Celite.  The organic layer was 
separated, dried with anhyd MgSO4 and evaporated.  The residue was co-evaporated with 
toluene to afford 14 as a pale yellow powder (63 mg, 86% yield), mp 173-174 °C.  1H NMR (400 
MHz, CDCl3):  δ (ppm) 7.97 (1H, dd, J = 2 and 7.6 Hz, H-3), 8.21 (1H, d, J = 7.6 Hz, H-4), 
8.43-8.46 (3H, m, H-1, H-7 and H-8) and 8.95 (1H, d, J = 1.2 Hz, H-5).  13C NMR (100 MHz, 
CDCl3):  δ (ppm) 116.5 (q, J = 289 Hz, CF3), 128.5, 129.5 (q, J = 3 Hz, C-5), 129.6, 130.8, 
130.8, 132.1, 134.0, 134.4, 134.8 (q, J = 1 Hz, C-7), 137.2, 138.1, 179.9 (q, J = 36 Hz, COCF3), 
181.1 and 181.2 (C-9 and C-10).  19F NMR (282 MHz, CDCl3):  δ (ppm) –72.4.  HRMS (EI) 
calcd for C16H6BrF3O3 [M]+ 381.9452, found 381.9453. 
 
  
85
3.5.10.  5'-O-tert-Butyldiphenylsilyl-8-[(6-formylanthraquinone-2-yl)ethynyl]-2'-
deoxyadenosine (1) 
To 13 (43 mg, 0.11 mmol) was added Pd(PPh3)4 (8.0 mg, 0.01 mmol, 0.05 equiv), CuI (3 
mg, 10 µmol, 0.1 equiv) and TEA (0.04 mL, 0.27 mmol, 2.0 equiv).  A solution of 7 (67 mg, 
0.13 mmol, 0.95 equiv) in anhyd DMF (5 mL) was immediately added to the reaction mixture.  
The mixture was stirred under a nitrogen atmosphere in the dark at 65 °C in an oil bath for 3 h.  
DMF was removed under reduced pressure, and the brown residue was purified on a silica gel 
column eluted with MeOH/CH2Cl2 (0:100-3:97) to yield yellow glass after evaporation of the 
eluting solvent.  This glass was dissolved in a minimum amount of CH2Cl2 and precipitated by 
adding hexane.  Evaporation of CH2Cl2/hexane from the precipitate afforded 1 as a bright yellow 
solid (55 mg, 57% yield).  ε355 (THF):  11730 ± 100 Lmol-1cm-1, ε355 (acetonitrile):  7133 ± 100 
Lmol-1cm-1, ε355 (MeOH):  6907 ± 100 Lmol-1cm-1.  1H NMR (400 MHz, CDCl3):  δ (ppm) 1.01 
[9H, s, t-Bu (TBDPS)], 1.90 [1H, br s, OH-3’ (dA)], 2.43-2.49 [1H, m, H-2’ (dA)], 3.47-3.54 
[1H, m, H-2’ (dA)], 3.90 [1H, dd, J = 5.2 and 10.4 Hz, H-5’ (dA)], 4.03 [1H, dd, J = 8 and 10.4 
Hz, H-5’ (dA)], 4.12-4.17 [1H, m, H-4’ (dA)], 4.99-5.02 [1H, m, H-3’ (dA)], 6.33 (2H, br s, 
NH2), 6.57 [1H, t, J = 6.8 Hz, H-1’ (dA)], 7.27-7.39 [6H, m, Ph-ortho and para (TBDPS)], 7.59-
7.64 [4H, m, Ph-meta (TBDPS)], 7.81 [1H, d, J = 7.2 Hz, H-3 (AQ)], 8.03 [1H, s, H-2 (dA)], 
8.13 [1H, d, J = 7.2 Hz, H-4 (AQ)], 8.17 [1H, d, J = 8 Hz, H-7 (AQ)], 8.32 [1H, d, J = 8 Hz, H-8 
(AQ)], 8.46 [1H, s, H-1 (AQ)], 8.71 [1H, s, H-5 (AQ)] and 10.12 (1H, s, CHO).  13C NMR (100 
MHz, CDCl3):  δ (ppm) 19.4, 27.1, 37.1, 64.5, 73.3, 82.0 (C≡C), 85.5, 87.4, 94.1 (C≡C), 119.9, 
126.2, 127.4, 128.0, 128.2, 130.1, 131.2, 132.7, 133.0, 133.4, 133.4, 133.7, 134.0, 135.7, 136.2, 
136.4, 139.8, 148.9, 155.4, 181.0 and 181.6 [C-9 and C-10 (AQ)] and 190.6 (CHO).  HRMS 
(ESI) calcd for C43H38N5O6Si [M + H]+ 748.2591, found 748.2627. 
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3.5.11.  5'-O-tert-Butyldiphenylsilyl-8-{[6-(2,2,2-trifluoro-1,1-
dihydroxyethyl)anthraquinone-2-yl]ethynyl}-2'-deoxyadenosine (2) 
To 14 (44 mg, 0.11 mmol) was added Pd(PPh3)4 (7.0 mg, 0.01 mmol, 0.05 equiv), CuI 
(2.0 mg, 0.01 mmol, 0.10 equiv), and TEA (30 µL, 0.23 mmol, 2.0 equiv).  A solution of 7 (53 
mg, 0.10 mmol, 0.90 equiv) in anhyd DMF (3.5 mL) was immediately added to the reaction 
mixture. The mixture was stirred under a nitrogen atmosphere in the dark at 65 °C in an oil bath 
for 3 h.  DMF was removed under reduced pressure, and the brown residue was purified on a 
silica gel column eluted with MeOH/EtOAc/hexane (0:1:1- 0.02:1:1) to yield yellow glass after 
evaporation of the eluting solvent.  This glass was dissolved in a minimum amount of CH2Cl2 
and precipitated by adding hexane.  Evaporation of CH2Cl2/hexane from the precipitate afforded 
2 as a bright yellow solid (40 mg, 48% yield).  ε355 (THF):  4502 ± 100 Lmol-1cm-1, ε355 
(acetonitrile):  4588 ± 100 Lmol-1cm-1, ε355 (MeOH):  4597 ± 100 Lmol-1cm-1.  1H NMR (400 
MHz, CDCl3/CD3OD):  δ (ppm) 0.93 [9H, s, t-Bu (TBDPS)], 2.37 [1H, ddd, J = 4, 6.8 and 13.6 
Hz, H-2’ (dA)], 3.41-3.49 [1H, m, H-2’ (dA)], 3.79 [1H, dd, J = 5.6 and 10.8 Hz, H-5’ (dA)], 
3.96 [1H, dd, J = 6.8 and 10.8 Hz, H-5’ (dA)], 4.09-4.11 [1H, m, H-4’ (dA)], 4.80-4.85 [1H, m, 
H-3’ (dA)], 6.56 [1H, t, J = 6.8 Hz, H-1’ (dA)], 7.19-7.32 [6H, m, Ph-ortho and para (TBDPS)], 
7.51-7.56 [4H, m, Ph-meta (TBDPS)], 7.90 [1H, dd, J = 2 and 8 Hz, H-3 (AQ)], 7.99 [1H, s, H-2 
(dA)], 8.05 [1H, dd, J = 1.6 and 8 Hz, H-7 (AQ)], 8.24 [1H, d, J = 8 Hz, H-4 (AQ)], 8.28 [1H, d, 
J = 8 Hz, H-8 (AQ)], 8.41 [1H, d, J = 2 Hz, H-1 (AQ)] and 8.54 [1H, d, J = 1.6 Hz, H-5 (AQ)].  
13C NMR (100 MHz, CDCl3/CD3OD):  δ (ppm) 19.3, 26.9, 37.1, 64.2, 72.4, 82.0 (C≡), 85.5, 
87.6, 93.9 (C≡), 126.8, 127.6, 127.7, 127.8, 127.9, 129.8, 129.8, 131.0, 133.3, 133.4, 133.5, 
133.6, 133.7, 134.0, 134.3, 135.6, 135.7, 137.2, 141.7, 149.3, 153.7, 155.2 and 182.04 [C-9 and 
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C-10 (AQ)].  19F NMR (282 MHz, CDCl3/CD3OD):  δ (ppm) –83.57.  HRMS (ESI) calcd for 
C44H39F3N5O7Si [M + H]+ 834.2574, found 834.2609.  
3.5.12.  5'-O-tert-Butyldiphenylsilyl-8-[2-(6-dimethoxymethylanthraquinone-2-yl)ethyl]-2'-
deoxyadenosine (15)   
Compound 1 (33 mg, 0.04 mmol) was dissolved in MeOH (20 mL) by slight heating 
while stirring.  The resulting solution was transferred to a hydrogenation vessel containing 10% 
Pd/C (17 mg) that had been activated by stirring under H2 gas (45 psi) in MeOH (5 mL) for 30 
min at rt.  The vessel was next charged with H2 gas and then degassed using an aspirator in a 
cycle that was repeated 5-6 times.  The vessel was finally charged with H2 gas at 40 psi and 
stirred at rt for 24 h, by which time TLC (MeOH/CH2Cl2, 7:93 v:v) showed complete conversion 
of an initial spot to a more polar spot.  The Pd/C catalyst was then removed by filtration over 
Celite, and the adsorbed nucleoside residue was extracted from the catalyst by washing with 
boiling 10% MeOH in CHCl3.  The crude product was applied to a silica gel column and eluted 
with MeOH/CH2Cl2 (0:100-3:97) to yield a pale yellow glass after evaporation of the eluting 
solvent. This glass was dissolved in a minimum amount of CH2Cl2 and precipitated by adding 
hexane.  Evaporation of CH2Cl2/hexane from the precipitate afforded 4 as a pale yellow solid (29 
mg, 82% yield).  1H NMR (400 MHz, CDCl3):  δ (ppm) 0.97 [9H, s, t-Bu (TBDPS)], 2.30 [1H, 
ddd, J = 4, 6.8 and 13.2 Hz, H-2’ (dA)], 3.23-3.33 (4H, m, CH2-CH2), 3.35 (6H, s, OCH3), 3.56-
3.65 [1H, m, H-2’ (dA)], 3.78 [1H, dd, J = 5.2 and 10.4 Hz, H-5’ (dA)], 3.92 [1H, dd, J = 6.8 and 
10.4 Hz, H-5’ (dA)], 4.01-4.06 [1H, m, H-4’ (dA)], 4.90-4.97 [1H, m, H-3’ (dA)], 5.50 [1H, s, 
CH(OMe)2], 5.63 (2H, br s, NH2), 6.22 [1H, t, J = 6.8 Hz, H-1’ (dA)], 7.25-7.39 [6H, m, Ph-
ortho and para (TBDPS)], 7.54-7.62 [5H, m, Ph-meta (TBDPS) and H-3 (AQ)], 7.86 [1H, dd, J 
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= 1.2, 8 Hz, H-7 (AQ)], 8.08 [1H, s, H-2 (dA)], 8.17 [1H, d, J = 8 Hz, H-4 (AQ)], 8.20 [1H, d, J 
= 1.6 Hz, H-1 (AQ)], 8.27 [1H, d, J = 8 Hz, H-8 (AQ)] and 8.36 [1H, d, J = 1.2 Hz, H-5 (AQ)].  
LRMS (ESI) calcd for C46H48N5O7Si [M + H]+ 798.3, found 798.6. 
3.5.13.  4'-Bromo-2,4,5-trimethylbenzophenone (16) 
A mixture of 4-bromobenzoyl chloride (6.09 g, 27.7 mmol) and AlCl3 (3.88 g, 29.1 
mmol, 1.05 equiv) were dried in vacuo for 1h.  The flask was filled with nitrogen gas and placed 
in a –20 °C bath (ethanol-ice-salt).  Anhyd CH2Cl2 (30 mL) was added, and the mixture was 
stirred at the same temperature for 10 min.  To the resulting homogeneous mixture was added 
1,2,4-trimethylbenzene (3.78 mL, 27.8 mmol, 1.00 equiv) dropwise (over a period of 30 min) via 
a syringe.  The ice bath was removed and the obtained light brown mixture was stirred overnight.  
The reaction mixture was then poured into a mixture of ice (20 g) and conc. HCl (9 mL), which 
led to discharge of the dark color.  CH2Cl2 and water were added, and the mixture was 
transferred to a separatory funnel and shaken.  The organic layer was separated, washed with 
saturated aqueous NaHCO3, dried with anhyd MgSO4, and evaporated to dryness.  The white 
foam obtained was purified by crystallization from EtOAc/MeOH to afford 16 as white needle-
like crystals (6.79 g, 81% yield), mp:  69-71 °C.  1H NMR (400 MHz, CDCl3):  δ (ppm) 2.21 
(3H, s, CH3), 2.25 (3H, s, CH3), 2.27 (3H, s, CH3), 7.04 (1H, s, H-3), 7.05 (1H, s, H-6), 7.55-7.58 
(2H, m, H-3’ and H-5’) and 7.62-7.65 (2H, m, H-2’ and H-6’).  13C NMR (100 MHz, CDCl3):  δ 
(ppm) 19.4, 19.8, 20.0, 128.2, 130.4, 131.8, 131.9, 132.8, 133.7, 134.8, 135.7 and 137.3, 139.9 
and 197.8 (CO).  HRMS (ESI) calcd for C16H16BrO [M + H]+ 303.0385, found 303.0374; and for 
C16H15BrNaO [M + Na]+ 325.0204, found 325.0157. 
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3.5.14.  4'-Bromobenzophenone-2,4,5-tricarboxylic acid (17) 
To a two-neck flask containing 16 (6.619 g, 21.83 mmol) was added 20% HNO3 (44 
mL), and then a condenser was attached.  The contents of the flask was heated to 120 °C using 
oil bath, and the mixture was refluxed for 48 h, by which time a pale yellow semisolid was 
formed on the bottom.  The mixture was cooled to 0 °C for 1 h, and the HNO3 solution was 
removed with a pipette.  The remaining semisolid was triturated with water (3 × 30 mL) that was 
also removed with a pipette.  Addition of 10% NaOH (50 mL) followed by H2O (75 mL) 
dissolved the semisolid.  The resulting dark colored solution was then heated to reflux (110 °C 
oil bath), and solid KMnO4 (13.8 g, 87.5 mmol, 4.00 equiv) was added in small portions over 1 h 
(caution: frothing occurs with rapid addition).  The reaction mixture was refluxed for additional 
3 h, and then the resulting brown solid was removed by filtration while still hot.  The collected 
solid was mixed with water (50 mL) and refluxed overnight, then removed once again by 
filtration and washed with hot water.  The filtrates were combined, treated with solid NaHCO3 (5 
g), and reduced in volume to 100 mL by evaporation under reduced pressure.  The resulting 
solution was heated (~ 70 °C) and filtered once more over a layer of Celite while still hot, and 
then treated immediately with conc. HCl until bubbling stopped and pH was about 2 (pH paper).  
The resulting white precipitate was separated by filtration using a Büchner funnel, washed with 
water, air dried and finally further dried in vacuo to afford 17 as a white solid (6.314 g, 74% 
yield), mp 224-227 °C.  1H NMR (400 MHz, DMSO-d6):  δ (ppm) 7.58 (2H, d, J = 8.4 Hz, H-3’ 
and H-5’), 7.70 (1H, s, H-3), 7.73 (2H, d, J = 8.4 Hz, H-2’ and H-6’), and 8.27 (1H, s, H-6).  13C 
NMR (100 MHz, DMSO-d6):  δ (ppm) 127.3, 127.7, 130.4, 130.9, 131.3, 132.0, 133.0, 135.4 and 
137.2, 143.2, 165.5 (COOH), 167.0 (COOH), 167.7 (COOH) and 194.3 (CO).  HRMS (ESI) 
calcd for C16H8BrO7 [M–H]– 390.9453, found 390.9468. 
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3.5.15.  6-Bromoanthraquinone-2,3-dicarboxylic acid (18)66 
To dry 17 (0.800 g, 2.04 mmol) was added conc. H2SO4 (3.5 mL) under a nitrogen 
atmosphere.  The resulting homogeneous brown reaction mixture was stirred at 125 °C for 3 h, at 
which time a precipitate formed in the mixture.  After cooling to rt the mixture was poured over 
ice (10 g), and the resulting beige suspension was transferred to two 20-mL centrifuge tubes.  
Additional water (3.5 mL) was used to transfer all of the crude material.  After centrifugation, 
the supernatant was removed with a pipette, and the remaining paste was lyophilized.  The 
resulting oily brown suspension was transferred (with methanol) to a 100-mL recovery flask.  
The methanol was removed under reduced pressure and vacuum was applied to the remaining 
residue overnight.  The anhydrous crude obtained (mixed with H2SO4) was used in the next step 
without further purification.  A pure sample of 18 (3 mg), for NMR analysis, was obtained from 
a small amount of this crude by further washing it with water.  1H NMR (400 MHz, DMSO-d6):  
δ (ppm) 8.13-8.18 (2H, m, H-5 and H-6), 8.31 (1H, d, J = 1.6 Hz, H-8) and 8.37 (2H, s, H-1 and 
H-4).  13C NMR (100 MHz, DMSO-d6):  δ (ppm) 126.66 and 126.69, 128.89, 129.1, 129.2, 
132.1, 134.1, 134.2, 134.6, 137.3, 137.4, 167.31 (COOH), 167.34 (COOH), 180.5 and 180.9 (C-
9 and C-10).  HRMS (ESI) calcd for C16H6BrO6 [M–H]– 372.9348, found 372.9335. 
3.5.16.  Dimethyl 6-bromoanthraquinone-2,3-dicarboxylate (19) 
The flask containing crude mixture was flushed with nitrogen gas and a condenser was 
attached.  Anhyd methanol (25 mL) was added under nitrogen gas, and the yellow suspension 
obtained was refluxed (80 °C) for 24 h until TLC (CH2Cl2) showed no further progress in the 
reaction.  The mixture was cooled to rt and treated with saturated aqueous solution of NaHCO3 
until the reaction mixture became basic (pH paper); water (20 mL) was then added.  The 
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precipitate in the reaction mixture was separated by filtration, washed with water followed by 
cold methanol, and finally air dried to afford 19 as a fine yellow powder (487 mg, 60% yield 
from 17), mp 174-175 °C (lit.66 178-179 °C).  1H NMR (400 MHz, CDCl3):  δ (ppm) 3.97 (6H, s, 
CH3), 7.95 (1H, dd, J = 2 and 8 Hz, H-7), 8.18 (1H, d, J = 8 Hz, H-8), 8.44 (1H, d, J = 2 Hz, H-
5) and 8.60 (2H, s, H1 and H4).  13C NMR (100 MHz, CDCl3):  δ (ppm) 53.4 (CO2CH3), 128.4, 
128.4, 129.5, 1130.6, 130.7, 132.0, 134.3, 134.5, 134.7, 136.8, 137.0, 137.9, 166.5 (CO2Me), 
166.5 (CO2Me), 180.7 and 181.0 (C-9 and C-10).  HRMS (ESI) calcd for C18H12BrO6 [M + H]+ 
402.9817, found 402.9802. 
3.5.16.  5'-O-tert-Butyldiphenylsilyl-8-[(2,3-dicarboxyanthraquinone-6-yl)ethynyl]-2'-
deoxyadenosine dimethyl ester (3) 
Compound 19 (86 mg, 0.21 mmol) was reacted with Pd(PPh3)4 (13 mg, 0.01 mmol, 0.05 
equiv), CuI (4.0 mg, 0.02 mmol, 0.10 equiv), TEA (0.06 mL, 0.43 mmol, 2.0 equiv) and 7 (104 
mg, 0.200 mmol, 0.950 equiv) in anhyd DMF (5 mL) for 30 min under the same conditions used 
to prepare 2 above.  Similar purification procedure to the one described above afforded 3 as a 
bright yellow solid (82 mg, 49% yield).  ε355 (THF):  14898 ± 100 Lmol-1cm-1, ε355 (acetonitrile):  
12013 ± 100 Lmol-1cm-1, ε355 (MeOH):  12292 ± 100 Lmol-1cm-1.  1H NMR (400 MHz, CDCl3):  
δ (ppm) 0.96 [9H, s, t-Bu (TBDPS)], 2.31 [1H, br s, OH-3’ (dA)], 2.41 [1H, ddd, J = 4.9, 6.8 and 
13.6 Hz, H-2’ (dA)], 3.42-3.49 [1H, m, H-2’ (dA)], 3.82 [1H, dd, J = 5.2 and 10.4 Hz, H-5’ 
(dA)], 3.92 (6H, s, CO2CH3), 3.92-3.97 [1H, m, H-5’ (dA)], 4.05-4.10 [1H, m, H-4’ (dA)], 4.96-
5.01 [1H, m, H-3’ (dA)], 5.84 (2H, br s, NH2), 6.53 [1H, t, J = 6.8 Hz, H-1’ (dA)], 7.22-7.34 
[6H, m, Ph-ortho and para (TBDPS)], 7.55 [4H, t, J = 8 Hz, Ph-meta (TBDPS)], 7.88 [1H, dd, J 
= 1.2 and 8 Hz, H-7 (AQ)], 8.10 [1H, s, H-2 (dA)], 8.23 [1H, d, J = 8 Hz, H-8 (AQ)], 8.42 [1H, 
d, J = 1.2 Hz, H-5 (AQ)] and 8.60 [2H, s, H-1 and H-4 (AQ)].  13C NMR (100 MHz, CDCl3):  δ 
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(ppm) 19.4, 27.0, 37.3, 53.4 (CO2CH3), 64.4, 73.2, 82.5 (C≡), 85.4, 87.3, 93.91 (C≡), 120.3, 
126.8, 127.7, 127.9, 127.9, 128.25,128.5, 130.0, 131.1, 132.9, 133.1, 133.3, 133.4, 133.9, 134.5, 
134.7, 135.7, 135.7, 136.56 and 136.8, 136.9, 149.1, 154.0, 155.5, 166.4 (CO2Me), 166.5 
(CO2Me), 180.5 and 180.6 [C-9 and C-10 (AQ)].  HRMS (ESI) calcd for C46H42N5O9Si [M + 
H]+ 836.2752, found 836.2731. 
3.5.18.  5'-O-tert-Butyldiphenylsilyl-8-[2-(2,3-dicarboxyanthraquinone-6-yl)ethyl]-2'-
deoxyadenosine dimethyl ester (4) 
Compound 3 (54 mg, 0.06 mmol) was dissolved in EtOH (20 mL) by slight heating while 
stirring.  The resulting solution was transferred to a hydrogenation vessel containing 10% Pd/C 
(25 mg) that had been activated by stirring under H2 gas (45 psi) in EtOH (10 mL) for 30 min at 
rt.  The vessel was next charged with H2 gas and then degassed using an aspirator in a cycle that 
was repeated 5-6 times.  The vessel was finally charged with H2 gas at 40 psi and stirred at rt for 
24 h, by which time TLC (MeOH/CH2Cl2, 7:93 v:v) showed complete conversion of an initial 
spot to a more polar spot.  The Pd/C catalyst was then removed by filtration over Celite, and the 
adsorbed nucleoside residue was extracted from the catalyst by washing with boiling 10% 
MeOH in CHCl3.  The crude product was applied to a silica gel column and eluted with 
MeOH/CH2Cl2 (0:100-3:97) to yield a pale yellow glass after evaporation of the eluting solvent. 
This glass was dissolved in a minimum amount of CH2Cl2 and precipitated by adding hexane.  
Evaporation of CH2Cl2/hexane from the precipitate afforded 4 as a pale yellow solid (43 mg, 
80% yield).  ε355 (THF):  2553 ± 100 Lmol-1cm-1, ε355 (acetonitrile):  2907 ± 100 Lmol-1cm-1, ε355 
(MeOH):  2598 ± 100 Lmol-1cm-1.  1H NMR (400 MHz, CDCl3):  δ (ppm) 0.97 [9H, s, t-Bu 
(TBDPS)], 2.30 [1H, ddd, J = 2.4, 6.8 and 13.2 Hz, H-2’ (dA)], 3.23-3.38 (4H, m, CH2-CH2), 
3.60-3.67 [1H, m, H-2’ (dA)], 3.80 [1H, dd, J = 5.2 and 10.4 Hz, H-5’ (dA)], 3.92-3.97 [1H, m, 
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H-5’ (dA)], 3.98 (6H, s, CO2CH3), 4.08-4.12 [1H, m, H-4’ (dA)], 4.92-4.95 [1H, m, H-3’ (dA)], 
5.91 (2H, br s, NH2), 6.26 [1H, t, J = 6.8 Hz, H-1’ (dA)], 7.24-7.38 [6H, m, Ph-ortho and para 
(TBDPS)], 7.55-7.65 [5H, m, Ph-meta (TBDPS) and H-7 (AQ)], 8.06 [1H, s, H-2 (dA)], 8.13 
[1H, d, J = 8 Hz, H-8 (AQ)], 8.19 [1H, d, J = 1.2 Hz, H-5 (AQ)], 8.54 [1H, s, H-1 (AQ)] and 
8.56 [1H, s, H-4 (AQ)].  13C NMR (100 MHz, CDCl3):  δ (ppm) 19.9, 27.0, 29.2 (CH2), 33.4 
(CH2), 37.0, 53.4 (CO2CH3), 64.1, 72.6, 84.4, 87.0, 118.9, 127.6, 127.8, 127.8, 128.1, 128.2, 
129.9, 131.7, 133.3, 133.3, 133.4, 134.8, 133.9, 135.1, 135.6, 135.6, 136.5, 136.6, 148.4, 150.9, 
152.0, 154.8, 166.7 (CO2Me), 166.5 (CO2Me), 181.3 and 181.7 [C-9 and C-10 (AQ)].  HRMS 
(ESI) calcd for C46H46N5O9Si [M + H]+ 840.3065, found 840.3062. 
3.5.19.  Electrochemical measurements 
Cyclic voltammograms were recorded using a CHI750C electrochemical workstation 
with Faraday cage using an Ag wire reference electrode and platinum auxiliary and working 
electrodes (BAS Inc.).  The reference electrode solution [Ag/AgNO3 (0.01 M) + 0.1 M TBAH in 
CH3CN] was prepared and the electrochemical apparatus was assembled in the glove box.  The 
reference electrode was calibrated against ferrocene potential, taken as E1/2= 0.087 V.  The 
working electrode was mechanically polished using 0.05 µm alumina powder (Buhler) and 
sonicated in 1:1 methanol:water (18.6 MΩ-cm from a Milli-Q water purification system, 
Millipore) for 5 min before taking data on each compound.  Compounds were dried for 30 min to 
24 h on a vacuum line (4 × 10–4 torr) or in the antechamber of the glove box (25 millitorr) before 
measurements were taken.  All AQ derivatives solutions were freshly prepared in acetonitrile 
with 0.10 M TBAH as the electrolyte in a glove box under nitrogen.  They were then loaded into 
the CV cell which had the electrodes in place and transferred to the electrochemical workstation 
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under nitrogen.  The Faraday cage was filled with argon prior to taking the measurement, which 
was done at room temperature (22 ˚C).  The scan rate was 0.100 V s-1 unless indicated otherwise.  
Each measurement was repeated with 3 - 5 scans at least twice on separate solutions.  All 
electrode potentials are quoted relative to the saturated calomel electrode (SCE). 
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Chapter 4. 
Synthesis of Anthraquinone Derivatives for Electrochemical Studies. 
4.1.  Introduction 
 In the course of our work on designing and synthesizing novel anthraquinone conjugates 
for incorporation into DNA, a variety of other anthraquinone model compounds and conjugates 
were made.  In general, the syntheses of those compounds followed established literature 
procedures.  Below I discuss molecules that were new or have been made by routes that are 
improvements over those in the literature.  These molecules include anthraquinones modified 
with electron withdrawing groups and anthraquinone linked to deoxyadenosine or deoxyuridine. 
4.2.  Results and Discussion 
4.2.1.  2-Cyanoanthraquinone (AQCN) 
Of note was the use of Pd(0) coupling1 to make the cyano derivative (AQCN) from the 
iodo precursor, which had a very high yield of 93% under mild conditions.  The time required for 
this conversion depended on the solvent used.  The completion of the reaction required 11 h 
when neat THF was used, but only 30 min when acetonitrile was added to THF.  A mixture of 
these two solvents was used because of the limited solubility of the iodo starting material in 
acetonitrile alone.  This approach may be useful in addition of the cyano group to other, more 
substituted, anthraquinones because it has a much higher yield than the reported yield of 43% 
when the same compound was prepared from the chloro precursor using CuCN/pyridine.2   
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Scheme 4.1.  Reagents and conditions:  Pd(Ph3P)4, CuI, KCN, THF/CH3CN, 70 °C, 30 min. 
4.2.2.  Carbonyl modified AQ derivatives:  Ketones, amides and esters 
Following a reported procedure of preparing aromatic ketones,3 the acetyl- and benzoyl- 
derivatives AQAc and AQBz, respectively, were synthesized from iodoanthraquinone via 
tributylstannylanthraquinone, which in turn was reacted with the corresponding acyl chloride in a 
Pd(II) catalyzed reaction as shown in Scheme 4.2.  Use of acyl anhydrides, reported to transform 
aromatic tributylstannyl derivatives to trifluoroketones,4 instead of acyl chlorides did not yield 
the desired products.   
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Scheme 4.2.  Reagents and conditions:  (a) Pd(Ph3P)2Cl2, n-Bu6Sn2, toluene , 80 °C, 96 h; (b) 
Pd(Ph3P)2Cl2, CH3COCl or PhCOCl, toluene, 50 - 90 °C, 3 h - overnight.   
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As shown in Scheme 4.3 the n-propyl amide derivative (AQAmPr) was synthesized in 
93% yield from the N-hydroxysuccinimide ester5 by reaction with n-propyl amine.   
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Scheme 4.3.  Reagents and conditions:  n-propylamine, DMF/dioxane, rt, 30 min.   
The corresponding methyl and tert-butyl amides, AQAmMe and AQAmBut respectively 
were synthesized by I. M. Abdou in the laboratory of Dr. L. Strekowski from the carboxylic acid 
in 40-60% by activation with carbonyldiimidazole6 followed by treatment with the 
corresponding amine (Scheme 4.4).  Spectra are reported herein as they have not been previously 
published. 
COOH
O
O
O
O
NHR
O
AQAmMe: R = Me
40-60%
AQAmBut: R = But
 
Scheme 4.4.  Reagents and conditions:  i.  1,1'-carbonyldiimidazole, DMF, rt, 2 h.  ii.  MeNH2 or 
tert-BuNH2, rt - 40 °C, 12 h.  
The TMS protected ethynyl diester (TMS-Y-AQdiester) was synthesized starting with the 
bromo diester derivative (Chapter 3) via palladium coupling with trimethylsilylacetylene 
(TMSA) under the conditions shown in Scheme 4.5.  Treatment with fluoride gave the free 
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alkyne (H-Y-AQdiester) that was reduced with H2 gas over 10% Pd/C turn to give the ethyl 
derivative (Et-AQdiester). 
O
O
CO2CH3
CO2CH3Br a
98%
O
O
CO2CH3
CO2CH3
R
TMS-Y-AQdiester: R=TMS
H-Y-AQdiester: R=H
b
c
O
O
CO2CH3
CO2CH3
98%
84%
Et-AQdiester
 
Scheme 4.5.  Reagents and conditions:  (a) Pd(PPh3)2Cl2, CuI, Et3N, THF, TMSA, 60 °C, 45 
min; (b) KF, THF/MeOH, rt, 1h; (c) 10% Pd/C, H2, 40 psi, EtOAc, rt, 24 h. 
4.2.3.  AQ-dU conjugates 
Four steps were employed to synthesize the conjugate AQ-Y-dU(DMTr) from the 
commercially available 5-iodo-2’-deoxyuridine.  First, the 5’-OH was protected using 4,4’-
dimethoxytrityl chloride (DMTrCl), 4-(dimethylamino)pyridine (4-DMAP) and triethylamine 
(TEA) as described in the literature.7  Second, the resulting 5’-O-DMT nucleoside was coupled 
to TMSA using Pd(II) catalyzed chemistry, which was followed, after purification, by removal of 
the TMS group with KF.  Finally, as shown in Scheme 4.6, the obtained 5-ethynyl derivative of 
dU was coupled to 2-iodoanthraquinone via Pd(0) coupling to give AQ-Y-dU(DMTr).  
Treatment of AQ-Y-dU(DMTr) with dichloroacetic acid (DCA) gave the free 5’-OH derivative, 
AQ-Y-dU in 22% yield.  The low yield of this deprotection reaction was due to the extremely 
low solubility of AQ-Y-dU, which hindered its complete extraction during workup and 
chromatography.  The solubility of AQ-Y-dU was also unsuitable for CV measurements, and 
hence, the AQ-Y-dU(DMTr) was used.   
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Scheme 4.6.  Reagents and conditions:  (a) Pd(Ph3P)4, CuI, TEA, DMF, 65 °C, 30 min; (b) DCA 
in CH2Cl2, rt, 45 min; (c) 10% Pd/C, H2, 40 psi, EtOAc/MeOH, rt, 7 h. 
Catalytic hydrogenation of AQ-Y-dU(DMTr) over 10% Pd/C for 24 h resulted in the 
desired product AQ-E-dU(DMTr) with the ethanyl linker along with a hydrogenation side 
product.  HPLC showed that the ratio between AQ-E-dU(DMTr) and this side product was ca 
2:1.  This ratio did not change if the hydrogenation reaction was stopped once the alkyne starting 
material was consumed, which was done by UV-vis monitoring of the starting material 
absorbance at 377 nm (See Figure 4.1.  The Rf of AQ-E-dU(DMTr) and the side product on silica 
gel TLC were similar in most common eluting systems.  The use of MeOH/THF/hexane (1:40:60 
v:v:v) as the eluent allowed separation by silica gel.  The side product showed two C-13 signals 
at 184.85 and 184.89 ppm (similar to the shifts of AQ carbonyls) and a shift in the UV-vis 
spectrum (blue spectrum in Figure 4.1).  It is reported that some AQ derivatives degrade on 
carbon supported palladium catalysts to give different products including reduction of a double 
bonds in the AQ ring.8   
AQ-E-dU(DMTr) had limited stability in solution.  Over a few hours, it darkened and 
gave decomposition products, the major of which were of higher polarity than AQ-E-dU(DMTr) 
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itself as observed on TLC eluted with MeOH/THF/hexane (1:40:60 v:v:v) or MeOH/CH2Cl2 
(5:95 v:v).  
0.0
0.5
1.0
1.5
2.0
250 300 350 400 450
AQ-E-dU(DMTr)
Hydrogenation side product
AQ-Y-dU(DMTr)
A
bs
or
ba
nc
e
Wavelength (nm)  
Figure 4.1.  UV-vis absorbance of AQ-Y-dA, AQ-E-dA and AQ-Y-dA hydrogenation side 
product. 
AQ-8-dU(DMTr) was synthesized by coupling between 2-[3-(deoxyuridine-5-
yl)acrylamido]ethylamine and N-succinimidyl 2-anthraquinonecarboxylate as shown in Scheme 
4.7.5 
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Scheme 4.7.  Reagents and conditions:  TEA, DMF, rt, overnight. 
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4.2.4.  Unprotected AQ-dA conjugates 
 AQ-Y-dA was synthesized by a palladium catalyzed cross-coupling between 8-bromo-2’-
deoxyadenosine and 2-ethynylanthraquinone as shown in Scheme 4.8.  The low solubility of 
AQ-Y-dA in organic solvents made loading the crude reaction product for column purification 
problematic.  The following solvents and many of their combinations were tried to dissolve AQ-
Y-dA:  dichloromethane, chloroform, THF, methanol, ethyl acetate, acetone, isopropanol, 
benzene, and water.  The best solvent combination was 15% (by volume) methanol in 
chloroform.  However, 10 mL of this solvent mixture dissolved only 60 mg of AQ-Y-dA with 
slight heating and 30 min of stirring.  This solubility problem meant that it was not practical to 
purify more than 100 mg of AQ-Y-dA at a time.  To do this, a solution of the crude product AQ-
Y-dA in methanol/chloroform (15:85 v:v) was divided into three parts to load silica gel for 
column chromatography.  Each third was successively loaded onto the same gel, and the excess 
solvent was removed in vacuo.  After all three parts of the solution of AQ-Y-dA were loaded 
onto the gel, normal column purification was carried out. 
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AQ-E-dA  
Scheme 4.8.  Reagents and conditions:  (a) Pd(Ph3P)4, CuI, Et3N, DMF, 8-bromo-2’-
deoxyadenosine, 60 oC, 3h; (b) 10% Pd/C, H2, 40 psi, MeOH, rt, 24 h. 
 The conjugate with reduced linker (AQ-E-dA) was prepared from AQ-Y-dA by catalytic 
hydrogenation over 10% Pd/C for 24 h 
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4.3.  Experimental 
4.3.1.  Materials and general synthetic considerations 
Anhydrous DMF was purchased from Aldrich and stored in a Vacuum Atmospheres 
M040-2 glove-box that was pressurized with nitrogen gas from a liquid nitrogen tank.  All 
starting materials for anhydrous reactions were dried prior to use on a vacuum line (5 × 10-4 torr) 
for at least 12 h.  Solvents for synthesis were dried and redistilled in a continuous circulation 
distillation apparatus.  THF was dried with benzophenone /Na0 and stored over activated 
molecular sieves in the glove-box.  Water was provided by a Millipore (Milli-Q Plus) ultrapure 
water system.  All manipulations of Pd(PPh3)2Cl2 and Pd(PPh3)4 were performed in the glove-
box.  Most of the reactions were monitored with glass-backed TLC Plates precoated with silica 
gel 60 F254 (EMD Chemicals).  HPLC grade solvents were used for chromatographic 
purifications.  Flash column chromatography was carried out on either a Biotage Flash-40™ 
system using prepackaged KP-Sil™ cartridges or on Whatman™ flash silica (60Å pore, 230 – 
400 mesh) that was packed in glass columns and pressurized with nitrogen.  Melting points were 
corrected.  Molar absorption values were determined using Beer’s law.  NMR spectra were 
obtained on either a Varian Unity +300 NMR spectrometer or on a Brucker Avance 400 MHz 
NMR spectrometer.  High resolution MS (HRMS) were obtained with a Q-TOF QSTAR mass 
spectrometer.  Negative ion ESI (electrospray ionization) MS were recorded for all compounds 
by loop injections into a flow of 50/50 water/ACN containing 0.5% triethylamine (TEA).  The 
samples were dissolved in about 100 µL of CHCl3, diluted 1/100 with the water/ACN/TEA 
solvent, and injected into the mass spectrometer.  Low-resolution (LR) electron impact (EI) MS 
were recorded in positive ion mode on a Shimadzu 5050A MSD single quadrupole spectrometer 
with one amu resolution. 
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4.3.2.  2-Cyanoanthraquinone (AQCN)   
To a solution of 2-iodoanthraquinone (70 mg, 0.21 mmol) in THF/CH3CN (1:1 v:v, 6 
mL) was added in the glove box Pd(Ph3P)4 (12 mg, 0.01 mmol, 0.05 equiv), CuI (4 mg, 0.02 
mmol, 0.1 equiv) and finely ground, anhydrous KCN (27 mg, 0.42 mmol, 2.0 equiv).  The 
mixture was removed from the glove-box and stirred under a nitrogen atmosphere for 30 min at 
70 °C in an oil bath, at which time TLC (CH2Cl2/hexane, 1:1 v:v) showed complete reaction.  
The solvent was removed under reduced pressure, and the residue was purified by silica gel 
column eluted with CH2Cl2/hexane (0:10-7:10).  Evaporation of the eluting solvent afforded the 
title product as a pale yellow solid (46 mg, 93% yield), mp 213-215 °C (lit.9 217 °C).  1H NMR 
(400 MHz, CDCl3):  δ (ppm) 7.85-7.90 (2H, m, H-6 and H-7), 8.07 (1H, dd, J = 1.6 and 8 Hz, H-
3), 8.32-8.36 (2H, m, H-5 and H-8), 8.43 (1H, d, J = 8.0 Hz, H-4) and 8.60 (1H, d, J = 1.6 Hz, 
H-1).  The 13C NMR10 (100 MHz, CDCl3):  δ (ppm) 117.17 and 117.73 (CN and C-2), 127.58, 
127.59, 128.02, 131.28, 132.96, 133.08, 133.81, 134.83, 134.84, 135.62, 136.62, 181.18 and 
181.66 (C-9 and C-10).  EI MS m/z (M+):  233.  
4.3.3.  2-tri-n-Butylstannylanthraquinone 
In a round bottom flask was placed dry 2-iodoanthraquinone (300 mg, 0.9 mmol), 
Pd(Ph3P)2Cl2 (33 mg, 0.050 mmol, 0.050 equiv), hexabutyldistannane (0.70 mL, 1.3 mmol, 1.5 
equiv) and anhydrous toluene (10 mL), and the mixture was stirred at 80 °C for 96 h under a 
nitrogen atmosphere.  The reaction was quenched by adding a solution of KF (105 mg) in water 
(1 mL) and stirring overnight.  The mixture was filtered over a layer of Celite, and the filtrate 
was diluted with ethyl acetate and water.  The organic layer was separated, dried with MgSO4 
and evaporated to dryness.  The residue  was loaded on silica gel and purified using silica gel 
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chromatography on a Biotage column (40+S cartridge) eluted with CH2Cl2/hexane (3:8 v:v).  
Evaporation of the eluting solvent afforded the title product as a yellow oil (295 mg, 66% yield).  
1H NMR (400 MHz, CDCl3):  δ (ppm) 0.87 (9H, t, J = 7.2 Hz, CH3), 1.12-1.16 (6H, m, 
CH2CH3), 1.27-1.37 (6H, m, CH2CH2CH3), 1.50-1.62 [6H, m, CH2(CH2)2CH3], 7.74-7.78 (2H, 
m, H-6 and H-7), 7.91 (1H, dd, J = 0.8 and 7.6 Hz, H-3), 8.18 (1H, d, J = 7.6 Hz, H-4), 8.26-
8.30 (2H, m, H-5 and H-8) and 8.40 (1H, d, J = 0.8 Hz, H-1).  13C NMR (100 MHz, CDCl3):  δ 
(ppm) 9.87 (CH2), 13.65 (CH3), 27.31 (CH2), 29.03 (CH2), 125.50, 127.06, 127.11, 131.55, 
132.98, 133.49, 133.61, 133.97, 134.03, 134.78, 142.36, 152.68, 183.77 and 183.96 (C-9 and C-
10).   
4.3.4.  2-Acetylanthraquinone (AQAc) 
To 2-tri-n-butylstannylanthraquinone (113 mg, 0.230 mmol) was added Pd(Ph3P)2Cl2 (8.0 
mg, 0.01 mmol, 0.05 equiv), anhydrous toluene (4 mL) and CH3COCl (0.05 mL, 0.70 mmol, 3.0 
equiv).  The dark brown reaction mixture was stirred under nitrogen gas at 50 °C overnight.  The 
solvent was evaporated and the residue was purified by a silica gel column eluted with 
CH2Cl2/hexane (2:3-4:1).  Evaporation of the eluting solvent afforded the title product as a pale 
yellow solid (39 mg, 69% yield), mp 142-144 °C (lit.11 143-144 °C).  1H NMR12 (400 MHz, 
CDCl3):  δ (ppm) 2.72 (3H, s, CH3), 7.80-7.84 (2H, m, H-6 and H-7), 8.31-8.36 (3H, m, H-3, H-
5 and H-8), 8.39 (1H, dd, J = 0.4 and 8.0 Hz, H-4) and 8.81 (1H, dd, J = 0.4 and 1.6 Hz, H-1).  
13C NMR (100 MHz, CDCl3):  δ (ppm) 27.28 (CH3), 127.59, 127.68, 127.70, 128.08, 133.14, 
133.62, 133.66, 133.97, 134.73, 136.27, 141.27, 182.68 and 182.74 (C-9 and C-10) and 197.01 
(COCH3).  HRMS m/z (M+H)+:  calcd for C16H11O3 251.0708, found 251.0720. 
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4.3.5.  2-Benzoylanthraquinone (AQBz).13 
To 2-tri-n-butylstannylanthraquinone (102 mg, 0.210 mmol) was added Pd(Ph3P)2Cl2 (7.0 mg, 
0.01 mmol, 0.05 equiv), anhydrous toluene (4 mL) and PhCOCl (0.07 mL, 0.60 mmol, 3.0 
equiv).  The yellow reaction mixture was stirred under nitrogen gas at 90 °C for 3 h.  The solvent 
was evaporated and the residue was purified by a silica gel column eluted with CH2Cl2/hexane 
(2:3-4:1).  Evaporation of the eluting solvent afforded the title product as a pale yellow solid (45 
mg, 71% yield), mp 217-218 °C (lit.13 217 °C).  1H NMR (400 MHz, CDCl3):  δ (ppm) 7.49-7.54 
[2H, m, H-meta (Ph)], 7.61-7.66 [1H, m, H-para (Ph)], 7.79-7.84 [4H, m, H-ortho (Ph), H-6 and 
H-7], 8.18 (1H, dd, J = 1.6 and 8.0 Hz, H-3), 8.29-8.35 (2H, m, H-5 and H-8), 8.42 (1H, d, J = 
8.0 Hz, H-4) and 8.62 (1H, d, J = 1.6 Hz, H-1).  13C NMR (100 MHz, CDCl3):  δ (ppm) 127.45, 
127.46, 127.63, 128.58, 128.73, 130.15, 133.33, 133.40, 133.47, 134.50, 134.61, 135.44, 136.40, 
142.50, 182.42 and 182.57 (C-9 and C-10) and 195.12 (COPh).  EI MS m/z (M+):  312. 
4.3.6.  N-(n-Propyl)anthraquinone-2-carboxamide (AQAmPr) 
To a solution of N-succinimidyl 2-anthraquinonecarboxylate5 (51 mg, 0.11 mmol) in 
DMF/dioxane (1:1 v:v, 4 mL) was added n-propylamine (0.090 mL, 1.1 mmol).  The reaction 
mixture was stirred at rt for 30 min, by which time a white precipitate had formed.  The solvent 
was evaporated to dryness and the residue was purified using preparative TLC (10 cm long x 10 
cm wide x 0.2 cm thick) eluted with 2% methanol in dichloromethane.  The product band was 
scratched off the plate and eluted with 5% MeOH in CH2Cl2.  Evaporation of the solvent 
afforded the title compound as a white solid (30 mg, 93% yield), mp 201-202 °C (lit.14 300 °C).  
1H NMR (300 MHz, CDCl3):  δ (ppm) 1.03 (3H, t, J = 7.5 Hz, CH3), 1.65-1.78 (2H, m, 
CH2CH3), 3.50 (2H, q, J = 7.2 Hz, CH2CH2),  6.54 (1H, br s, NH), 7.81-7.84 (2H, m, H-6 and H-
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7), 8.26-8.37 (4H, m, H-3, H-5, H-4 and H-8) and 8.54 [1H, d, J = 1.8 Hz, H-1].  13C NMR (100 
MHz, CDCl3):  δ (ppm) 11.43 (CH3), 22.83 (CH2CH3), 42.10 (CH2CH2), 124.68, 127.36, 127.38, 
127.89, 133.14, 133.35, 133.41, 134.34, 134.42, 135.04, 139.76, 165.61 (CONH), 182.38 and 
182.53 (C-9 and C-10).  HRMS m/z (M+H)+:  calcd for C18H16NO3 294.1130, found 294.1121. 
4.3.7.  N-Methylanthraquinone-2-carboxamide (AQAmMe, reaction run by I. M. Abdou)15 
To a suspension of anthraquinone 2-carboxylic acid (0.25 g, 1.0 mmol) in dry DMF (3 
mL) was gradually added a solution of 1,1'-carbonyldiimidazole (0.20 g, 1.1 mmol) in dry DMF 
(1 mL) and the mixture was stirred at rt for 2 h, by which time the reaction mixture became 
homogeneous.  Methylamine (2 M solution in THF, 2 mL, 2 mmol) was added, and the reaction 
mixture was stirred under nitrogen gas at rt for 12 h.  The solvent was evaporated to dryness and 
the residue was purified using silica gel column eluted with MeOH/CH2Cl2 (0:100-3:97).  
Evaporation of the solvent afforded the title compound as a white solid (0.16 g, 60% yield), mp 
228-230 °C (lit.6 227-229 °C).  1H NMR (300 MHz, CDCl3):  δ (ppm) 3.1 (3H, d, J = 4.8 Hz, 
CH3), 6.50 (1H, br s, NH), 7.81-7.85 (2H, m, H-6 and H-7), 8.27-8.34 (3H, m, H-3, H-5 and H-
8), 8.35 (1H, dd, J = 8.1 Hz, H-4) and 8.50 [1H, d, J = 1.8 Hz, H-1].  13C NMR (75 MHz, 
CDCl3):  δ (ppm) 27.09 (CH3), 124.78, 127.42, 127.45, 127.99, 133.13, 133.40, 133.45, 133.49, 
134.42, 134.50, 135.15, 139.53, 166.30 (CONH), 182.45 and 182.56 (C-9 and C-10).  Anal calcd 
for C16H11NO3:  C, 72.45; H 4.18; N 5.28.  Found:  C, 72.39; H, 4.28; N, 5.31. 
4.3.8.  N-(tert-Butyl)anthraquinone-2-carboxamide (AQAmBut, reaction run by I. M. 
Abdou) 
To a suspension of anthraquinone 2-carboxylic acid (0.25 g, 1.0 mmol) in dry DMF (3 
mL) was gradually added a solution of 1,1'-carbonyldiimidazole (0.20 g, 1.1 mmol) in dry DMF 
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(1 mL) and the mixture was stirred at rt for 2 h, by which time the reaction mixture became 
homogeneous.  tert-Butylamine (0.21 mL, 2.0 mmol) was added, and the reaction mixture was 
stirred under nitrogen gas at 40 °C for 12 h.  The solvent was evaporated to dryness and the 
residue was purified using silica gel column eluted with MeOH/CH2Cl2 (0:100-3:97).  
Evaporation of the solvent afforded the title compound as a white solid (0.12 g, 40% yield), mp 
235-237 °C.  1H NMR (300 MHz, CDCl3):  δ (ppm) 1.53 (9H, s, t-Bu), 6.16 (1H, br s, NH), 
7.82-7.88 (2H, m, H-6 and H-7), 8.25 (1H, dd, J = 1.8 and 8.1 Hz, H-3), 8.32-8.39 (3H, m, H-4, 
H-5, H-8) and 8.5 [1H, d, J = 1.8 Hz, H-1].  13C NMR (75 MHz, CDCl3):  δ (ppm) 28.82 (CH3), 
52.31 (CMe3), 124.56, 127.43, 127.94, 133.12, 133.38, 133.41, 133.45, 134.39, 134.49, 134.93, 
140.88, 164.98 (CONH), 182.50 and 182.73 (C-9 and C-10).   Anal calcd for C19H17NO3:  C, 
74.27; H, 5.58; N, 4.56.  Found:  C, 74.24; H, 5.62; N, 4.50. 
4.3.9.  Dimethyl 6-(trimethylsilylethynyl)anthraquinone-2,3-dicarboxylate (TMS-Y-
AQdiester) 
Dimethyl 6-bromoanthraquinone-2,3-dicarboxylate (73 mg, 0.18 mmol), Pd(PPh3)2Cl2 
(7.0 mg, 0.010 mmol, 0.05 equiv), CuI (4.0 mg, 0.020 mmol, 0.10 equiv), TEA (50 µL, 0.40 
mmol, 2.0 equiv) and TMSA (60 µL, 0.50 mmol, 3.0 equiv)  were combined and stirred in dry 
THF (3.5 mL) under a nitrogen atmosphere at 60 °C for 45 min.  TLC (eluting three times in 
CH2Cl2) showed complete consumption of the starting material.  The solvent was evaporated in 
vacuuo, and the crude material was purified by flash silica gel column chromatography eluted 
with CH2Cl2/hexanes (1:1-4:1).  Evaporation of the eluting solvent afforded the title compound 
as a yellow solid (74 mg, 98%), mp 185-188 °C.  1H NMR (400 MHz, CDCl3):  δ (ppm) 0.27 
[9H, s, Si(CH3)3], 3.97 (6H, s, CO2CH3), 7.84 (1H, d, J = 8 Hz, H-7), 8.25 (1H, d, J = 8 Hz, H-
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8), 8.36 (1H, s, H-5), 8.59 (1H, s) and 8.60 (1H, s) (H-1 and H-4).  13C NMR (100 MHz, CDCl3):  
δ (ppm) -0.06 [Si(CH3)3], 53.43 (CO2CH3), 101.33, 103.07, 127.83, 128.42, 128.48, 130.29, 
131.16, 132.39, 133.30, 134.84, 134.99, 136.81, 136.95, 137.57, 166.64 (CO2Me), 166.68 
(CO2Me), 181.18 and 182.29 (C-9 and C-10).  HRMS m/z (M+H)+:  calcd for C23H21O6Si 
421.1107, found 421.1089. 
4.3.10.  Dimethyl 6-ethynylanthraquinone-2,3-dicarboxylate (H-Y-AQdiester) 
To a solution of dimethyl 6-(trimethylsilylethynyl)anthraquinone-2,3-dicarboxylate (63 
mg, 0.15 mmol) in THF/MeOH (1:1 v:v, 6 mL) was added KF (13 mg, 0.23 mmol, 1.5 equiv) 
and the mixture was stirred at rt for 1 h.  The solvent was evaporated, and the crude product was 
purified by flash silica gel column chromatography eluted with CH2Cl2.  Evaporation of the 
eluting solvent afforded the title compound as a pale yellow powder (51 mg, 98%), mp 187-190 
°C.  1H NMR (400 MHz, CDCl3):  δ (ppm) 3.37 (1H, s, ≡C-H), 3.96 (6H, s, CH3), 7.84 (1H, dd, 
J = 1.6 and 8 Hz, H-7), 8.24 (1H, d, J = 8 Hz, H-8), 8.35 (1H, d, J = 1.6 Hz, H-5), 8.55 (1H, s) 
and 8.57 (1H, s) (H-1 and H-4).  13C NMR (100 MHz, CDCl3):  δ (ppm) 53.29 (CH3), 82.02 and 
82.74 (C≡C), 127.83128.40, 128.44, 129.23, 131.29, 132.86, 134.82, 134.93, 136.95, 137.06, 
137.75, 166.50 (CO2Me), 166.54 (CO2Me) and 180.05 (C-9 and C-10).  
4.3.11.  Dimethyl 6-ethylanthraquinone-2,3-dicarboxylate (Et-AQdiester) 
Dimethyl 6-ethynylanthraquinone-2,3-dicarboxylate (0.040 g, 0.12 mmol) was dissolved 
in EtOAc (30 mL).  The resulting solution was transferred to a hydrogenation vessel containing 
10% Pd/C (20 mg) that had been activated by stirring under H2 gas (45 psi) in EtOAc (10 mL) 
for 30 min at rt.  The vessel was next charged with H2 gas and then degassed using an aspirator 
in a cycle that was repeated 5-6 times.  The vessel was finally charged with H2 gas at 40 psi and 
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stirred at rt for 24 h, by which time TLC (alumina, eluted with CH2Cl2) showed a complete 
conversion of an initial spot to a more polar spot.  The Pd/C catalyst was then removed by 
filtration over Celite, and the adsorbed nucleoside residue was extracted from the catalyst by 
washing with boiling CHCl3.  The crude product was loaded on silica gel and purified using 
silica gel column eluted with CH2Cl2/hexane (4:1-4:0).  Evaporation of the eluting solvent 
afforded the title product as a pale yellow solid (34 mg, 84% yield), mp 152-155 °C.  1H NMR 
(400 MHz, CDCl3):  δ (ppm) 1.29 (3H, t, J = 7.6 Hz, CH3CH2), 2.79 (2H, q, J = 7.6 Hz, 
CH3CH2), 3.95 (6H, s, CO2CH3), (1H, dd, J = 8 and 2 Hz, H-7), 8.09 (1H, d, J = 2 Hz, H-5), 8.17 
(1H, d, J = 8 Hz, H-8), 8.547 (1H, s) and 8.550 (1H, s) (H-1 and H-4).  13C NMR (100 MHz, 
CDCl3):  δ (ppm) 15.11 (CH3CH2), 29.39 (CH3CH2), 53.33 (CO2CH3), 126.88, 128.07, 128.21, 
128.24, 131.39, 133.45, 134.62, 134.99, 135.04, 136.51, 136.62, 152.34, 166.74 (CO2Me), 
181.55 and 182.05 (C-9 and C-10).  HRMS m/z (M+Na)+:  calcd for C20H16O6Na 375.0845, 
found 375.0839. 
4.3.12.  5’-O-Dimethoxytrityl-5-[(trimethylsilyl)ethynyl]-2’-deoxyuridine 
To 5-iodo-2’-deoxyuridine (810 mg, 1.23 mmol), previously dried 2 times by co-
evaporation with anhydrous THF, was added in the glove-box Pd(Ph3P)4 (72 mg, 0.060 mmol, 
0.050 equiv), CuI (24 mg, 0.12 mmol, 0.10 equiv), TEA (0.34 mL, 2.5 mmol, 2.0 equiv), 
trimethylsilylacetylene (0.42 mL, 3.7 mmol, 3.0 equiv) and anhydrous DMF (6 mL).  The 
homogeneous mixture was removed from the glove-box and stirred overnight under a nitrogen 
atmosphere at 50 °C in an oil bath; after which time DMF was removed under reduced pressure.  
The residue was applied to a silica gel column that had been pre-equilibrated with 1% TEA in 
CH2Cl2, and eluted with MeOH/CH2Cl2 (0:100-2:98).  Evaporation of the eluting solvent 
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afforded the title compound as a white foam (768 mg, 99% yield).  1H NMR (300 MHz, CDCl3):  
δ (ppm) 0.00 [9H, s, CH3 (TMS)], 2.16-2.25 (1H, m, H-2’), 2.49 (1H, ddd, J = 2.1, 5.4 and 13.5 
Hz, H-2’), 3.31 (1H, dd, J = 3.3 and 10.8 Hz, H-5’), 3.41 (1H, dd, J = 3 and 10.8 Hz, H-5’), 3.79 
[6H, s, OCH3 (DMTr)], 4.04-4.16  (1H, m, H-4’), 4.42-4.51 (1H, m, H-3’), 6.28 (1H, dd, J = 6 
and 7.2 Hz, H-1’), 6.84 [4H, d, J = 8.4 Hz, OPh-meta (DMT)], 7.18-7.35 [7H, m, OPh-ortho 
(DMTr, 4H) and Ph-meta and para (DMTr, 3H)], 7.44 [2H, d, J = 8.1 Hz, Ph-ortho (DMTr)], 
and 8.00 [1H, s, H-6 (dU)].  13C NMR (75 MHz, CDCl3):  δ (ppm) –0.41 [CH3 (TMS)] , 41.37 
(C-2’), 55.17 [OCH3 (DMTr)], 63.44 (C-5’), 72.15 (C-3’), 85.59, 86.33, 86.87 [C-1’, C-4’ and 
CAr3 (DMTr)], 94.96, 99.38 (C≡C), 100.44 [C-5 (dU)], 113.29 [OPh-meta (DMTr)], 126.88, 
127.87, 128.00, 129.94, 135.50, 142.64, 144.39 [DMTr and C-6 (dU)], 149.36 [C-2 (dU)], 
158.52 [OPh-C-4 (DMTr)], and 161.56 [C-4 (dU)].  HRMS m/z (M–H)–:  calcd 625.2370, found 
625.2329. 
4.3.13.  5’-O-Dimethoxytrityl-5-ethynyl-2’-deoxyuridine.16,17 
To a solution of 5’-O-Dimethoxytrityl-5-[(trimethylsilyl)ethynyl]-2’-deoxyuridine (587 
mg, 0.940 mmol) in THF/MeOH (1:1 v:v, 10 mL) was added KF (0.070 g, 1.2 mmol, 1.2 equiv) 
and the mixture was stirred overnight at room temperature.  The solvent was removed under 
reduced pressure and the residue was purified on a silica gel column that had been pre-
equilibrated with 1% TEA in CH2Cl2, and eluted with MeOH/CH2Cl2 (0:100-3:97).  Evaporation 
of the eluting solvent afforded the title compound as a white foam (500 mg, 96% yield).  1H 
NMR (300 MHz, CDCl3):  δ (ppm) 2.21-2.33 (1H, m, H-2’), 2.52 (1H, ddd, J = 3, 5.7 and 13.5 
Hz, H-2’), 2.90 (1H, s, ≡C-H), 3.32-3.43 (2H, m, H-5’), 3.78 [6H, s, OCH3 (DMTr)], 4.06-4.13  
(1H, m, H-4’), 4.52-4.56 (1H, m, H-3’), 6.30 (1H, dd, J = 6 and 7.5 Hz, H-1’), 6.82-6.87 [4H, m, 
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OPh-meta (DMT)], 7.18-7.35 [7H, m, OPh-ortho (DMTr, 4H) and Ph-meta and para (DMTr, 
3H)], 7.40-7.45 [2H, m, Ph-ortho (DMTr)], and 8.07 [1H, s, H-6 (dU)].  13C NMR (100 MHz, 
CDCl3):  δ (ppm) 41.53 (C-2’), 55.30 [OCH3 (DMTr)], 63.45 (C-5’), 72.18 (C-3’), 74.38 (≡C-H), 
81.85 (≡C-dU), 85.71, 86.45, 87.10 [C-1’, C-4’ and CAr3 (DMTr)], 99.22 (C-5 (dU)), 113.40 
[OPh-meta (DMTr)], 127.01, 127.95, 128.07, 130.03, 135.36, 135.53, 143.58, 144.42 [DMTr 
and C-6 (dU)], 149.53 [C-2 (dU)], 158.65 [OPh-C-4 (DMTr)], and 161.96 [C-4 (dU)].  HRMS 
m/z (M–H)–:  calc’d 553.1975, found 553.2001. 
4.3.14.  5’-O-Dimethoxytrityl-5-[(anthraquinone-2-yl)ethynyl]-2’-deoxyuridine [AQ-Y-
dU(DMTr)] 
To 2-iodoanthraquinone (0.40 g, 1.2 mmol) was added in the glove box Pd(Ph3P)4 (0.07 
g, 0.06 mmol, 0.05 equiv), CuI (23 mg, 0.12 mmol, 0.10 equiv), TEA (0.33 mL, 2.4 mmol, 2.0 
equiv), 5’-O-dimethoxytrityl-5-ethynyl-2’-deoxyuridine, previously dried three times by co-
evaporation with anhydrous THF, (0.48 g, 0.86 mmol, 0.72 equiv) and anhydrous DMF (10 mL).  
The mixture was removed from the glove box and stirred under a nitrogen atmosphere for 30 min 
at 60 °C in an oil bath, after which time the mixture became homogeneous.  DMF was removed 
under reduced pressure, and the residue was purified on a Biotage silica gel column that had 
been pre-equilibrated with 1% TEA in CHCl3, and eluted with MeOH/CHCl3 (0:100-5:95).  
Evaporation of the eluting solvent afforded AQ-Y-dU(DMTr) as a yellow foam (640 mg, 98% 
yield).  ε378 = 15,817 ± 100 Lmol-1cm-1 in MeOH.  1H NMR (300 MHz, CDCl3):  δ (ppm) 2.36-
2.46 (1H, m, H-2’), 2.51 (1H, ddd, J = 2.4, 5.4 and 13.5 Hz, H-2’), 3.34 (1H, dd, J = 3 and 10.8 
Hz, H-5’), 3.52 (1H, dd, J = 2.7 and 10.8 Hz, H-5’), 3.69 [3H, s, OCH3 (DMTr)], 3.70 [3H, s, 
OCH3 (DMTr)], 4.14-4.20  (1H, m, H-4’), 4.62-4.68 (1H, m, H-3’), 6.40 (1H, dd, J = 6 and 7.2 
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Hz, H-1’), 6.79 [4H, dd, J = 1.8 and 9 Hz, OPh-meta (DMT)], 7.04 [1H, dd, J = 1.5 and 8.1 Hz, 
H-3 (AQ)],  7.14 [1H, t, J = 7.2 Hz, Ph-para (DMTr)], 7.27 [2H, dd, J = 7.2 and 7.8 Hz, Ph-
meta (DMTr)], 7.36 [4H, dd, J = 0.9 and 9 Hz, OPh-ortho (DMTr)], 7.46 [2H, d, J = 7.8 Hz, Ph-
ortho (DMTr)], 7.76-7.84 [2H, m, H-6 (AQ) and H-7 (AQ)], 8.00 [1H, d, J = 8.1 Hz, H-4 (AQ)], 
8.11 [1H, d, J = 1.5 Hz, H-1 (AQ)], 8.25-8.32 [2H, m, H-5 (AQ) and H-8 (AQ)], and 8.40 [1H, 
s, H-6 (dU)].  13C NMR (75 MHz, CDCl3):  δ (ppm) 41.85 (C-2’), 55.17 [OCH3 (DMTr)], 63.41 
(C-5’), 72.26 (C-3’), 84.85 (≡C-dU), 85.99, 86.78, 87.18 [C-1’, C-4’ and CAr3 (DMTr)], 92.31 
(≡C-AQ), 99.68 [C-5 (dU)], 113.35 [OPh-meta (DMTr)], 126.81, 127.08, 127.25, 127.87, 
128.08, 128.66, 129.89, 132.20, 133.10, 133.39, 133.47, 134.16, 135.44, 136.62, 143.41, 144.41 
[AQ, DMTr and C-6 (dU)], 148.92 [C-2 (dU)], 158.64 [OPh-C-4 (DMTr)], 160.74 [C-4 (dU)], 
182.26 and 182.52 [C-9 and C-10 (AQ)].  HRMS m/z (M–H)–:  calcd for C46H35N2O9 759.2343, 
found 759.2320. 
4.3.15.  5-[(Anthraquinone-2-yl)ethynyl]-2’-deoxyuridine (AQ-Y-dU) 
5’-O-Dimethoxytrityl-5-[(anthraquinone-2-yl)ethynyl]-2’-deoxyuridine (130 mg, 0.17 
mmol) was dissolved in CH2Cl2 (1.31 mL), and then dichloroacetic acid (DCA) (560 µL, 6.80 
mmol, 40.0 equiv) was added.  The resulting red slurry was stirred at room temperature for 45 
min.  The reaction mixture was then diluted by adding CHCl3 (20 mL), and quenched by addition 
of triethylamine until the red color of the DMTr cation disappeared.  More CHCl3 (200 mL) and 
water (10 mL) were added, and the organic layer was separated, washed with water dried with 
anhydrous MgSO4, and evaporated to dryness.  The solid was purified using flash silica gel 
chromatography on a Biotage column with MeOH/CH2Cl2 (0:100-7:93) as the eluting system to 
yield AQ-Y-dU as an orange solid after evaporation of the eluting solvent (17 mg, 22% yield).  
1H NMR (300 MHz, DMSO-d6):  δ (ppm) 2.12-2.27 (2H, m, H-2’ and H-2’), 3.57-3.73 (2H, m, 
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H-5’ and H-5’), 3.80-3.84  (1H, m, H-4’), 4.24-4.31 (1H, m, H-3’), 5.24 (1H, t, J = 4.8 Hz, 5’-
OH), 5.28 (1H, d, J = 4.2 Hz, 3’-OH), 6.13 (1H, t, J = 6.6 Hz, H-1’), 7.88-7.95 [3H, m, H-3 
(AQ), H-6 (AQ), and H-7 (AQ)],  8.12 (1H, d, J = 1.8 Hz, H-1 (AQ)), 8.14-8.27 [3H, m, H-4 
(AQ), H-5 (AQ), and H-8 (AQ)], and 8.53 [1H, s, H-6 (dU)].  1H NMR (300 MHz, DMSO-d6 + 
D2O):  δ (ppm) 2.04-2.26 (2H, m, H-2’ and H-2’), 3.57 (1H, dd, J = 3 and 12 Hz, H-5’), 3.67 
(1H, dd, J = 3 and 12 Hz, H-5’), 3.79-3.86  (1H, m, H-4’), 4.24-4.28 (1H, m, H-3’), 6.11  (1H, t, 
J = 6.6 Hz, H-1’), 7.87-7.94 [3H, m, H-3 (AQ), H-6 (AQ), and H-7 (AQ)],  8.10 [1H, d, J = 1.8 
Hz, H1 (AQ)], 8.14-8.20 [3H, m, H-4 (AQ), H-5 (AQ), and H-8 (AQ)], and 8.50 [1H, s, H-6 
(dU)].  13C NMR (100 MHz, DMSO-d6):  δ (ppm) 39.74 (C-2’), 60.23 (C-5’), 69.29 (C-3’), 
84.56 (≡C-dU), 87.14, 87.21 (C-1’ and C-4’), 90.19 (≡C-AQ), 96.79 [(C-5 (dU)], 126.27, 
126.80, 127.83, 128.15, 131.43, 132.38, 132.55, 132.73, 134.04, 134.18, 135.51 (AQ), 144.66 
[C-6 (dU)], 148.85 [C-2 (dU)], 160.72 [C-4 (dU)], 181.20 and 181.36 [C-9 and C-10 (AQ)].  
HRMS m/z (M–H)–:  calcd for C25H17N2O7 457.1036, found 457.1021. 
4.3.16.  5’-O-Dimethoxytrityl-5-[2-(anthraquinone-2-yl)ethyl]-2’-deoxyuridine [AQ-E-
dU(DMTr)] 
5’-O-Dimethoxytrityl-5-[(anthraquinone-2-yl)ethynyl]-2’-deoxyuridine (1.0 g, 1.3 mmol) 
was dissolved in a mixture of ethyl acetate (50 mL) and MeOH (80 mL).  The resulting solution 
was transferred to a hydrogenation vessel containing 10% Pd/C (500 mg) that had been activated 
by stirring under H2 gas (45 psi) in MeOH (30 mL) for 30 min at rt.  The vessel was next charged 
with H2 gas and then degassed using an aspirator in a cycle that was repeated 5-6 times.  The 
vessel was finally charged with H2 gas at 40 psi and stirred at rt.  The reaction progress was 
monitored by UV-vis absorbance at 377 nm until the reaction mixture showed no absorbance (7 
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h).  The Pd/C catalyst was then removed by filtration over Celite, and the adsorbed nucleoside 
residue was extracted from the catalyst by washing with boiling 10% MeOH in CHCl3.  The 
crude product was loaded on silica gel and purified using silica gel chromatography on a Biotage 
column (40+M cartridge) that had been pre-equilibrated with 1% TEA in THF/hexane (2:3 v:v), 
eluting with MeOH/THF/hexane (1:40:60 v:v:v).  Evaporation of the eluting solvent afforded 
AQ-E-dU(DMTr) as a pale yellow foam (323 mg, 32% yield). 1H NMR (300 MHz, CDCl3):  δ 
(ppm) 1.82-1.97 (1H, m, H-2’), 2.23-2.41 (2H, m, CH2CH2), 2.46-2.63 (2H, m, CH2CH2),  2.73-
2.87 (1H, m, H-2’), 3.35 (1H, dd, J = 2.5 and 8.4 Hz, H-5’), 3.56 (1H, dd, J = 2.7 and 8.4 Hz, H-
5’), 3.68 [6H, s, OCH3 (DMTr)], 4.10-4.18  (1H, m, H-4’), 4.59-4.67 (1H, m, H-3’), 6.52 (1H, 
dd, J = 6 and 7.2 Hz, H-1’), 6.72-6.85 [4H, m, OPh-meta (DMT)], 7.08 [1H, dd, J = 1.5 and 8.1 
Hz, H-3 (AQ)],  7.14-7.34 [7H, m, Ph-para, Ph-meta and OPh-ortho (DMTr)], 7.42 [2H, d, J = 
7.2 Hz, Ph-ortho (DMTr)], 7.70-7.79 [3H, m, H-6 (AQ), H-7 (AQ) and H-6 (dU)], 7.84 [1H, d, J 
= 1.5 Hz, H-1 (AQ)], 8.11  [1H, d, J = 8.1 Hz, H-4 (AQ)] and 8.22-8.27 [2H, m, H-5 (AQ) and 
H-8 (AQ)].  13C NMR (75 MHz, CDCl3):  δ (ppm) 28.03 (CH2CH2), 34.74 (CH2CH2), 40.99 (C-
2’), 55.08 [OCH3 (DMTr)], 63.51 (C-5’), 72.39 (C-3’), 84.80, 86.39, 86.68 [C-1’, C-4’ and CAr3 
(DMTr)], 113.14 and 114.16 [OPh-meta (DMTr) and C-5 (dU)], 126.69, 126.96, 127.01, 127.14, 
127.89, 128.14, 129.96, 130.07, 131.34, 133.16, 133.36, 133.40, 133.84, 134.16, 135.15, 135.26, 
136.43, 144.14 [AQ, DMTr and C-6 (dU)], 148.40 [C-2 (dU)], 150.57 [C-2 (AQ)],158.55 [OPh-
C-4 (DMTr)], 163.46 [C-4 (dU)], 182.92 and 182.95 [C-9 and C-10 (AQ)].  HRMS m/z (M–H)–:  
calcd for C46H39N2O9 763.2661, found 763.2648. 
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4.3.17.  (E)-N-{2-[3-(5’-O-Dimethoxytrityl-2'-deoxyuridine-5-yl)acrylamido]ethyl}-
anthraquinone-2-carboxamide [AQ-8-dU(DMTr)] 
To a solution of dry (E)-2-[3-(5’-O-Dimethoxytrityl-2'-deoxyuridine-5-
yl)acrylamido]ethylamine (Berry & Associates, Dexter, MI, 0.02 g, 31 µmol) in anhydrous DMF 
(1.5 mL) was added N-succinimidyl 2-anthraquinone-carboxylate5 (22 mg, 62 µmol), and 
triethylamine (13 µL, 93 µmol).  The yellow solution was stirred overnight at room temperature.  
The solvent was evaporated and the residue was purified using preparative TLC (20 cm long x 
10 cm wide x 0.2 cm thick) eluted with 6.5% methanol in dichloromethane.  The product band 
was scratched off the plate and eluted with 10% methanol in dichloromethane.  Evaporation of 
the solvent afforded AQ-8-dU(DMTr) as a pale yellow solid (26 mg, 95% yield).  ε304 (MeOH):  
19157 ± 100 Lmol-1cm-1.  1H NMR (400 MHz, DMSO-d6):  δ (ppm) 2.15-2.21 (1H, m, H-2’), 
2.26-2.34 (1H, m, H-2’), 3.13-3.20 (2H, m, H-5’), 3.37-3.42 (4H, m, ethylene), 3.70 (1H, s, 
OCH3), 3.71 (1H, s, OCH3), 3.87-3.90 (1H, m, H-4’), 4.22-4.26 (1H, m, H-3’), 5.26 (1H, d, 6.55, 
J = 4.7 Hz, OH3’), 6.15 (1H, t, J = 6.5 Hz, H-1’), 6.83-6.87 (4H, m, OPh-meta (DMTr)), 7.11 
(2H, d, J = 7.7, vinyl), 7.17 (1H, t, J = 8 Hz, Ph-para (DMTr)), 7.22-7.29 (6H, m, OPh-ortho 
(DMTr, 4H) and Ph-meta (DMTr, 2H)), 7.35 (2 H, d, J = 8 Hz, Ph-ortho (DMTr)), 7.92-7.96 
(3H, m, NH (amide), H-6 (AQ), and H-7 (AQ)), 8.21-8.25 (3H, m, H-3 (AQ), H-5 (AQ) and H-8 
(AQ)), 8.27 (1H, s, H-6 (dU)), 8.32 (1H, dd, J = 1.6 and 8 Hz, H-4 (AQ)), 8.65 (1H, d, J = 1.6 
Hz, H-1 (AQ)), 8.99 (1H, t, J = 5 Hz, NH (amide)), and 11.58 (1H, s, H-3 (dU)).  13C NMR (100 
MHz, DMSO-d6):  δ (ppm) 55.44, 55.45, 64.39, 70.74, 85.16, 86.07, 109.76, 113.66, 122.29, 
126.06, 127.14, 127.29, 127.34, 127.52, 128.15, 128.28, 130.11, 132.98, 133.30, 133.54, 133.57, 
133.60, 135.01, 135.14, 135.97, 136.06, 139.93, 143.38, 145.27, 149.75, 158.54, 162.27, 165.28, 
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166.47, and 182.62 (CO (AQ)). HRMS m/z (M–H)–:  calcd for C50H43N4O11 875.2928, found 
875.2907. 
4.3.18.  8-[(Anthraquinone-2-yl)ethynyl]-2’-deoxyadenine (AQ-Y-dA) 
Pd(Ph3P)4 (32 mg, 0.028 mmol), CuI (11 mg, 0.055 mmol), and TEA (0.40 mL, 2.9 
mmol) and 2-ethynylanthraquinone (32 mg, 0.55 mmol) were combined and stirred in dry DMF 
(4.6 mL) under a nitrogen atmosphere.  To this mixture was transferred a suspension of 8-bromo-
2’-deoxyadenosine (140 mg, 0.61 mmol) in DMF (8 mL).  After stirring the reaction mixture at 
60 0C for 3 h, the solvent was evaporated in vacuuo, and the crude material was purified three 
times by silica gel column chromatography (once by CH2Cl2/methanol, 0:100-7:93 v:v, and then 
twice by EtOAc/methanol, 0:100-2:98 v:v) to afford AQ-Y-dA (200 mg, 76%), mp 239-241 °C.  
1H NMR (300 MHz, DMSO-d6):  δ (ppm) 2.17 (1H, ddd, J = 12.9, 6.6, 2.7 Hz, H2’), 3.22-3.13 
(1H, m, H-2’), 3.56-3.47 (1H, m, H-5’), 3.72-3.65 (1H, m, H-5’), 3.93 (1H, dd, J =13.5, 4.5 Hz, 
H-4’), 5.29 (1H, dd, J = 7.2, 4.5 Hz, H-3’), 5.40 (1H, d, J = 4.2 Hz, OH), 6.90 (1H, t, J = 6.59 
Hz, H-1’), 7.68 (2H, br s, NH2), 7.98-7.93 [2H, m, H-6, and H-7 (AQ)], 8.24-8.15 [4H, m, H-3, 
H-5 and H-8 (AQ), and H-2 (dA)], 8.27 [1H, d, J = 7.8 Hz, H-4 (AQ)], and 8.37 [1H, d, J = 1.5 
Hz, H-1 (AQ)].  13C NMR (75 MHz, DMSO-d6):  δ (ppm) 62.18, 71.21, 82.30, 85.23, 88.38, 
92.61, 119.92, 125.72, 126.91, 127.48, 129.74, 132.22, 132.95, 133.09, 133.34, 133.45, 134.79, 
134.87, 136.98, 148.62, 153.80, 156.26, 181.70, and 181.80.  HRMS (FAB) m/z for C26H19N5O5 
(M + H)+:  calc’d. 482.47, found 482.10. 
4.3.19.  8-[2-(Anthraquinone-2-yl)ethyl]-2’-deoxyadenine (AQ-E-dA) 
Compound AQ-Y-dA (100 mg, 0.2 mmol) was dissolved in MeOH (150 mL) by heating 
while stirring.  The resulting solution was transferred to a hydrogenation vessel containing 10% 
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Pd/C (50 mg) that had been activated by stirring under H2 (40 psi) in MeOH (20 mL) for 30 min 
at room temperature.  The vessel was next charged with H2 gas and then degassed using an 
aspirator in a cycle that was repeated 5-6 times.  The vessel was finally charged with hydrogen 
gas at 40 psi and stirred at room temperature for 24 h, by which time TLC showed a complete 
conversion of an initial spot to a more polar spot.  The Pd/C catalyst was then removed by 
filtration over Celite, and adsorbed nucleoside residue was extracted from the catalyst by 
washing with boiling 10% MeOH in CHCl3.  The crude product was applied to a silica gel 
chromatography column eluted with MeOH/EtOAc (0:100-5:95).  Evaporation of the eluting 
solvent afforded AQ-E-dA as a yellow powder (91 mg, 90% yield), mp 207-208 °C.  1H NMR 
(400 MHz, DMSO-d6):  δ (ppm) 2.13 (1H, ddd, J = 8.4, 6.0, 2.0 Hz, H2’), 3.05-3.10 (1H, m, H2’), 
3.27-3.41 (4H, m, CH2CH2), 3.47-3.52 (1H, m, H-5’), 3.63-3.66 (1H, m, H-5’), 3.86-3.89 (1H, 
m, H-4’), 4.45 (1H, br s, OH), 5.27 (1H, br s, OH), 5.44-5.53 (1H, m, H-3’), 6.32 (1H, t, J = 6.8 
Hz, H-1’), 7.21 (2H, s, NH2), 7.82-7.95 [3H, m, H-3, H-6, and H-7 (AQ)] and 8.06-8.18 [5H, m, 
H-1, H-4, H-5, and H-8 (AQ).  13C NMR (100 MHz, DMSO-d6):  δ (ppm) 27.91, 32.27, 37.37, 
61.66, 70.74, 83.86, 87.59, 117.70, 126.06, 126.15, 126.21, 126.51, 130.79, 132.50, 133.92, 
133.99, 134.32, 147.64, 149.30, 150.35, 150.95, 154.95, 181.68 and 181.99.  HRMS m/z 
(M+H)+:  calcd for C26H24N5O5 486.1777, found 486.1769. 
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Chapter 5 
Synthesis, Electrochemistry and Spectroscopic Studies of (2-
Anthraquinonyl)trimethylammonium Trifluoromethanesulfonate 
5.1.  Introduction 
Previous work in our research group1 showed that photoexcitation of an AQ-dA 
conjugate (AQEdA, Figure 5.1) at 341 nm in methanol did not produce the expected AQ•−/dA•+ 
product.  On the other hand, photoexcitation at the same wavelength of an aqueous solution of 
dA and 2-anthraquinone sulfonic acid sodium salt (AQ2S-) did produce the AQ2S•2−/dA•+ 
product.  This implies that in the second case, the CS product may have been stabilized by proton 
transfer reactions with water or by the presence of the electron-withdrawing sulfonate group on 
AQ, or by both processes together.  This suggested to us that introduction of a quaternary 
ammonium group on AQ in an AQ-dA conjugate (for example, AQqN+-dA, Figure 5.1) might 
both stabilize an electron transfer (ET) product and render the conjugate soluble in aqueous 
solutions.  Furthermore, the quaternary ammonium group on the AQ subunit of the conjugate 
would allow formation of an AQqN•/dA+ charge shift (CShf) product upon photoexcitation.  A 
CShf product might live longer than a CS product due to the lack of Coulombic attraction 
between the oxidized and reduced subunits.  Herein I report the synthesis of AQqN+ (both as 
CF3SO3¯ and PF6¯ salts), measurements of the UV-vis spectra of its CF3SO3¯ salt in acetonitrile 
(MeCN), methanol (MeOH), and water, and results of electrochemical measurements.   
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Figure 5.1.  Structural drawings of AQEdA and AQN+-dA. 
5.2.  Results and Discussion 
5.2.1.  Synthesis of AQNMe3Tf (1a) 
As shown in Scheme 5.1, the starting material 2-dimethylaminoanthraquinone (3) was 
prepared from 2-aminoanthraquinone (2) and iodomethane in the presence of sodium hydride in 
N,N-dimethylformamide (DMF).2  Treatment of 3 with 10 equivalents of iodomethane3 in 
refluxing dichloromethane for 24 hours did not result in quaternization of the amine of 3.  
Instead, 3 was completely recovered.  The observed lack of reactivity of this dialkylamine 
derivative toward quaternization might be attributed to the presence of the dialkylamine moiety 
para to one of the carbonyl groups of AQ.  This para substitution pattern could delocalize the 
lone pair of electrons of the amino group of 3 into the ring and consequently deactivate it with 
respect to nucleophilic reactions.  Trifluoromethanesulfonate (Tf) is a better leaving group than 
iodide and indeed methyl trifluoromethanesulfonate (MeTf) has been reported to quaternerize 
tertiary aromatic amines having electron-withdrawing groups on their ring.4,5 Treatment of 3 
with 1.1 equivalent of MeTf in CH2Cl2 and stirring overnight at room temperature resulted in the 
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formation of AQNMe3Tf (1a) in a quantitative yield.  Interestingly, a change in the color 
characteristics of the dialkylamine derivatives upon quaternization was observed.  The colors of 
3, 4, and 5 were bright reddish, while 1a and 1b had a light pink color.  This color change upon 
quaternization indicated loss of a low energy amine-to-AQ charge transfer state in the 
ammonium salt. 
We envisioned that the presence of groups with more lipophilic character than methyl on 
the ammonium group of AQqN+ would enhance its solubility in the organic solvents.  This 
enhanced solubility would  be needed for multistep synthesis of the nucleoside conjugate and for 
spectroscopic studies.  Thus, 2-diethylaminoanthraquinone (4) and 2-dipropylaminoanthra-
quinone (5) were synthesized using the corresponding iodoalkanes under the same conditions 
used for the synthesis of 3.  Compound 1a was found to be soluble in dimethylsulfoxide 
(DMSO), MeOH, MeCN, and also water.  Thus 1a meets our solubility requirements for 
spectroscopic studies.  The triflate counter ion in 1a was exchanged for hexafluorophosphate by 
addition of a saturated aqueous solution of NH4PF6 to a saturated aqueous solution of 1a.  The 
mixing resulted in the immediate precipitation of AQNMe3PF6 (1b).  The identity of 1b was 
confirmed by IR as shown as shown in Figure 5.2.  An attempt to exchange the triflate with 
chloride using 10 equivalents of HCl in methanol6 failed due to the much lower pKa of triflic 
acid compared to HCl.  The stability of 1a toward basic conditions, such as concentrated 
ammonium hydroxide (which is used during solid phase oligonucleotide synthesis) was also 
tested.  Anthraquinone 1a was dissolved in concentrated aqueous ammonium hydroxide for 5 
hours while stirring at 60 ˚C.  No decomposition of 1a occurred as judged by 1H NMR. 
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Figure 5.2.  IR spectra of AQNMe3Tf (1a) and AQNMe3PF6 (1b). 
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5.2.2.  UV-vis Studies of (2-Anthraquinonyl)trimethylammonium 
Trifluoromethanesulfonate (1a) 
Figure 5.3 shows the UV-Vis absorbance spectrum of a 2.89×10-5 M solution of 1a in 
MeOH.  The two characteristic (π, π*) bands of anthraquinone1 have absorbance maxima (λmax) 
at 251 and 316 nm.  The forbidden (n, π*) state occurs at 424 nm, but is not seen in this spectrum 
due to its very low molar absorbance. 
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Figure 5.3.  UV-Vis absorbance spectrum of a 2.89×10-5 M solution of AQNMe3Tf in MeOH. 
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Figure 5.4.  Normalized UV-Vis absorption spectra of AQNMe3Tf in MeCN, MeOH, and water.  
Solution concentrations were 1.84×10-4, 2.31×10-4, and 2.02×10-4 M respectively.  (Note that the 
spectra in MeOH and MeCN are nearly identical.) 
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Figure 5.5.  UV-Vis absorption spectra of AQNMe3Tf in MeCN, MeOH, and water at the same 
concentrations in Figure 5.4. 
Figure 5.4 shows the UV-vis normalized absorbance spectra of 1a in MeCN, MeOH, and 
water.  The 316 nm band occurs at the same wavelength in both MeCN and MeOH, but is red-
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shifted 7 nm to 323 nm in water.  Molar absorbances (ε) for this band are, respectively, 5210, 
4140, and 4750 (± 100) M-1cm-1 in MeCN, MeOH, and water.  A new absorbance band not 
present in anthraquinone itself also occurs for 1a in all three solvents:  468 nm in MeCN, 476 nm 
in MeOH and 531 nm in water (Figure 5.5).  Compound 1b (the PF6¯ salt) shows the same new 
band in water also at the 531 nm.  The small molar absorbance (108 M-1cm-1 in both MeCN and 
MeOH, and 54 M-1cm-1 in water) of this new band and its wavelength shift with change in 
solvent dielectric properties strongly suggest that it is due to a counter ion-to-AQqN+ charge 
transfer state.   
5.2.3.  Electrochemical and Laser Transient Absorbance results 
Electrochemical measurements were performed by Y. Hussein for compound 1b in both 
anhydrous acetonitrile and aqueous media and reduction potential values were reported versus 
saturated calomel electrode (SCE) (Table 5.1).  Experiments in acetonitrile with 0.10 M TBAH 
as the supporting electrolyte and aqueous electrochemistry was run using 0.10 M KCl in 
phosphate buffer at different pH values.   
Table 5.1.  Reduction potential values of AQ and AQNMe3PF6. 
Compound Solvent E1/2 (V) vs. SCE 
AQ MeCN –0.939 
AQNMe3PF6 MeCN –0.713 
AQNMe3PF6 H2O (pH = 13) –0.560 
AQNMe3PF6 H2O (pH = 7) –0.439 
AQNMe3PF6 H2O (pH = 1) –0.128 
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Modification of AQ with the ammonium group made AQNMe3PF6 easier to reduce than 
AQ itself by 226 mV in acetonitrile.  In water the reduction potential values were in general 
lower than in acetonitrile.  The reduction potential at pH 7 is lower than that at pH 13 by 121 
mV.  An additional decrease by 311 mV in the reduction potential occurred when the pH was 
further lowered to 1.  This decrease in potential at low pH is due to the stabilization of the 
resulting AQ anion radical by proton transfer from the buffer. 
Transient absorbance measurements of AQNMe3PF6 was also done by Y. Hussein and 
showed that excitation at 341 nm at pH 1 and pH 5 resulted in the formation of electron transfer 
product with the fully protonated anion formed [AQNMe3(H)●+].  Excitation at pH 7-12 resulted 
in the formation of the non-protonated anion product (AQNMe3●), while excitation at pH 6 the 
spectra for both the protonated and non-protonated anion product.  On the other hand, excitation 
at pH 13 did not show any electron transfer product.  In conclusion, excitation of AQNMe3PF6 at 
pH < 13 can result in electron transfer and reduction of AQ by anions from the buffer.  It has 
been previously reported that some excited AQ derivatives undergo electron transfer reactions 
with simple inorganic anions.7 
5.3.  Experimental 
5.3.1.  Reagents and General Procedures 
2-Aminoanthraquinone was purchased from Lancaster as a yellowish brown powder 
(96% purity) and used as received.  Solvents were dried and redistilled in continuous circulation 
distillation apparatus.  THF was dried with benzophenone /Na0, and both DMF and methylene 
chloride were redistilled over CaH2.  Water was supplied from a Millipore ultrapure water 
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system (model Milli-Q plus).  All manipulations of methyl triflate were performed in a Vacuum 
Atmospheres M040-2 glove box pressurized with dry nitrogen gas.  Additions of alkyl iodide 
and methylene chloride were carried out on the benchtop under a dry nitrogen atmosphere using 
cannula techniques.  Most of the reactions were monitored with glass-backed TLC Plates 
precoated with silica gel 60 F254 (EMD Chemicals).  HPLC grade solvents were used for 
chromatographic purifications.  Flash column chromatography was carried out on either a 
Biotage Flash-40™ system using prepackaged KP-Sil™ cartridges or on Whatman™ flash silica 
(60Å pore, 230 – 400 mesh) that was packed in glass columns and pressurized with nitrogen.  
Melting points were corrected. 
5.3.2.  UV-vis Spectroscopy and NMR 
UV-vis absorbance spectra were recorded with a Shimadzu UV-2501 spectrophotometer.  
THF, MeCN, and MeOH solvents used in these measurements were HPLC grade and used 
without further purification.  Molar absorption values were determined using Beer’s law.  NMR 
Spectra were obtained at Georgia State University from a Varian Unity+300 NMR spectrometer 
operating at either 75 or 300 MHz frequencies. 
5.3.3.  2-(Dimethylamino)anthraquinone (3) 
Dry 2-aminoanthraquinone 2 (300 mg, 1.34 mmol) was dissolved in neat DMF (7 mL), 
followed by addition of NaH (71 mg, 3.0 mmol). The dark green mixture was stirred under a 
nitrogen atmosphere for one hour, and turned reddish upon addition of iodomethane (0.20 mL, 
3.2 mmol).  The reaction was quenched with ammonium chloride when TLC showed complete 
consumption of the starting material after stirring for 2 hours.  The solvent was evaporated under 
reduced pressure, the crude product was extracted with methylene chloride, washed with water, 
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dried over MgSO4, and purified by nitrogen pressurized silica gel column chromatography 
(CH2Cl2/ ethyl acetate, 9:1-1:1 v:v), to give 3 (329 mg, 97% yield) as red-orange solid, mp 183-
185 °C (lit.8 186 °C).  1H and 13C NMR spectra for 3 were identical to those  published in the 
literature.2   
5.3.4.  2-(Diethylamino)anthraquinone (4)9 
Dry 2-aminoanthraquinone 2 (3 g, 13.4 mmol) was dissolved in neat DMF (20 mL), 
followed by addition of NaH (0.71 g, 29.6 mmol). The dark green mixture was stirred under 
nitrogen atmosphere for one hour, and formed a reddish paste upon addition of iodoethane (2.68 
mL, 33.5 mmol).  The reaction was quenched with ammonium chloride after stirring for 2 hours.  
The solvent was evaporated under reduced pressure; the crude product was extracted with 
methylene chloride, washed with water, dried over MgSO4, and purified by unpressurized silica 
gel column chromatography using 20% hexanes in CH2Cl2 as the eluting system.  A fluorescent 
by-product was still present after chromatography and was removed by extraction with hexane.  
Crystallization of the remaining solid from ethanol gave 4 as bright red needles (1.07 g, 29% 
yield), mp 161-163 °C (lit.10 164-165 °C).  1H NMR (300 MHz, CDCl3):  δ (ppm) 8.29-8.22 (m, 
2H), 8.14 (d, 1H, J = 9 Hz) 7.80-7.66 (m, 2H), 7.42 (d, 1H, J = 3 Hz), 6.90 (dd, 1H, J = 9 and 3 
Hz), 3.51 (q, 4H, J = 7.2 Hz), and 1.25 (t, 6H, J = 7.2 Hz). 13C NMR (75 MHz, CDCl3):  δ (ppm) 
184.31, 181.22, 151.63, 135.13, 134.38, 133.83, 133.62, 132.78, 129.95, 126.76, 126.75, 121.28, 
115.29, 107.92, 44.72, and 12.52. 
5.3.5.  2-(Dipropylamino)anthraquinone (5) 
Dry 2-aminoanthraquinone 2 (3.00 g, 13.4 mmol) was dissolved in neat DMF (20 mL), 
followed by addition of NaH (0.710 g, 29.6 mmol). The dark green mixture was stirred under 
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nitrogen atmosphere for one hour.  It formed a reddish paste upon addition of 1-iodopropane 
(3.27 mL, 33.5 mmol).  The reaction was quenched with ammonium chloride after stirring for 2 
hours.  The solvent was evaporated under reduced pressure; the crude product was extracted with 
methylene chloride, washed with water, dried over MgSO4, and purified by unpressurized silica 
gel column chromatography using 30% hexanes in CH2Cl2 as the eluting system.  A fluorescent 
by-product was still present after chromatography and was removed by extraction with hexane.  
Crystallization of the remaining solid from ethanol gave 5 as dark red plates (0.83 g, 20% yield), 
mp 142-144 °C.  1H NMR (300 MHz, CDCl3):  δ (ppm) 8.29-8.22 (m, 2H), 8.14 (d, 1H, J = 9 
Hz) 7.77-7.67 (m, 2H), 7.42 (d, 1H, J = 3 Hz), 6.90 (dd, 1H, J = 9 and 3 Hz), 3.4 (t, 4H, J = 7.5 
Hz), 1.69 (sixtet, 4H, J = 7.5 Hz), and 0.99 (t, 6H, J = 7.5 Hz). 13C NMR (75 MHz, CDCl3):  δ 
(ppm) 184.43, 181.31, 152.18, 135.12, 134.47, 133.91, 133.70, 132.87, 129.93, 126.82, 121.30, 
115.51, 108.19, 52.85, 20.47 and 11.37. 
5.3.6.  (2-Anthraquinonyl)trimethylammonium Trifluoromethanesulfonate (1a) 
To a solution of 3 (125 mg, 0.497 mmol) in dry dichloromethane, methyl 
trifluoromethanesulfonate (0.055 mL, 0.55 mmol) was added in a glove box.  The mixture was 
stirred for 48 hr until the red-orange color of the mixture disappeared, and TLC (10% hexanes in 
CH2CL2) showed complete consumption of the starting material.  The resulting precipitate was 
filtered, washed with CH2CL2, and dried in vacuuo to afford 1a as a pink solid (202 mg, 98% 
yield), mp 276-278 °C.  ε323 (H2O):  4747 ± 100 Lmol-1cm-1, ε316 (MeCN):  5191 ± 100 Lmol-
1cm-1, ε316 (MeOH):  4139 ± 100 Lmol-1cm-1, ε317 (THF):  4697 ± 100 Lmol-1cm-1.  1H NMR (300 
MHz, CDCl3):  δ (ppm) 8.63 (d, 1H, J = 2.7 Hz), 8.49 (dd, 1H, J = 9 and 2.7 Hz), 8.39 (d, 1H, J 
= 9 Hz), 8.26-8.21 (m, 2H), 7.97-7.94 (m, 2H), and 3.70 (s, 9H)  13C NMR (75 MHz, CDCl3):  δ 
  
141
(ppm) 181.33, 181.29, 151.10, 135.00, 134.90, 134.32, 133.70, 132.99, 132.87 129.01, 127.00, 
126.94, 126.59, 119.05, and 56.37.  IR (cm-1, solid film) 1680, 1586, 1500, 1475, 1413, 1331, 
1300, 1258, and 1147. 
5.3.7.  (2-Anthraquinonyl)trimethylammonium hexafluorophosphate (1b) 
To a saturated solution of 1a (100 mg) in water, was added an excess amount of saturated 
aqueous solution of ammonium hexafluorophosphate while stirring.  A pink precipitate formed 
immediately and was filtered, washed with water, and dried in vaccuo to afford 1b as a pink 
solid in a quantitative yield, mp 267-269 °C.  ε324 (H2O):  6435 ± 100 Lmol-1cm-1, ε341 (H2O):  
4803 ± 100 Lmol-1cm-1.  1H NMR (300 MHz, CDCl3):  δ (ppm) 8.63 (d, 1H, J = 2.7 Hz), 8.49 
(dd, 1H, J = 9 and 2.7 Hz), 8.39 (d, 1H, J = 9 Hz), 8.25-8.20 (m, 2H), 7.96-7.93 (m, 2H), and 
3.71 (s, 9H). 13C NMR (75 MHz, CDCl3):  δ (ppm) 181.31, 181.27, 151.10, 134.99, 134.90, 
134.32, 133.70, 132.97, 132.85 129.03, 127.00, 126.94, 126.57, 119.05, and 56.37.  IR (cm-1, 
solid film) 1685, 1589, 1428, 1331, and 1300. 
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Chapter 6 
Synthesis of Two Intermediates Useful for Substituting DNA with AQ-dA Conjugates and 
Optimization of 3’-Phosphorylation and Other Reaction Conditions using 2’-
Deoxyadenosine as a Substrate. 
6.1  Introduction 
Herein is reported the synthesis of two intermediates useful for substituting DNA with 
AQ-dA conjugates via solid phase DNA synthesis.  Also reported is the optimization of reaction 
conditions starting with 2’-deoxyadenosine (dA) to obtain the corresponding 3’-benzyl hydrogen 
phosphate.  The optimized reaction conditions were used to prepare the 3’-benzyl hydrogen 
phosphate of AQ-dA conjugates described in Chapter 2.  dA was used for this purpose for three 
reasons:  1) to test phosphoramidite chemistry without N6-protection, 2) to determine stability of 
phosphate protection toward DMTr deprotection, and 3) to establish the stability of both the N-
glycosidic bond and the phosphate group itself toward the variety of reaction conditions needed 
to produce 2’-deoxyadenosine 3’-benzyl phosphate (20).   
6.2.  Results and Discussion 
6.2.1. Synthesis of Two Intermediates Useful for Substituting DNA With AQ-dA 
Conjugates 
6.2.1.1.  N6-Benzoyl-5’-O-(4,4’-dimethoxytrityl)-8-bromodeoxyadenosine (21) 
Compound 21 (shown in Scheme 6.1) was prepared from 3 (8-bromo-2’-deoxyadenosine) 
by protection of 6-NH2 with benzoyl and 5’-OH with DMTr, respectively, using BzCl and 
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DMTrCl.  Both of these protecting groups were specifically required for dA incorporation into 
DNA by standard solid-phase synthetic protocols.  Literature methods to produce brominated 21 
employed separate steps of benzoylation and tritylation of 3 in arbitrary in either order.1-3  On the 
other hand, a one-pot reaction procedure was reported for small scale preparation of non-
brominated N6-benzoyl-5’-O-dimethoxytrityl-2’-deoxyadenosine from 2’-deoxyadenosine.  In 
this method 2’-deoxyadenosine is successively tritylated and then benzoylated in one step 
without isolation of an intermediate.4  Here, we applied this same one-pot procedure to produce 
brominated 21 from 3 (see Scheme 6.1).  Thus, the 5’-OH of 3 was first protected with DMTr by 
treatment with 1.1 equivalents of DMTrCl in anhydrous pyridine while monitoring the reaction 
with TLC.  Next, 3’-OH was transiently protected with TMS,5 and lastly, 6-NH2 was protected 
with Bz. The reaction was kept anhydrous, and 5 equivalents of TMSCl were added to the 
reaction mixture to silylate 3’-OH.  This was followed by addition of 5 equivalents of BzCl to 
the same mixture to dibenzoylate 6-NH2.  Successive stirring with 2 M NH4OH for 1 h cleaved 
both the trimethylsilyl group at 3’-OH and one of the benzoyl groups at 6-NH2 to give 21 after 
chromatography (42% unoptimized yield).   
N
N N
N
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DMTrO
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N
N N
N
NH2
O
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Scheme 6.1.  Reagents and conditions:  (a) i- DMTrCl, 4-DMAP, TEA, Py, rt, 4h; ii- TMSCl, rt, 
1h, iii- BzCl, rt, overnight, iv- NH4OH, MeOH, rt, 2h. 
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To incorporate an AQ-dA conjugate into DNA, 21 could be joined to AQ via palladium 
catalyzed cross-coupling and then treated with 2-cyanoethyl N,N-diisopropylchlorophosphor-
amidite to produce the 3’-β-cyanoethylphosphoramidite of the AQ-dA or 21 itself could be 
turned into a phosphoramidite.  In the latter case ethynyl-AQ could be Pd cross-coupled to 8-
bromo-dA on the DNA strand during solid-phase synthesis, but prior to detritylation.6,7  To date 
neither of these reactions has been run on 21, so we do not know their efficiencies. 
6.2.1.2. 5’-O-(4,4’-Dimethoxytrityl)-8-[(anthraquinone-2-yl)ethynyl]-2’-deoxyadenosine (22) 
In case benzoylation of 6-NH2 leads to problems during alkynylation of 21, it is also 
possible to form 22 first (see Scheme 6.2) via palladium catalyzed cross-coupling between 5’-O-
(4,4-dimethoxytrityl)-8-bromo-2’-deoxyadenosine (4) and 2-ethynylanthraquinone (6) 
(Syntheses of 4 and 6 are shown in Chapter 2).  Alkynylation of 4 was achieved by stirring the 
reactants for 6 h with catalytic amounts of Pd(Ph3P)4 and CuI, and 2 equivalents of TEA (as 
base) in DMF at 65 °C under anhydrous conditions.  Filtration of the reaction mixture over Celite 
removed unwanted insoluble materials.  Evaporation of DMF and silica gel purification afforded 
22 in 85% yield. 
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Scheme 6.2.  Reagents and conditions:  (a) Pd(Ph3P)4, CuI, TEA, DMF, 65 °C, 6 h. 
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Compound 22 is a possible intermediate for the synthesis of the 3’-β-
cyanoethylphosphoramidite of an ethynyl linked AQ-dA conjugate for incorporation into DNA.  
Prior to phosphitylation, 22 would have to be protected at N6 with benzoyl.  This reaction on 22 
has not been run yet.  Additionally, in Chapter 2, 4 was phosphorylated to produce 5 prior to 
alkynylation via Pd cross-coupling to produce 7.  Thus, Pd catalyzed cross-coupling of either 4 
or 5 proceeds smoothly.  However, the yield of 22 (85%) exceeds the yield of 7 (57%).   
6.2.2.  Optimization of Phosphorylation and Other Reaction Conditions using 2’-
Deoxyadenosine as a Substrate 
Compound 17 in Scheme 6.3 was prepared in 65% yield by tritylation of 2’-
deoxyadenosine using DMTrCl, TEA and 4-DMAP (as a catalyst) in pyridine.4  This relatively 
low yield was due to the conversion of the remainder of 2’-deoxyadenosine to a ditritylated 
product as identified by 1H NMR.  This latter product was separated first during a silica gel 
column using 3% MeOH in CH2Cl2 as eluent; then 17 was collected by increasing the polarity of 
the eluent to 5% MeOH in CH2Cl2.   
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Scheme 6.3.  Compounds used to optimize reaction conditions.  Reagents and conditions:  (a) 
DMTrCl, 4-DMAP, TEA, Py, rt, 2 h; (b) i- (BnO)2PN(iPr)2, Me-tetrazol, THF, rt, 1 h; ii- m-
CPBA in CH2Cl2, -78 °C, 15 min; (c) 30% DCA in CH2Cl2, rt, 30 min; (d) DABCO, 1,4-
dioxane, reflux, 2 h. 
5’-O-Dimethoxytrityl-2’-deoxyadenosine 3’-dibenzyl phosphate (18) was prepared from 
17 using the earlier described phosphoramidite chemistry.  Similar phosphitylation reactions in 
the literature used a range of equivalents of the phosphoramidite reagent (2.5-1.1).8-10  To test 
reacting the 3’-OH of 17 while avoiding N6-phosphorylation and to optimize the yield of 18, the 
reaction was run three times in THF using 2.5, 1.5, and 1.1 equivalents of (BnO)2PN(iPr)2 (see 
Table 6.1).  The amount of Me-tetrazol was equimolar to (BnO)2PN(iPr)2, and (BnO)2PN(iPr)2 
was added dropwise at 0 °C to increase the reaction selectivity; finally, the reaction mixture was 
slowly warmed to room temperature as stirred for 1 h.  Reacting 2.5 equivalents of the reagent 
led to complete consumption of 17 and showed a single spot on TLC.  Later, 1H NMR of the 
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final oxidized phosphorylation products showed that this single TLC spot was actually due to 
phosphorylation at 3’-OH as well as at 6-NH2.  Subsequent treatment with m-CPBA at -78 °C for 
1 h produced 2 spots, one from each phosphorylation product.  Table 6.1 shows that the yield of 
18 in this case was 72% after chromatographic purification.  Reacting 1.5 equivalents of 
(BnO)2PN(iPr)2 with 17 using the same procedures produced 18 in 89% yield after 
chromatographic separation also, less N6-phosphorylated product was produced than with 2.5 
equivalents of reagent.  Decreasing the equivalents of (BnO)2PN(iPr)2 to 1.1, however, dropped 
the yield of 18 to about 60% (as observed via TLC before oxidation) and 40% of 17 remained 
unreacted. 
Table 6.1.  Yield of 18 Versus the Number of Equivalents of (BnO)2PN(iPr)2. 
Entry No. of equiv. %Yield 
1 2.5 72a 
2 1.5 89a 
3 1.1 60b 
a Yield after separation of final oxidized product 18. 
b Yield estimated based on TLC spot size before the m-CBPA oxidation step. 
As shown in Scheme 6.3, detritylation of 18 produced 2’-deoxyadenosine 3’-dibenzyl 
phosphate (19).  This was accomplished by treatment of 18 with 40 equivalents of 30% DCA in 
dichloromethane at room temperature for 30 min.  Lower concentrations or equivalents of the 
acid caused incomplete detritylation.  This result was surprising as DMTr was readily cleaved at 
5’-O in less than 1 min either using 3% DCA,11 or 1% TFA12 during solid-phase 
oligodeoxynucleotide synthesis.  Here use of TFA was avoided, because it might lead to 
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depurination.11  After the treatment of 18 with DCA, the acidic reaction mixture was neutralized 
with TEA or saturated aqueous sodium bicarbonate, and 19 was extracted from the aqueous 
phase with dichloromethane.  Purification of the crude product by silica gel chromatography 
gave 19 in 85% yield.  This result showed that dibenzyl protection of the phosphate group was 
stable under DMTr-deprotection conditions; additionally, no depurination occurred for either the 
nucleotides 18 or 19.   
Monodeprotection of the dibenzyl phosphate 19 formed 20 in 80% yield.  Deprotection of 
benzyl groups by hydrogenolysis could not be used in this work, because it would reduce the 
ethynyl linker in the synthesis of nucleotide 1.  Therefore, we tested two other literature 
procedures for deprotection of dibenzyl phosphates.  The first procedure used 5 equivalents of 
TMSBr in anhydrous CH2Cl2, with quenching of the reaction under slightly basic conditions 
using a 1 M aqueous solution of ammonium bicarbonate to yield a dideprotected product.13  
However, in our reaction with 19 a dark color was produced after evaporation of the reaction 
solvent, and 1H NMR showed a mixture of unidentified products.  These products could have 
been due to side reactions with HBr generated by silylation of 5’-OH, as a red color developed 
immediately upon addition of TMSBr.  A second reported procedure used stoichiometric 
amounts of DABCO in refluxing toluene for 2 h to monodeprotect benzylphosphonic acid 
dibenzyl ester.14  In an attempt to cleave both benzyl groups, 19 was treated with 2.2 equivalents 
of DABCO in refluxing 1,4-dioxane/toluene (1:1).  1,4-Dioxane was used because 19 was not 
sufficiently soluble in toluene.  1H NMR for the crude product showed that only 
monodeprotection of 19 occurred to give 20 as an anion with Bn-quaternarized DABCO as the 
counter cation.  A remaining trace amount of 19 was removed by dissolving the crude product in 
water and washing it with dichloromethane.  This did not remove, however, the excess DABCO.  
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No side products were observed.  Thus, the phosphate group of 20 was shown to be stable to 
reflux at 101-112 °C.  Since 20 was water soluble nucleotide, we applied the reaction steps 
summarized in Scheme 6.3 to the synthesis of the AQ-dA nucleotide conjugate 1 (in Chapter 2).  
The conjugate 1 was also water soluble.  
6.3.  Experimental 
6.3.1.  Materials and General Synthetic Considerations 
2’-Deoxyadenosine monohydrate was purchased from TCI America as white a powder.  
All reagents used were purchased from Aldrich, except DMTrCl which was obtained from Alfa-
Aesar.  2-Ethynylanthraquinone (6) was synthesized as described in Chapter 2.  Anhydrous DMF 
was purchased from Aldrich and stored in a Vacuum Atmospheres M040-2 glove-box that was 
pressurized with nitrogen gas from a liquid nitrogen tank.  All starting materials for anhydrous 
reactions were dried prior to use on a vacuum line (2 × 10-5 torr) for at least 12 h.  Two to three 
co-evaporation cycles were also used for drying compounds as indicated below.  THF was dried 
with benzophenone /Na0 and stored over activated molecular sieves in the glove-box.  Water was 
deionized by a Millipore (Milli-Q Plus) ultrapure water system.  All manipulations of Pd(Ph3P)4, 
and (BnO)2PN(iPr)2 were performed in the glove-box.  Most of the reactions were monitored 
with glass-backed TLC Plates precoated with silica gel 60 F254 (EMD Chemicals).  TLC was run 
using 5-7% MeOH in CH2Cl2 as the eluent.  HPLC grade solvents were used for 
chromatographic purifications.  Flash column chromatography was carried out on either a 
Biotage Flash-40™ system using prepackaged KP-Sil™ cartridges, or on Whatman™ flash silica 
(60Å pore, 230 – 400 mesh) that was packed in glass columns and pressurized with nitrogen.  
NMR spectra were obtained on either a Varian Unity +300 NMR spectrometer or on a Brucker 
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Avance 400 MHz NMR spectrometer.  Low-resolution (LR) electron impact (EI) MS were 
recorded in positive ion mode on a Shimadzu 5050A MSD single quadrupole spectrometer with 
one amu resolution. 
6.3.2.  5’-O-(4,4’-Dimethoxytrityl)-N6-benzoyl-8-bromodeoxyadenosine (21) 
Compound 3 (140 mg, 0.42 mmol) was dried three times by co-evaporation with 
anhydrous pyridine, and then suspended in anhydrous pyridine.  To this suspension was added 4-
DMAP (7.0 mg, 0.055 mmol, 0.12 equiv) in the glove box.  Outside the glove box, DMTrCl (156 
mg, 0.460 mmol, 1.1 equiv) was dissolved in pyridine and transferred dropwise using cannula to 
the reaction mixture with 3 under nitrogen at 0 °C (ice-water bath).  After the reaction mixture 
was stirred under a nitrogen atmosphere for 4 h, it was cooled to -4 °C using an ice-water-salt 
bath, and TMSCl (0.27 mL, 2.1 mmol, 5 equiv) was added dropwise (over 15 min) using a 
syringe.  This reaction mixture was then stirred at room temperature for 1 h under nitrogen.  
Next, it was cooled to 0 °C using an ice-water bath, and benzoyl chloride (0.25 mL, 2.1 mmol, 
5.0 equiv) was added dropwise (over 15 min) using a syringe.  Finally, the reaction mixture was 
stirred at room temperature overnight under nitrogen; at this point a white precipitate had 
formed.  The reaction solvent was evaporated under reduced pressure, and the yellow residue 
obtained was dissolved in a mixture of MeOH (24 mL) and aqueous ammonia (2.73 mL) by 
stirring at room temperature for 45 min.  The resulting solution was stirred for an additional 30 
min, and then the solvent was evaporated.  The residue was dissolved in EtOAc (25 mL) and 
water (10 mL).  The EtOAc layer was collected and washed twice with water, dried over 
anhydrous MgSO4, and evaporated to dryness.  A silica gel column eluted with EtOAc/CH2Cl2 
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(0:100-60:40) afforded 21 as a pale yellow foam (130 mg, 42% yield).  1H and 13C NMR spectra 
for 21 were identical to ones published in the literature.2 
6.3.3.  8-[(Anthraquinone-2-yl)ethynyl]- 5’-O-(4,4’-dimethoxytrityl)-2’-deoxyadenosine (22) 
To 4 (0.50 g, 0.79 mmol) was added in the glove-box Pd(Ph3P)4 (46 mg, 0.040 mmol, 
0.050 equiv), CuI (16 mg, 0.080 mmol, 0.10 equiv), TEA (220 µL, 1.58 mmol, 2.00 equiv), 
compound 6 (221 mg, 0.950 mmol, 1.20 equiv) and anhydrous DMF (7 mL).  The mixture was 
removed from the glove-box and stirred under a nitrogen atmosphere for 6 h at 65 °C in an oil 
bath; then DMF was removed under reduced pressure.  The residue was dissolved in 
dichloromethane and filtered over Celite to remove insoluble materials.  After evaporation the 
crude product was applied to a silica gel column (16×3 cm) that had been pre-equilibrated with 
1% TEA in CHCl3.  MeOH/CHCl3 (0:100-3:97) was used as the eluting system to afford 22 (521 
mg, 85%) as a yellow foam after evaporation of the eluting solvent.  1H NMR (300 MHz, 
CDCl3):  δ (ppm) 2.46-2.57 (1H, m, H2’α), 3.49 (2H, d, J = 5.4, H5’α and H5’β), 3.52-3.52 (1H, m, 
H2’β), 3.71 (6H, d, J = 1.2, OCH3 (DMTr)), 4.26-4.36 (1H, m, H4’), 4.89-4.98 (1H, m, H3’), 6.63 
(1H, t, J = 6.9 Hz, H1’), 6.74 [4H, dd, J = 3.6 and 9 Hz, OPh-meta (DMT)], 7.05 (2H, br s, NH2), 
7.10-7.31 [7H, m, OPh-ortho (DMTr, 4H) and Ph-meta and para (DMTr, 3H)], 7.37-7.61 [5H, 
m, Ph-ortho (DMTr, 2H), H3 (AQ), H6 (AQ) and H7 (AQ)], 7.85 [1H, s, H2 (dA)], 7.96-8.03 [2H, 
m, H5 (AQ) and H8 (AQ)], 8.17 [1H, d, J = 7.8 Hz, H4 (AQ)] and 8.46 [1H, s, H1 (AQ)]. 
6.3.4.  5’-O-Dimethoxytrityl-2’-deoxyadenosine 3’-Dibenzyl Phosphate (18) 
To 17 (0.10 g, 0.18 mmol), previously dried 2 times by co-evaporation with anhydrous 
THF, was added 5-Me-tetrazole (23 mg, 0.27 mmol, 1.5 equiv) and anhydrous THF (3 mL) in 
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the glove-box.  The mixture was removed from the glove-box and cooled to 0 °C using an ice-
water bath; (BnO)2PN(iPr)2 (0.090 mL, 0.27 mmol, 1.5 equiv) was added dropwise under a 
nitrogen atmosphere with a syringe.  The reaction mixture was stirred under a nitrogen 
atmosphere for 10 minutes at 0 °C; then it was warmed to room temperature, and the reaction 
progress was monitored by TLC.  A white precipitate began to form after 20 min, and TLC 
showed complete consumption of 17 after a total reaction time of 1 h.  The mixture was cooled 
to -78 °C using a dry ice-acetone bath, and a solution of m-CPBA (70 mg) in CH2Cl2 (3 mL) was 
added gradually to the chilled reaction mixture.  After 15 minutes of stirring at -78 °C, the 
mixture became homogeneous.  The reaction mixture was warmed to room temperature and 
stirred for an additional 30 min; then the reaction was quenched by adding a saturated aqueous 
solution of NaHCO3.  More CH2Cl2 (10 mL) and water (5 mL) were added; the organic layer was 
separated, washed with water, dried with anhydrous MgSO4, and the solvent was evaporated.  
The syrup obtained was purified using silica gel chromatography on a column pre-equilibrated 
with 1% TEA in CH2Cl2 and eluted with MeOH/CH2Cl2 (0:100-2:98).  Evaporation of the 
eluting solvent afforded 18 as a white foam (131 mg, 89% yield).  1H NMR (300 MHz, CDCl3):  
δ (ppm) 2.59 (1H, dd, J = 5.7 and 13.8 Hz, H2’α), 2.86-2.95 (1H, m, H2’β), 3.27-3.38 (2H, m, 
H5’α, H5’β), 3.75 [H, s, OCH3 (DMTr)], 4.26-4.30  (1H, m, H4’), 5.01-5.06 [4H, m, CH2 (Bn)], 
5.16-5.19 (1H, m, H3’), 6.08 (2H, br s, NH2),  6.33 (1H, dd, J = 5.7 and 8.4 Hz, H1’), 6.76 [4H, d, 
J = 9 Hz, OPh-meta (DMTr)], 7.18-7.38 [19H, m, OPh-ortho (DMTr, 4H), Ph (DMTr, 5H), and 
Ph (Bn, 10H)], 7.87 [1H, s, H8 (dA)] and 8.24 [1H, s, H2 (dA)].  31P NMR (121 MHz, CDCl3):  δ 
(ppm) –0.72. 
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6.3.5.   2’-Doxyadenosine 3’-Dibenzyl Phosphate (19) 
Compound 18 (65 mg, 0.080 mmol) was dissolved in a 30% DCA in CH2Cl2 mixture (1.5 
mL), and the resulting red solution was stirred at room temperature for 30 min.  The reaction was 
quenched by adding TEA until the red color of the DMTr cation disappeared.  More CH2Cl2 (10 
mL) and water (5 mL) were added; then the organic layer was separated, washed with saturated 
aqueous solution of NaHCO3 and then with water, dried with anhydrous MgSO4, and evaporated 
to dryness.  The syrup obtained was purified using a silica gel column for which MeOH/CH2Cl2 
(0:100-3:97) was used as the eluting system.  Evaporation of the eluting solvent afforded 19 as a 
white foam (35 mg, 86% yield).  1H NMR (300 MHz, CDCl3):  δ (ppm) 2.46 (1H, dd, J = 5.1 and 
13.8 Hz, H2’α), 2.97-3.06 (1H, m, H2’β), 3.56-3.65 (1H, m, H5’α) 3.83 (1H, d, J = 12.6 Hz, H5’β), 
4.25 (1H, s, H4’), 5.02-5.19 [5H, m, CH2 (Bn), and H3’], 6.07 (1H, dd, J = 5.1 and 9.9 Hz, H1’), 
6.23 (2H, br s, NH2), 6.62 (1H, br s, OH5’), 7.38 [10H, s, Ph (Bn)], 7.75 [1H, s, H8 (dA)], and 
8.26 [1H, s, H2 (dA)].  31P NMR (121 MHz, CDCl3):  δ (ppm) –1.38.  
6.3.6.   2’-Deoxyadenosine 3’-Benzyl Phosphate Benzyl-quaternarized DABCO Salt (20) 
To 19 (61 mg, 0.12 mmol) was added DABCO (31 mg, 0.27 mmol, 2.3 equiv) and 
anhydrous toluene/1,4-dioxane (1:1, 10 mL).  The mixture was refluxed for 3 h under a nitrogen 
atmosphere.  The solvent was evaporated, and the product was dissolved in water and washed 
once with CH2Cl2.  Water was evaporated to afford 20 (60 mg, 80%) as a colorless solid.  1H 
NMR (300 MHz, D2O):  δ (ppm) 2.18-2.44 (2H, m, H2’α and H2’β), 2.8-2.91 [6H, m, CH2N 
(DABCO)], 3.02-3.15 [6H, m, CH2N+ (DABCO)], 3.38-3.53 (2H, m, H5’α and H5’β), 3.92-4.01 
(1H, m, H4’), 4.09 [2H, s, DABCO-CH2 (Bn)], 4.52-4.62 (1H, m, H3’), 4.7 [2H, d, J = 8.1, PO4-
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CH2 (Bn)], 6.07 (1H, dd, J = 6 and 7.8 Hz, H1’), 6.95-7.19 [10H, m, Ph (Bn)], 7.73 [1H, s, H8 
(dA)], and 7.82 [1H, s, H2 (dA)].  31P NMR (121 MHz, CDCl3):  δ (ppm) –0.34.  
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APPENDIX A:  1H, 13C, 32P and 19F NMR spectra 
NMR spectra for compounds in Chapter 2: 
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31P NMR (121 MHz, CDCl3) 
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NMR spectra for compounds in Chapter 3: 
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1H NMR (400 MHz, DMSO-d6) 
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NMR spectra for compounds in Chapter 4: 
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1H NMR (300 MHz, DMSO-d6 + D2O) 
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MR spectra for compounds in Chapter 5: 
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1H NMR (300 MHz, DMSO-d6) 
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MR spectra for compounds in Chapter 6: 
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APPENDIX B:  UV-vis spectroscopic measurements 
 
UV-vis and molar absorption spectra: 
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UV-vis absorbance spectra of AQ-E-dU(DMTr) and the major hydrogenation side product of 
AQ-Y-dU(DMTr) (Chapter 4) 
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UV-vis molar absorption spectrum in MeOH 
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Determination of molar absorption using Beer’s law: 
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